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ABSTRACT
ANOTHER STEP IN DIAGNOSTICS CONSULTATION MODEL© ACTUALIZATION:
EXAMINING THE IMPACT OF CONSULTATION WORKFLOW PROCESSES ON
PROVIDERS' CLINICAL DECISION MAKING
By Elizabeth Kenimer Leibach, Ph.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2022
Major Director: Teresa S. Nadder, Ph.D.,
Chair and Associate Professor, Department of Clinical Laboratory Sciences
The medical literature is replete with reports of the impact on quality of communication
errors in health services delivery and the disproportionate contribution of incomplete,
inadequate, and conflicting communications to errors in medical decision making. Diagnostic
information generated by clinical laboratories is foundational to any consideration of efficiency
and effectiveness of health service delivery given that as much as 93% of the objective data in
the clinical record is contributed by the laboratory, much of which impacts clinical decision
making. The purpose of this study was to describe the Diagnostics Consultation Model©
(DCM©), a clinical laboratory (CL) communications portal, designed and proposed to support
clinical decision making (CDM) within interprofessional teams, providers, and institutions.
Specific aims supporting the purpose were to design, develop and validate a workflow prediction
index (the complexity index, CI) that could assign consultation requests for resolution based on
an algorithm comprised of consultation characteristics available at the point of consultation
initiation. The CI is intended to function as the entry point into a workflow process directing
diagnostics consultation requests, first, to the appropriately qualified medical laboratory

xv
professional (MLP) for investigation and then branching into processes for tracking medical
history and clinical information accumulation, documenting resolution logic and detail, verifying
conclusions, and communicating recommendations to all health professionals involved in
consultation CDM and to the health record.
Data to develop and validate the CI were collected during clinical laboratory (CL) daily
activities and describe types of consultation requests brought to the CL, types of health
professionals requesting consultation, steps and health professionals involved in the request
resolution process, and processes involved in results and recommendations reporting. From
analysis of data collected at the point of consultation initiation, diagnostics test cycle phase (preanalytic, analytic, post-analytic) related to the consultation question and medical service of origin
emerged as statistically significant pre-consultation predictors of the MLP practice level best
prepared to resolve particular consultations. A second workflow predictive model was
constructed from data collected after consultation completion. Number of handoffs/logic steps
among health professionals in consultation resolution and medical subject emerged as
statistically significant post-consultation predictors of the MLP practice level best prepared to
resolve particular consultations. Findings from the post-consultation model were then employed
to assess and validate the predictive performance of the CI.
The work has produced methodology for establishing processes to generate data for
streamlining workflow and improving clinical decision support for MLP and other health
professionals throughout the health system. Methodology developed to direct workflow and
document and communicate consultation findings in the CL, including the design of data
collection processes and collection tools, can be adapted to the operations of other clinical
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services. Implementation of these DCM© methods in health professions’ daily practice has the
potential to change health services delivery by the redistribution of care through interprofessional
teams (IPT) coordinated by standardized workflow and communication processes. IPT
membership would be determined by documented clinical developments necessitating changes in
individuals’ care paths and would follow patient/consumers through all care environments and
levels of care. In addition, this care delivery structure provides the capability to follow
individuals’ medical histories longitudinally and, through regular consultations, to address issues
of access, equity, and compliance for the purpose of development of an evidence based,
individualized care plan for every patient/consumer.
INDEX WORDS:

A6 Method for Healthcare Clinical and Quality Research, Artificial
Intelligence, Care Path, Care Pathway, Clinical Decision Making, Clinical
Decision Support, Clinical Research, Critical Thinking, Diagnostics
Algorithms, Diagnostics Consultant, Doctor of Clinical Laboratory
Science (DCLS), Evidence Based Medicine, Evidence Based Practice,
Health Services Research, Health Services Science, Human Factors,
Human Factors Science, Interprofessional Teams, Machine Learning,
Organizational Theory, Patient Centered Care, Quality Improvement,
Quality Theory, Shared Decision Making, System Factors

CHAPTER 1
Introduction
Context of the Problem
Increasingly, the attention of clinical laboratory scientists (CLS) is being directed toward
assessment of quality of clinical laboratory information as correlated with patient outcomes,
clinical decision making, and cost. Gaining increased attention is the concept of “value-based
healthcare” in which information regarding quality and cost of services is made accessible to
consumers, who generate demand for these products and services. Producers compete to increase
the value of services which is defined as quality of patient outcomes relative to the cost
(Castañeda-Méndez, 1996; Cattell et al, 2020; Porter, 2009; Porter, 2010; Porter et al., 2020).
For CLS, the distillate of these developments is that the quality of diagnostics services will be
evaluated, not only on analytic validity, but on value of services, that is, by how well they
support positive health outcomes, the extent to which they favorably influence clinical decisions,
and the benefit/cost ratio of services delivered.
Options for ordering and utilizing diagnostic laboratory testing are burgeoning. In a 2017
World Health Organization Bulletin, it was estimated that more than 40,000 diagnostic,
monitoring, and prognostic laboratory tests, performed in the clinical lab and via point of care
testing, are available to providers to aid in disease diagnosis and treatment (Kasack et al., 2017)
The bulk of the in vitro diagnostics (IVD) market is concentrated in developed countries; the
U.S. market is estimated at $19 billion (Morel et al., 2016). With an increase in genomic testing
1

capability, the changing regulatory environment encouraged by the rapid SARS-CoV-2 response,
incorporation of AI-assisted in vitro diagnostics (IVD) evaluation, and the proliferation of directto-consumer diagnostics, numbers of tests and their costs are increasing daily (Bandeiras, 2020;
Fitzgerald et al., 2021; Iacobucci, 2021; Isbell, 2020). Unfortunately, the services delivery gap
between analytic accuracy (laboratorians’ providing valid, actionable test results) and medical
meaningfulness (providers’ understanding of what to do with them) is growing larger, as well
(Carayon et al., 2006; Carayon et al., 2018). Issues related to re-interpretation of diagnostic
laboratory information produced by older generations of technology considering information
from new, more sensitive and specific generations are increasing, also, because of the rapid
advancement of technology and computerization (Graziadio et al., 2020; Zuckerman, 2021).
Rapid advancements in diagnostics technologies coupled with similar growth in testing options
and choices mandate the development of evidence based testing algorithms linked to the care
paths of the major chronic diseases and health challenges encountered most frequently (Church
& Naugler, 2020; Kratz & Laposata, 2002). There is an equally compelling mandate to provide
these evidence based algorithms to providers and patients for their use in shared clinical decision
making (Carayon et al., 2018; Baker & Waller, 2008; Leibach, 2008b; Leibach, 2011).
In 2015, the National Academy of Medicine (formerly the Institute of Medicine, IOM)
published a landmark report, “Improving Diagnosis in Health Care,” identifying diagnostic error
as a major contributor to the general category of medical error (NAM, 2015). Based on the
seminal work in healthcare quality of Donabedian (1988), the diagnostic process is described as
a series of activities engaging patient/consumers with healthcare throughout their lifetimes
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embedded in a work system comprised of structures, processes, and outcomes. The report
continues with evidence that most patient/consumers will experience at least one diagnostic error
with possible negative outcomes in their lifetimes.
Diagnostic information generated by clinical laboratories is foundational to any
consideration of efficiency and effectiveness of health service delivery given that as much as
93% of the objective data in the clinical record is contributed by the laboratory, much of which
impacts the clinical decision making process (Armstrong & Metlay, 2020; Forsman, 2002;
Hallman, 2011; Zhi et al., 2013). Inefficiencies involving the generation of orders (pre-analytical
processing) and utilization of laboratory data (post-analytical processing) increase the possibility
of inappropriate resource utilization. An estimated 50-60% of all laboratory orders may be
inappropriate (Bissell, 2000); and most laboratory errors (68-87%), including inappropriate
orders, have been shown to be non-analytic (Bonini et al., 2002). In fact, the ordering of
diagnostic tests is rarely based on evidence of comparative effectiveness over the entire cycle of
care (Christenson et al, 2011; Glaser, 2020; NAM, 2015; Porter, 2009).
The medical literature is replete with reports of the impact on quality of communication
errors in health services delivery (Desmedt et al., 2020; NAM, 2001; NAM 2015). Also widely
reported is the disproportionate contribution of incomplete, inadequate, and conflicting
communications to errors in medical decision making (Bate et al., 2012; Blazin, 2020; Cheloff &
Huang, 2021); medical errors are not just the result of miscommunications by individual
practitioners but are also precipitated by systems, processes, and conditions that have failed
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(Abraham et al., 2021a; Applebaum et al., 2021; Blazin et al., 2020; Classes et al., 2020;
Krasowski et al., 2015; NAM, 2001).
To address the outcomes of these communication failures, standardized communication
tools to be used in the handoff/handover of patient/consumer information among healthcare
providers during transitions of care have been designed, implemented, and evaluated (Desmedt et
al, 2020). Most of these tools are structured to be used during care transitions involving unit to
unit transfers, e.g., surgery to ICU, anesthesia to surgery; within unit transfers, e.g., nursing shift
report, within radiology communications; or during inpatient rounding (Blazin et al, 2020;
Brown et al., 2020; Burns et al., 2021; Cao et al., 2018). Reports of the use of standardized tools
for care transitions between different institutions are less common even though the probability of
breakdowns in patient care communications is acknowledged to increase without in person
exchanges (Helmig et al., 2020).
Universal implementation of the electronic health record (EHR) has also been implicated
in healthcare communications failures (Palojoki et al., 2020). Lapses in clinical reasoning
leading to inadequate clinical decision making (CDM) have been attributed to EHR structure as
primarily transactional data repositories, i.e., EHRs, simultaneously provide a glut and dearth of
information (Glaser, 2020). EHRs lack meaningful organization schemes, e.g., a library of care
plans, and synthetic and cumulative sections for interprofessional team synopses to guide CDM
throughout the care continuum (Arsoniadis, 2020). Difficulties involved in following complex
treatment plans and formulating evidence based priorities and next steps have led to patientrelated safety incidents and practitioner burnout (Adler-Milstein et al., 2020; Classes et al., 2020;
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Palojoki et al., 2020; Williams, 2021). As a result of these system design flaws, application
program interfaces (APIs) connecting EHR frameworks to middleware providing expanded CDS
capability are being envisioned and developed (Casey et al., 2020; Caudell-Feagen & Thompson,
2021; Krasowski et al., 2015; Shanbhag & Bender, 2020; Stendhl et al., 2021).
Though the need for more closely controlled communications among healthcare
providers is being addressed in these various ways, a brief review of the designs of the
communication tools in use reveals gaps related to electronic health record (EHR) integration of
summaries of care activities from handoff communications, which can be considered significant
steps in patient/consumers’ care paths (Casey et al., 2020; Glaser, 2020; Palojoki et al., 2020). A
contributor to the integration gap in continuity of care is the lack of an evidence based method
for determining interprofessional team (IPT) member roles and functions. A recent international
review of the utility and quality of IPT rounding practices in intensive care units summarizes the
wide variation in IPT composition and lack of evidence related to impact of IPT practices on
consumer/patient clinical outcomes (Amaral et al., 2020). In North America, according to
Amaral et al. (2020), both handoff (sending) and receiving physicians and nurses are consistently
included as IPT, clinical pharmacists are common IPT members, and other health professions
(HP) are included ad hoc according to the identified clinical problem. However, medical
laboratory professions (MLP) were not reported as either designated or ad hoc IPT members.
Statement of the Problem
Diagnostics information should be delivered by specialized laboratory professionals in
the context of best evidence and risk assessment tailored to patient/consumers’ medical
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circumstances. Communication of diagnostics information by a specialized team would expand
the MLP consultative role and significantly facilitate, substantiate, and improve the shared
decision making process among healthcare professionals and patient/consumers participating in
IPT health services (Bate et al., 2012; Booth et al, 2019; Church & Naugler, 2020; Laposata &
Cohen, 2016; Theparee et al., 2018; Stendhl et al., 2021). Therefore, the emerging role for MLP,
specifically doctoral clinical laboratory scientists, is to design and conduct clinical research to
generate evidence for development of testing algorithms positively impacting patient safety and
health outcomes as part of laboratory and institutional quality improvement programs (Burns et
al, 2019; Cheloff & Huang, 2021; Christenson et al, 2011; Church & Naugler, 2019; Crews et al.,
2020; Laposata & Cohen, 2016; Leibach, 2008a; Leibach, 2008b; Porter, 2010; Theparee et al.,
2018; Stendhl et al., 2021). The information thus generated would be tailored specifically to the
needs of providers and patient/consumers and provided as best evidence for evaluation of
treatment and other care options (Bate et al., 2012; Rashidi et al., 2019).
Study Purpose
The overarching goal of this work was to describe the Diagnostics Consultation Model©
(DCM©), a clinical laboratory (CL) communications portal, designed and proposed to support
clinical decision making (CDM) within interprofessional teams, providers, and institutions. The
study was founded on a retrospective review of records of medical laboratory professionals’
(MLP) consultations with other healthcare providers and will address characterization of these
consultation elements occurring in various clinical settings. This information was used to design
methods describing workflow processes through each consultation scenario based on evidence
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extracted from consultation characterization. Also, a typology of practice characteristics
attributable to each MLP practice level involved in consultation resolution was developed from
the analyses of consultation characteristics. These findings and projections based on consultation
analyses and associated MLP practice characteristics suggested an approach to direction of
consultation requests to appropriately educated and experienced MLP practice levels and to
communication of diagnostic findings to appropriate IPT members in appropriate documentation
formats (Carayon et al., 2018). This approach to healthcare communications, in turn, informs
evidence based decisions regarding clinical laboratory staffing, clinical quality improvement
studies, and MLP curriculum development.
Consultation characterization occurred in the following two steps that summarize the
specific study aims, research questions, and hypotheses: development of the complexity index
(CI) and subsequent evaluation of its predictive performance. First a prediction model will be
developed from consultation case data that was used to predict consultation workflow to
appropriately educated and experienced MLP to resolve consultation questions the most safely,
thoroughly, and expeditiously (Shipe et al., 2019). The prediction model, the complexity index,
CI, was developed from consultation characteristics available at the time of consultation
initiation. Then MLP practice levels were associated with these consultation characteristics to
define requisite education, CT skills, and experience required for consultation resolution among
the practice levels. These MLP practice level descriptions, defining a typology of increasing
scope of knowledge and professional responsibility, served to validate the predictive
performance of the complexity index. The evidence based methods thus developed were applied
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to describe a communications portal for clinical laboratory workflow direction and staffing
assignments with parallel development of position responsibilities and training curriculum, as
well.
Study Research Questions
Using data from consultation events occurring in the clinical laboratory, consultations
were characterized by MLP practice level resolving the consultation. Three MLP practice levels
have been associated with handoffs/logic steps and consultation final disposition: (a) MLP Level
1, MLT/MLS; (b) MLP Level 2, MLS Specialist/Manager; and (c) MLP Level 3,
DCLS/Ph.D/MD. A prediction model, the complexity index (CI), was developed, using
characteristics (variables) available at the point of consultation initiation, to be utilized
prospectively to direct workflow to appropriately educated and experienced MLP at the point of
consultation initiation. Consultation characteristics (variables) available after consultation
completion were used to evaluate the predictive performance of the CI.
Research question 1. The first research question for the study was: Can the MLP
practice level resolving consultations be predicted by an index derived from the variables test
cycle phase and medical service/hospital location? Data from the pilot study indicated
complexity varies with four descriptors. The first descriptor is test cycle phase: pre-analytic (test
selection, order placement, specimen collection), analytic (obtain results), and post-analytic
(results interpretation, analytic test sequencing). The second descriptor is medical
service/hospital location. Both test cycle phase and medical service/hospital location are
variables available at the point of consultation initiation and were tested for their contributions to
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the predictive performance of the complexity index, CI. The third descriptor is handoffs/logic
steps; the fourth descriptor is medical subject. These latter two variables are available only after
consultation completion and were used to evaluate the predictive performance of the CI.
Research question 2. The second research question for the study was: Can MLP practice
levels resolving consultations be predicted by number of handoffs/logic steps and medical
subject associated with consultation cases? Preliminary findings suggested that an increasing
number of handoffs/logic steps involved in consultation resolution and the medical subject
involved related to increases in position responsibilities, i.e., education and scope of practice,
from MLP level 1 through MLP Level 3. Analyses of associations among MLP practice levels
and these variables available only after consultation completion predicted similar MLP practice
levels resolving consultation as the CI. Thus, these retrospective associations were used to
evaluate the prospective predictive performance of the CI.

9

LIST OF DEFINITIONS
Artificial Intelligence
The capacity of machines to imitate intelligent human behavior (Rashidi et al., 2019).
Care Path/Care Pathway
A care pathway is a complex intervention for the mutual decision making and
organization of care processes for a well-defined group of patients during a well-defined
period. (Schrijvers, van Hoorn, & Huiskes, 2012)
Clinical Decision Making
Clinical decision making (including prescribing decisions) involves the judicious use of
evidence, considering both clinical expertise and the needs and wishes of individual patients.
(Sackett et al., 1996)
Clinical Decision Support
Clinical decision support (CDS) provides clinicians, staff, patients or other individuals
with knowledge and person-specific information, intelligently filtered or presented at appropriate
times, to enhance health and health care. CDS encompasses a variety of tools to enhance
decision-making in the clinical workflow. These tools include computerized alerts and reminders
to care providers and patients; clinical guidelines; condition-specific order sets; focused patient
data reports and summaries; documentation templates; diagnostic support, and contextually
relevant reference information, among other tools. (HealthIT.gov)
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Complexity Index
The complexity index (CI) is a prediction model developed to direct diagnostics
consultation workflow to MLP practitioner levels with requisite competencies, i.e., education,
CT skills, and experience, to resolve consultation questions the most safely, thoroughly, and
expeditiously. “The goal of prediction models is to provide patient risk stratification to support
tailored clinical decision making with the hope of improving patient outcomes and quality of
care” (Shipe et al., 2018). The complexity index (CI) is developed from consultation
characteristics available at the time of consultation initiation.
Consultation Complexity
Consultation Complexity is defined as and measured by MLP practitioner CT
competencies and position responsibilities as well as number of health professions, number of
medical services, and number of data systems involved in consultation resolution.
Critical Thinking (CT) Operationalized Definition
“Critical thinking is a metaprocess that facilitates learning by interlinking the more basic
processes associated with the different learning orientations: behaviorist, cognitivist, humanist,
and situated/contextual learning.” (Kenimer, 1999; Kenimer 2002)
Critical Thinking (CT) Theoretical Definition
“Critical thinking is the intellectually disciplined process of actively and skillfully
conceptualizing, applying, analyzing, synthesizing, or evaluating information gathered
from, or generated by, observation, experience, reflection, reasoning, or communication, as
a guide to belief and action.” (Paul, 1991, p. 4).
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Critical Thinking (CT)-Associated Factors
Critical thinking (CT)-Associated Factors are CT skills, behaviors, competencies, and
environmental (contextual, situated) elements associated with the CT metaprocess.
Critical Thinking (CT) Behaviors
Critical thinking behaviors are observable events following from the critical thinking
metaprocess (operationalized, applied, competency-related CT definition). (Kenimer, 1999;
Kenimer, 2002)
Critical Thinking (CT) Practice Competencies
Critical Thinking (CT) Practice Competencies are observable healthcare disciplinerelated practices associated with the CT metaprocess (operationalized, applied CT definition).
(Kenimer, 1999; Kenimer, 2002)
Critical Thinking (CT) Practice Domain
Critical Thinking (CT) Practice Domain describes the learning domain associated with
observable healthcare discipline-related competencies as defined in the CT metaprocess
(operationalized, applied CT definition). (Kenimer, 1999; Kenimer, 2002)
Critical Thinking (CT) Skills
CT Skills are closely linked to Critical Thinking (CT) Behaviors as observable events
following from the CT metaprocess; the terms may be used interchangeably in this study.
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Diagnostics Care Pathway
A standardized, consensus algorithm of the best way to manage diagnostics related to an
individual patient’s condition over time. The phases of the pathway are screening, diagnosis,
monitoring, and prognosis (Kosack et al., 2017).
Diagnostics Consultation Model© (DCM©)
The Diagnostics Consultation Model© (DCM©), derived from Donabedian’s quality
framework, is structured to document the correlation of clinical laboratory information to health
outcomes for the purpose of evaluating quality of services and increasing the value (defined as
quality divided by cost) of diagnostics information for all consumers, i.e., providers and the
public (patient/consumers) at large.
Diagnostics Consultation Model© Settings
The four clinical settings of consultation, i.e., Community Intervention (CI), Diagnostics
Management Intervention (DMI), Patient Care Intervention (PCI), and Utilization Review
Intervention (URI), within the DCM©.
Diagnostics Algorithms
Diagnostics algorithms are included in a broader field under medical informatics and
medical decision making. Diagnostics algorithms guide diagnostics test selection within the care
path, i.e., screening, diagnosis, monitoring, prognosis, and automated/digital control of
diagnostics instrumentation and other medical equipment. (Adapted from en.wikipedia.org/)
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Diagnostics Consultants
Credentialed health professionals specializing in diagnostics clinical decision support
guided by the validated evidence base in diagnostics literature and algorithms.
Doctor of Clinical Laboratory Science (DCLS)
The DCLS is the clinical laboratory science practice doctorate, based in healthcare
quality theory and clinical research, developed to implement principles and competencies of CLS
EBP to evaluate and optimize diagnostics services delivery.
Evidence/Best Evidence
Evidence/best evidence includes findings and recommendations synthesized from
randomized controlled trials and other scientific methods such as descriptive and qualitative
research as well as use of validated information from case reports, scientific principles, and
expert opinion. (adapted from NCBI)
Evidence Based Medicine
“The conscientious, explicit, and judicious use of current best evidence in making
decisions about the care of individual patients.” (Sackett et al., 1996)
Evidence Based Practice (EBP) in Clinical Laboratory Science
“The conscientious, explicit, and judicious use of the best evidence from CLS in making
decisions about the care of individual patients.” (Leibach & Russell, 2010)
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Handoffs/Logic Steps
The total number of information handovers (handoffs) among health professions and
clinical question-guided information searches (logic steps) required to investigate a consultation
and produce an evidence based consultation summary resolution.
Health Services Science
The foundational theories and practices describing value-based healthcare comprised of
evidence based practice, quality improvement, and individualized patient/consumer care. DCM©
methodology, employed as a systems approach to evidence based practice, quality improvement,
and individualized patient/consumer care (i.e., health services science), provides the foundation
for continuous optimization of health services delivery to address the needs of individuals,
populations, and health systems throughout the continuum of care.
Human Factors/Human Factors Science
The interrelationship between humans, the tools and equipment they use in the
workplace, and the environment in which they work. (WHO)
Machine Learning
An application of artificial intelligence that allows computer systems to learn iteratively
from experience without explicit programming (Rashid et al., 2019).
Safety I
The traditional healthcare problem solving approach that addresses process failures
leading to errors or unsafe care (Smith & Valenta, 2018).
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Safety II
Systems thinking applied to healthcare problem solving in which errors and adverse
events are investigated as aberrations in systems rather than consequences of personal and/or
team fallibility (Mannion & Braithwaite, 2017).
System Factors
Environmental, contextual elements embedded within healthcare systems, i.e.,
interprofessional team communications protocols, database structures, and number of medical
services, impacting the complexity of consultation services within the care continuum.
Validity, External
The extent to which results from a study can be applied (generalized) to other situations,
groups or events. External validity, i.e., reliability or generalizability, can be one of two types:
(1) generalizability to different populations from a study sample (population validity) or (2)
generalizability to different, natural (real world) settings from a population sample (ecological
validity). (Scribbr)
Validity, Internal
The degree of confidence that the causal relationship being tested is trustworthy and not
influenced by other factors or variables. Internal validity is defined as the extent to which the
observed results represent truth in the population being studied and, thus, are not due to
methodological errors. (adapted from NCBI)
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CHAPTER 2
Literature Review
To address gaps in services delivery for the clinical laboratory, healthcare diagnostics
services can be evaluated through a quality framework that correlates CL structures (inputs),
operations (activities), and information (diagnostic and health outcomes) (Crews et al., 2020;
Donabedian, 1988; Carayon et al., 2018). First, significant health services delivery issues can be
identified and characterized through continuous quality improvement systems (Crews et al.,
2020). Next, evidence based protocols and processes are implemented to address these quality
gaps (Delahanty et al., 2019). Finally, outcomes, both clinical and operational, are evaluated for
their value as assessed by measures of clinical effectiveness and cost-efficiency (Crews et al.,
2020; Leibach, 2008a; Leibach, 2008b; Porter, 2010).
Justification for expansion of quality theory in this study was advanced from current
thinking in quality in the industry. Literature was accessed through key word searches in
PubMed, Biomed Central, and Google Scholar along with review of publications of professional
organizations related to quality measurement (e.g., AcademyHealth, ASQ, Clinical Laboratory
Standards Institute) and quality assessment (e.g., AABB, American Association for Clinical
Chemistry, American Society for Clinical Laboratory Science, American Society for
Microbiology).
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Elements of CLS evidence based consultation practice were defined through review of
literature in quality, critical thinking, knowledge transfer, decision science, healthcare
communications, and health services research domains. The theoretical basis of the structure and
implementation methods of workflow processes and communications within the DCM©
integrates critical thinking; knowledge translation; decision, implementation, and safety science;
and health services research theory with evidence based practice implementation methods all
under the Donabedian quality frame.
Critical Thinking
Critical thinking theory is employed in the more qualitative aspects of characterizing
consultations, e.g., identifying actionable questions brought to the diagnostics consultant,
evaluating diagnostics information through the lens of patient/consumers’ medical and testing
history, and identifying recommendations based on analysis of medical information and evidence
based guidelines from the literature (Aiken et al., 2003; Benner, 1984; Carayon et al., 2006;
Carayon et al., 2014; Dighe et al., 2001; Kratz & Laposata, 2002; Leibach, 2007; Leibach,
2008a, Leibach, 2008b).
Knowledge creation/knowledge transfer theory, then, frames the interface between
individual cognitive knowledge and shared community knowledge through delivery methods like
evidence based practice (EBP). In knowledge translation, existing validated knowledge, e.g.,
randomized clinical trials, evidence based clinical (observational, qualitative) studies, is
synthesized to produce action targeted toward improvement in quality measures (Khoddam et al.,
2014).
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Critical thinking and knowledge translation provide sequential theoretical frames for EBP
methods as described for laboratory medicine by Christenson, et al. (2011). This seminal work,
the Laboratory Medicine Best Practices (LMBP) A6 Method, defined methods for discovery of
best practices in laboratory medicine, measuring test performance indicators as well as health
outcomes, from the systematic review and meta-analysis of data collected from studies of
clinically relevant questions. Data for systematic reviews come from primary publications and
unpublished quality improvement studies addressing the same question. After synthesis of
practices and identification of best practices, the method yields recommendations (strategies) for
implementation of quality improvement studies to resolve the clinical question under study.
Thus, the method is used to guide standardized quality improvement efforts in laboratory
medicine. The method has been employed widely and recently in the systematic review
published by the U.S. Centers for Disease Control and Prevention LMBP Initiative,
“Effectiveness of Practices to Support Appropriate Laboratory Test Utilization: A Laboratory
Medicine Best Practices Systematic Review and Meta-Analysis” (Rubinstein et al., 2018).
Over the past decade, healthcare quality endeavors have involved the input of
patient/consumers themselves. Patient/consumer involvement in the healthcare delivery system
can occur at any point in delivery, from access to community services to construction of patient
and family-centered environments (Bombard, et al., 2018). Most frequently, patient involvement
has focused on direct discourse between patients and providers for the purpose of engaging
patients in the decision making process and/or patient education to improve self-care (Coulter,
2005; Légaré & Witteman, 2013). Efforts to include patient/consumer voices in all aspects of
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health services delivery, e.g., from health facility construction to sharing decisions about
treatments, have been generally accepted and promoted (Bate et al., 2006; Boivin et al., 2014;
Crawford et al., 2002; Johnson et al., 2008). And the focus of all these efforts is to improve the
quality of healthcare delivery throughout patient/consumers’ lifetimes in the healthcare
continuum by involving consumer/patient input, i.e., young to old, in the healthcare cycle (nonpatient to out-patient to in-patient to specialty care to return to out-patient consumer, etc.)
(Carman et al., 2003; Parand et al., 2014).
Much of the methodology for identification of evidence based best practices shown to
increase the value (quality to patient/consumers divided by cost) of diagnostics information, led
to the 2015 National Academy of Medicine (NAM) report, Improving Diagnosis in Health Care,
defined diagnostic error as critical in the assessment of healthcare quality. Identifying,
quantifying, and reducing diagnostic error is the first of three themes of the report. Reducing
diagnostic error is well within the quality goals of diagnostics services because of the pivotal role
of diagnostics information in clinical decision making of all healthcare providers (NAM, 2015).
Patient/consumer involvement in healthcare diagnostics services delivery, targeting their
involvement in improving diagnosis, is the second major theme of the 2015 report. Diagnostic
error is defined from the patient/consumer perspective as: “the failure to (a) establish an accurate
and timely explanation of the patient’s health problem(s) or (b) communicate that explanation
to the patient” (IOM/NAM, 2015, p. 85). This emphasis on patient/consumer involvement as
central to a solution for diagnostic errors serves as the mandate for those providing diagnostics
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services and/or interpreting and recommending applications of diagnostics information
(IOM/NAM, 2015).
The 2015 NAM report emphasized the patient-centric role of diagnostics laboratories as
the third major theme. The development of methodology for derivation of best practices in
laboratory medicine defined the framework for evidence based investigations into the
relationships of diagnostics information and individual patient/consumers’ health outcomes
(Carayon et al, 2014). This evidence based practice methodological framework has focused
clinical research and quality initiatives on optimization of population-based treatment and
diagnostics guidelines for all individuals who access the healthcare system (Carayon et al.,
2018). Because diagnostics consultants provide information that informs the clinical decision
making (CDM) of all healthcare providers, “consultation” for diagnostics consultants is defined
as the synthesis, analysis, production, evaluation, optimization, and dissemination of diagnostics
information to maximize value for patient/consumers (Leibach, 2012). The activities embodied
in “diagnostics consultation” subsume any encounters among healthcare provider,
patient/consumer, and diagnostics consultant. Thus, the diagnostics consultant is the point of
initiation of patient/consumers’ and IPT involvement in the diagnostics consultation process.
Literature domain review choices for this study facilitated development of a research
agenda to evaluate the value of diagnostics information for consultation. For diagnostics
consultants, this agenda addresses the strategic challenges raised in the NAM report, Health
professions education: A bridge to quality (Greiner & Knebel, 2003) as well as the NAM report,
Improving Diagnosis in Health Care: (1) addressing the multiple aspects of quality in the
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education of healthcare practitioners and (2) understanding the drivers of diagnostic error to
target interventions to reduce the impact of medical error in the total healthcare process.
Quality
Two major areas of literature relevant to the goals of the NAM reports and the
consultation communication portal model description are presented: quality and evidence based
practice. Quality theory provides the framework for the identification and evaluation of quality
measures in healthcare and subsumes the growing body of literature in health services research
(Carayon et al., 2006; Carayon et al., 2014; Carayon et al., 2018; Deming, 1986; Donabedian,
1988; Porter, 2010; Westgard, 2006; Westgard, 2013; Wilson, 2015). Within the quality
framework, critical thinking literature frames studies related to acquiring and processing
information for the purpose of creating new knowledge. Observable indicators of critical
thinking (CT) quality in the cognitive, behavioral, affective, and situational/contextual learning
domains can be identified and measured (Grosser et al., 2020; Kenimer, 2002). These observable
CT behaviors can be markers for achievement of quality discourse among diagnostics
consultants, healthcare providers, and patient/consumers.
Within the last decade, the Donabedian healthcare quality framework, i.e., structures,
processes, outcomes, has been expanded further with constructs developing in non-healthcare
safety management environments. An emerging field of human factors and ergonomics examines
the interaction of humans with machines and technology, deepening our understanding of human
characteristics contributing to communication errors occurring at the EHR interface or as the
result of environmental distractions and interruptions (Mannion & Braithwaite, 2017). This area
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of research produced the SEIPS (Systems Engineering Initiative for Patient Safety) model of
work systems and patient safety which expands the Donabedian structures, processes, and
outcomes framework to include measures of interactions among healthcare providers and their
environments that affect clinical performance, provider and patient physical safety, and moral
injury (Carayon et al., 2006; Carayon et al., 2014; Carayon et al., 2018). More recently, areas of
safety research have bifurcated into traditional interpretations of error measurement and
assessment, e.g., root cause analysis, plan-do-check-act, DMAIC (define, measure, analyze,
improve, and control), and real-time assessment of variances for purposes of refining systems
and processes (Blokland & Reniers, 2020). The more traditional view is designated “Safety I”
and includes the designs of most quality studies performed in healthcare. “Safety II” studies are
those emphasizing the more iterative, learning concepts of quality analyses involving the impact
of structures and processes on clinical outcomes (Hollnagel, 2012; Smith & Valenta, 2018;
Swuste et al., 2020). Safety II studies, therefore, include quality designs involving measures of
effectiveness of standardized handoff communication tools, artificial intelligence/machine
learning methods for guideline development from EHR data extraction and analysis, and
development of public health diagnostics recommendations (Caudell-Feagen & Thompson,
2021; Isbell, 2020; Shah et al., 2021; Zuckerman, 2021).
Knowledge creation/translation theory, also within the quality framework of this study,
provides context for investigation of effective knowledge transfer from creation to application
(De Simone, 2014; Khoddam et al., 2014; Salehi et al., 2015). Guidance of this body of work
informs development of measures evaluating the medical effectiveness of diagnostics
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information and communications in improvement of health outcomes of individual
patient/consumers (Bate et al., 2012). The total care process, from access of health services to
inpatient discharge planning can be investigated under the constructs of knowledge
creation/translation theory (Del Mas et al., 2020).
Evidence Based Practice
The second major area of literature providing a frame to operationalize the aims of the
NAM reports and the consultation research agenda presented in this study is evidence based
practice (EBP) methodology (Christenson et al., 2011; Leibach & Russell, 2010; Sacket et al.,
1996). The general approach to systematic synthesis of evidence of effectiveness in medical
practice, attributed first to Sacket (1996) and later customized for laboratory medicine through
identification of laboratory medicine best practices (Christenson et al., 2011; Procop et al.,
2019), has revolutionized the measure and evaluation of quality in health services delivery. EBP
methods have guided the translation of knowledge into practice applications in numerous
healthcare venues at the organizational level as well as in healthcare job development, continuing
healthcare education, and healthcare consultation initiatives (Bombard et al., 2018; Heyer et al.,
2012; Liebow et al., 2012; Snyder et al., 2012a; Snyder et al., 2012b; Yang, 2015; Yang, 2016).
The A6 cycle method for Laboratory Medicine Best Practices. The LMBP A6 Method
is a validation outline for the LMBP systematic review process and describes a stepwise
approach for synthesizing and evaluating the strength of literature in the investigation of
diagnostics-related clinical questions (A1: ASK); data collection (A2: ACQUIRE); synthesis
(A3: APPRAISE), analysis (A4: ANALYZE), implementation (A5: APPLY), and process
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improvement and evaluation (A6: ASSESS) required for recommendation of best practices in
diagnostics quality investigations. The LMBP A6 Method has been described in detail elsewhere
(Christenson et al., 2011) as have many applications in clinical investigations (Rubinstein et al.,
2018).
A6 method for Healthcare Clinical and Quality Research (A6 HCQR). This current
work describes an integration, augmentation, and expansion in scope of the CDC LMBP A6
Method, reported in 2011, which was developed to guide best practices systematic literature
review processes. The method expansion, the A6 Method for Healthcare Clinical and Quality
Research (A6 HCQR), described and reported here for the first time, integrates the rigor of this
literature synthesis process into the classic Quality Theoretical Framework developed and first
reported in 1988 by Donabedian, “the father of quality measurement,” and detailed more
thoroughly in the SEIPS Model, a work system design for patient safety (Carayon et al., 2006;
Carayon et al., 2014; Carayon et al., 2018; Donabedian, 1988; Reinke, 2017). The integration of
the systematic literature review process with Donabedian’s operational quality model describes a
systematic, evidence based approach to the development, implementation, and evaluation of
primary clinical research and quality improvement (QI) studies. The A6 HCQR method guides
the critical thinking and analysis required to formulate, implement, and evaluate not only
processes but health outcomes of clinical research and quality improvement initiatives, i.e.,
safety, timeliness, efficiency, effectiveness, equity, and patient-centeredness (i.e., the STEEEP
variables) (IOM/NAM, 2001). The six steps of the method reported here begin with the
identification of a specific clinical question (step A1, topic nomination), and then move through
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steps A2-A6 to topic development, literature review/study design, protocol/materials
development, protocol training/deployment, and evaluation of the evidence based intervention
(EBI) to address the clinical quality question. Templates have been designed to help develop
processes, track progress, and analyze barriers in the accomplishment of project milestones
related to each A6 step. (Templates not shown.) Completion of the templates will necessitate
accumulation of pertinent information and synthesis of critical processes and analyses required
for development, implementation, and evaluation of an evidence based clinical research and
quality improvement initiative, i.e., EBI.
The A6 HCQR Method life cycle is comprised of two phases. Phase 1, Topic Nomination
and Development, includes steps A1-A3: ask, acquire, and appraise, respectively. The second
phase includes the remaining three steps: Phase 2, Topic Implementation and Evaluation, A4-A6:
analyze, apply, and assess, respectively. Each of the method steps is further defined by substeps
related to activities described in Donabedian’s classic quality model and expanded by Canayon
and Colleagues in the SEIPS Model (Canayon et al., 2006; Canayon et al., 204; Canayon et al,
2018; Donabedian, 1988; Reinke, 2017).
Step A1: ASK. In step A1, a topic area is identified that is considered to contribute
significantly in performance related to failure, achievement, and/or maintenance of a quality
goal. The topic area could be derived from population level data sources, e.g., national, regional,
and local public health databases, from public-reportable quality indicators, e.g., Centers for
Medicare and Medicaid Services/Agency for Healthcare Research and Quality (CMS/AHRQ)
Hospital Compare and Hospital Consumer Assessment of Healthcare Providers and Systems
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(HCAHPS) Survey, and/or from internal system data sources, e.g., enterprise quality plans,
incident reporting, and/or clinical laboratory error detection processes. There should be
stakeholder consensus that the topic area is of significant quality importance and/or concern
based on evidence from baseline process, clinical, and provider wellness outcomes (Proctor,
2011).
In Step A1, stakeholders involved in the clinical research and quality improvement study,
the evidence-based initiative (EBI), are guided through the processes of forming a stakeholders’
quality research group, identifying possible topic areas, choosing and setting priority among
topic suggestions, and becoming familiar with the A6 HCQR structure, functions, and
requirements. The topic nomination template will guide the critical thinking (CT) required to
complete Step A1 ASK.
STEP A2: AQUIRE. In step A2, the EBI topic nominated in Step 1 is further distilled
into a specific and measurable clinical question. A preliminary review of the literature related to
the EBI question is conducted to determine the strength of the body of evidence supporting the
clinical impact of the question and to discover seminal reports that could inform further, more
extensive literature search strategies.
In Step A2, stakeholders refine a specific and measurable EBI clinical question from the
broader topic area discussed in Step A1. Beginning with key words compiled from reports of
practices addressing similar clinical questions, a search strategy is designed to identify many if
not most reports of best practices relevant to the clinical question. The search strategy is
designed to filter reports based on inclusion and exclusion criteria. A topic development template
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guides the collection of information and criteria necessary to formulate a search strategy that will
yield a sufficient number of rigorously designed and executed practices, with relevance to the
clinical question, for the purpose of synthesizing an EBI practice suitable not only for the clinical
question but also for the clinical environment described by the inclusion/exclusion criteria. In
development of this A2 template, guidelines developed by the Prevention Recovery Information
System for Monitoring and Analysis (PRISMA) Group for reporting systematic reviews were
adopted to assure that criteria for conduct and reporting of the results of literature searches are
followed and documented (Liberati et al., 2009; Moher, Liberati, Tetzlaf, Altman, & The
PRISMA Group, 2009).
STEP 3: APPRAISE. In Step A3, a pool of candidate practices is generated from the
extensive, if not exhaustive, review of literature evaluated on strength of reported evidence as
well as relevancy to the clinical situation for which the EBI is being designed. Also, a pool of
variables, i.e., measures reported to vary with changes in an EBI-related practice, is accumulated.
Literature identified previously will be analyzed in two processes, article abstraction and variable
extraction. The article abstraction procedure, using both an evidence abstraction and evidence
abstraction summary template, provides guidance through an abstraction of pertinent elements of
the practice reported in the reference article under review. The variable extraction procedure,
using a variables assignment template, provides guidance through identification and
characterization of variables measured in those same studies in practices in clinical settings
similar to the EBI under development. The templates for this step will guide the CT required to
analyze and judge the strength of the evidence supporting the effectiveness of candidate best
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practices. In addition, the templates will facilitate the characterization of variables according to
type, i.e., clinical (STEEEP), process, or client (wellness) variables, and subtypes within each of
those category types (Bodenheimer & Sinsky, 2014; Harvey, 2020; Liddy & Keely, 2018; Otto,
2011; Proctor, 2011; Rathert, Williams, & Linhart, 2018; Zhao & Granger, 2018;).
STEP 4: ANALYZE. The purpose of Step A4, the final step in the EBI life cycle phase 1,
“the build,” is to bring together all the products of the previous planning steps into an
implementation model represented by the analytic frame. The analytic frame diagrammatically
summarizes the EBI path for ready assimilation by stakeholders and aids in the understanding of
requisite steps and their prioritization in a timeline sequence. The EBI analytic framework
template provides a generic model that can be adapted for specific EBIs. The EBI logic model
template provides a format to document the evolving detail of milestone activities required
throughout the EBI life cycle. During Step A4, an EBI protocol is synthesized from candidate
practices from the literature, the path of the baseline comparator practice is carefully
documented, and variables identified and characterized that are to be measured and statistically
compared in both the comparator (pre-intervention) and intervention (post-EBI) processes.
Protocol refinement and variable identification can occur simultaneously. Candidate best
practices from the literature are further analyzed for homology with the clinical situation under
investigation, i.e., considering inclusion/exclusion criteria and existing structures and processes.
During those analyses, structures and processes that are the data sources of the variables
measured in candidate practices are identified. These structures and processes are compared to
those available for the EBI under development and the feasibility of data collection is
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considered. The ultimate choice of variables depends on the balance between impact in the EBI
path and feasibility of measurement.
Also, in Step A4, details regarding implementation are considered. For instance, plans
must include a projection of participant roles and responsibilities and a map of the informatics
infrastructure needed to collect variable data. Production of training materials for and
credentialing of all participants in EBI implementation are anticipated and data access and
storage considered. During Step A4 after roles and responsibilities and data handling processes
are defined, individuals are identified for each role and an Institutional Review Board (IRB)
application submitted.
STEP 5: APPLY. Step A5 begins EBI life cycle phase 2, “the execution.” These two
steps incorporate the remaining processes required for implementation and evaluation of the EBI.
In Step A5, the customization of the EBI is completed and any consents needed for participation
are garnered from individuals named in the IRB application. Data collection mechanisms (tools),
intervention training materials, and training schedules are developed. In addition, a plan for
variable analyses is devised that describes assessment of hypotheses related to STEEEP
(clinical), process, and wellness indicators; the assessment plan should include overall effect
measures that pool the impact assessments of all the different types of variables (Proctor, 2011;
Zhao & Granger, 2018.) During Step A5, baseline, comparator practice data collection can
begin.
STEP 6: ASSESS. In Step A6, EBI evaluation strategies are conducted. Analysts prepare
data for assessment to include pooling of indicators from different collection sources and by
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different variable types, missing data analyses, sensitivity analyses, and power determinations.
Data are then analyzed descriptively by individual variables (subtypes) as well as variable types,
i.e., STEEEP (clinical), process, and client (wellness). These analyses are then used to assess
significant differences between baseline and EBI performance on specific indicators and to
perform inferential analyses to determine the contribution of variable combinations to overall
EBI path effectiveness (Horwitz, Kunetsova, & Jones, 2019; Proctor, 2011). Analyses are also
undertaken to develop an overall effect measure, e.g., meta-analysis for types and subtypes with
enough power, describing the efficiency and effectiveness of the EBI path. Lastly, analyses of
barriers and implementation protocol breaches, identified as anticipated possible harms in the
analytic frame and/or from preliminary implementation results, are assessed for contributions to
bias in implementation and evaluation of conclusions and recommendations (Viswanathan et al.,
2012). The EBI evaluation template provides CT guidance through design of these hypothesesdriven descriptive and inferential analyses for EBI evaluation.
POST-A6 HCQR COMMUNICATION. Substantive attention is focused on
communication of EBI development, implementation, evaluation, and post-EBI conclusions and
recommendations. Throughout all A6 HCQR Steps, education is paramount to timely and
organized planning and implementation. Most healthcare providers involved in clinical and
quality research have not been exposed, through formal or continuing education, to quality
theory and associated research structures and processes. In addition, clinical and quality research
is not usually included in practitioner position responsibilities. However, with the advent of
value-based reimbursement, acknowledgement of the clinical value of personalized team-
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based services delivery, and the accelerated shift to telehealth, research to develop best practices
for delivery of these high value services is increasing (D’Avena et al., 2020). Therefore,
adequate time should be added for communication of EBP literature related to quality
gap/clinical question development, study design, methods, findings, bias analysis, suggestions
for EBP processes improvements, and recommendations for future EB clinical and quality
research initiatives. Communication should be both written (in manuscript form for publication
and internal distribution) and oral (platform and poster presentations) and should be developed
for both internal and external audiences.
For evaluation and communication of the results of continuous quality improvement
EBIs, e.g., daily updates of patient-centered care path diagnostics plans, communication formats
include IPT clinical notes, internal secure messages, email, and formal consultation reports
entered into the medical record. The current study, developing communication workflow
processes for diagnostics consultants, is an example of a continuous quality improvement EBI.
The A6 HCQR frame of this study will be described in detail later.
EBIs represent a timely, logical, and meaningful approach to developing an evidence
base of best practices describing high value services that can be customized uniquely for
individual health systems and their constituent populations. And perhaps just as important, the
mechanisms developed in the A6 HCQR Method are applicable throughout the total health
system ecosystem and amenable to and congruent with burgeoning artificial intelligence and
telehealth capabilities. That is, the A6 HCQR Method prescribes the nexus of human factors,
clinical and quality research strategies, and automation and digital platforms for services delivery
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as described in the DCM© Research Program as displayed in Figure 1. Further, the Method
outlines the integration of these components of health services delivery into high impact,
measurable interventions that improve quality in healthcare as assessed by clinical, process, and
provider wellness outcomes.
Healthcare knowledge creation/translation and A6 HCQR Method applications will
develop further the quality framework of this study and inform possible study designs to define
diagnostics consultation more fully. Literature from domains representing the major theoretical
underpinnings and applications of quality in practice was reviewed to fairly and adequately
describe inconsistencies between existing practices and evidence based approaches to CL
services delivery. Collectively, this body of work supports the formulation of strategies for
design of communications workflow processes to address diagnostics quality gaps/clinical
questions within the framework of the Diagnostics Consultation Model©. See Figure 1.

Figure 1. Structure of the Diagnostics Consultation Model© Research Program Establishing a
Continuous Quality Improvement System to Improve Health Outcomes
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Diagnostics Consultation Model© (DCM©) Research Program
In Arm 1 of the Consultation Model Research Program (Figures 1 and 2), Consultation
Characterization and Decision Science, qualitative studies informed by CT and knowledge
translation theory define the characteristics of consultations that indicate where in the care
process diagnostics consultation is needed to decrease the risk of poor health outcomes
(Blokland & Reniers, 2020; Swuste et al., 2020). Likewise, these theories provide guidance for
development of indicators of effectiveness in the evaluation studies of Arm 2, IT Systems,
Evaluation, and Quality Analytics. Studies in both Arms would employ EBP methods
and speak to quality improvement in both patient/consumer clinical, process, and human factors
(client) outcomes (Smith & Valenta, 2018).
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Figure 2. DCM© Research Program Description. A6 HCQR Method = The A6 Method for
Healthcare Clinical and Quality Research (Leibach, Personal Communication, 2020)
In summary, Figure 3 graphically represents the relationships of the relevant literature
areas leading to the theoretical constructs foundational to development of the concept and
practice of diagnostics consultation. Development of the Diagnostics Consultation Model©, as a
structure for consultation implementation, will be discussed in detail in the pages following.
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Figure 3. Theory Translation to Evidence Based Practice Methods. Cognitive and knowledge
translation theories are translated through evidence-based practice methods for the improvement
of value of diagnostics services for patient/consumers.

The Diagnostics Consultation Model© (DCM©) Operational Theory
Shared decision making theory. Supporting the indication for and design of the DCM©
are several evolutions in health services delivery following from the quest for services delivery
improvement through value based care (Cattell et al, 2020; Dubois et al., 2020; Porter, 2009;
Porter, 2010; Porter et al., 2020). For over a decade now, healthcare providers have understood
that to provide adequate healthcare access, patients/consumers must be involved in healthcare
decisions related to diagnosis, monitoring, and treatment options to feel ownership, along with
providers and payers, in the healthcare services delivery process (Bate & Robert, 2006; Bliss et
al., 2020). This patient/consumer-involved approach includes a commitment to meeting
patient/consumers in their own environments and in their own primary language (Applebaum et
al., 2016). In this model of healthcare services delivery, patient/consumers are the
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focus of the healthcare delivery system and should assume pivotal roles in decision making and
quality improvement (Boivin et al., 2014; Cao et al., 2018). As care paths are discussed,
patient/consumers become partners in healthcare delivery. They need to be thoroughly, honestly,
and accurately informed of risks and benefits of alternatives for care (Braschi et al., 2020). Then
the information compiled for and generated from care should be kept private yet readily available
to and analyzed for their healthcare providers. The competing goals of assuring timely access to
best evidence for all providers while maintaining the confidentiality of protected health
information (PHI) also link the realms of research and clinical care as interpretations regarding
the definitions of research and human protections are weighed (Damman et al., 2020; Dogba et
al., 2020).
Figure 4 is a schematic of an MLP consultation services logic model for intervention in
the shared decision making and informed consent process. In informatics terms, MLPs providing
this patient-centered information would supply clinical decision support (CDS) to providers and
patient/consumers. From an ethical perspective, provision of best available evidence addressing
the unique needs of patient/consumers as the basis of shared treatment and planning decisions
includes not only a thorough review and synthesis of current guidelines but consideration of the
patient/consumer’s environmental and social (ES) context, as well. Complete presentation of
current treatment evidence with impact to the ES context not only reduces potential bias related
to power inequality in the provider-patient relationship, but also addresses directly the six IOM
(STEEEP) aims characteristic of improved healthcare delivery: safe, timely, effective, efficient,
equitable, and patient-centered (Ballard et al., 2014; Craig et al, 2020). The three elements
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considered essential in shared decision making are recognizing and acknowledging that a
decision is required, knowing and understanding the best available evidence, and incorporating
patients’ values and preferences into the decision (Légaré et al., 2008; Légaré et al., 2011;
Légaré & Witteman, 2013). The role described for MLP would address the second element, i.e.,
compiling and formatting the best available evidence for the individual patient’s circumstances;
these steps can also be considered MLP knowledge creation (Graham et al., 2006). The patientcentered information provided should include an informed consent questionnaire that would
facilitate the discussion of treatment options and serve to document the patient/consumer’s
values and preferences. Consultation with providers and patient/consumers would be considered
MLP knowledge translation through the work processes related to structures (inputs), activities,
and measurement of clinical outcomes (Carayon et al., 2006; Carayon et al., 2014; Carayon et
al., 2018; Graham et al., 2006).
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Figure 4. MLP Consultation Logic Model MLP consultation involves directing existing
resources (INPUTS1) for the design of CDS materials (ACTIVITIES2) tailored for use in shared
decision making during the informed consent process. Medical subjects and services involved in
MLP consultation can be analyzed to discover and evaluate resource-intensive care paths and
establish priority diagnoses (OUTCOMES3) within the healthcare delivery system, e.g., medical
home, accountable care organization.
MLP evidence based practice theory. This MLP consultative role as described
represents an approach to increasing the value of CL information through MLP evidence based
practice, that is, the quest for increased value in health services delivery through patient-centered
clinical decision support (CDS) and quality improvement practices (Christenson et al., 2011;
Eichberger et al., 2020; Epner, 2017; Porter, 2009; Porter, 2010; Procop et al., 2019).
MLP role in healthcare services delivery has traditionally surrounded the production of
accurate and precise diagnostics test results. Consequently, quality measurements have been
focused on the analytic phase of the testing cycle to include instruments, assay methods, and
statistical control, i.e., analytic QC/QA or Safety I constructs (Hollnagel, 2012; Westgard, 2004;
Westgard, 2006). With the emergence of value-based concepts in healthcare services delivery,
non-analytic events impacting analyses, e.g., inappropriate orders, failures in results
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communications, substandard specimen collection, inadequate results interpretation, are being
included in quality investigations, i.e., Safety II constructs (Christenson, 2011; Hill et al., 2020;
Smith & Valenta, 2018). These evidence based quality improvement (QI) methodologies,
provide the clinical research strategies and structure to evaluate efficacy vis-à-vis effectiveness
of clinical laboratory services and provide evidence based benefit/cost analyses for provider and
consumer decision support (Procop et al., 2019). Also inherent in this methodology is the
capability to determine the medical effectiveness of emerging technologies like
pharmacogenomics and other molecular testing options (Armstrong & Metlay, 2020; Leibach,
2011; Westkopf & Weng, 2013).
Figure 5 summarizes the relationship of evidence based practice (EBP) to the total quality
management (TQM) process. Outside market pressures, e.g., competition, regulation, and
benchmarking best practices, suggest process standardization within healthcare delivery systems.
Implementing EBP, MLP practitioners then apply and evaluate those standards through quality
improvement (QI) processes like the Plan-Do-Act-Check (PDAC) cycle for assessing laboratory
analytics and the A6 method for measurement of non-analytic factor impact (Christenson, 2011;
Carayon et al., 2018; Deming, 1986). The summation of findings from these laboratory QI
processes is evaluated for quality impact at the systems level as part of the institution-wide TQM
program. Improvements to laboratory processes are made based on the evidence garnered from
these QI assessments. Findings from well-designed, well-executed QI studies can be generalized
to other (external) systems and thus modify the initiating outside market pressures in a quality
feedback loop (Blokland & Reniers, 2020). In MLP practice, the quality improvement cycle
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generated by EBP combines clinical care (clinical decision support, CDS, through shared
decision making) and research for improvement in patient safety and health outcomes (Carayon
et al., 2018; Leibach, 2010; Leibach, 2011).

Figure 5. Medical Laboratory Professionals’ (MLP) Evidence Based Practice. MLP evidence
based practice (EBP) is defined as, “the conscientious, explicit, and judicious use of the best
evidence from clinical laboratory information in making decisions about the care of individual
patients” (Leibach & Russell, 2010; Sackett et al., 1996). EBP involves the systematic evaluation
of existing evidence and incorporation of relevant conclusions from those evaluations into
clinical practice using quality methods, e.g., Plan-Do-Check-Act and the A6 Method for
Healthcare Clinical and Quality Research (A6 HCQR).
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In MLP EBP, the impact of laboratory information on patient outcomes is assessed and
compared to existing clinical care guidelines. Variances from expected outcomes are investigated
and processes involved targeted for QI study if observed outcomes are judged to fall short of
targeted quality thresholds. The iterative EBP process involves the analysis of individually
identifiable health information (“protected health information,” PHI) and, in some instances
related to evaluation of alternative treatment interventions, patient participation in human
subjects research. Figure 6 represents the interconnectivity (i.e., “interoperability,” in informatics
terms) among clinical and research databases (Arsoniadis, 2020; Weiskopf & Weng, 2013).

42

Figure 6. Interoperability of Databases Used in MLP Evidence Based Practice (EBP). MLP EBP
promotes the assessment of evidence, related to outcomes of laboratory information, garnered
from web searches, laboratory information systems (LIS), electronic health records (EHR) and
health information exchanges (HIE), and research databases. LIS, EHR, and HIE clinical care
databases are regulated, at a minimum, by HIPPA privacy and patient confidentiality
requirements; research databases are regulated by Common Rule standards for human subjects
research. If data are exchanged electronically, research databases must also meet HIPPA
requirements for privacy and patient confidentiality.
In the consultative role described, MLP practitioners’ interface with other healthcare
providers, patient/consumers, and information databases to provide the scientifically best, most
relevant laboratory evidence, tailored for the particular patient/consumer and care giver dyad, for
meaningful informed consent and shared decision making. Information would be drawn from
web sources (e.g., medical libraries and health information exchanges) as well as sources within
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the medical home (e.g., laboratory information systems and electronic health records). If
patient/consumers participate in clinical research studies, documentation of status and any
findings will become a part of consultation materials. In addition, patient/consumers would
review materials with the option to add their preferences in and document their understanding of
the issues surrounding the informed consent and shared decision making process (Arsoniadis,
2020; Légaré & Witteman, 2013; Leibach, 2014; Carayon et al., 2018).
With increasing emphasis on value-based healthcare services delivery, attention has been
focused on the substantial percentage of U.S. healthcare dollars wasted on overutilization of
laboratory resources, that is, dollars that include those spent on unnecessary testing or testing that
is too expensive to be feasible. Evidence based practice in MLP has (1) provided the
methodology for evaluating the impact of laboratory information on patient safety and other
health outcomes (Huang et al., 2020; Procop et al., 2019) and (2) supplied the measures for
calculating medical effectiveness and cost efficiency of laboratory information in clinical
decision support (Kavsak, 2019; Ko et al., 2019). Algorithms, i.e., order sets guiding diagnostics
test selection within the care path, i.e., screening, diagnosis, monitoring, prognosis, and
automated/digital control of diagnostics, instrumentation and other medical equipment, to guide
the behavior of practitioners ordering diagnostics tests, can be developed from the evaluation of
evidence based quality improvement studies (Kudler & Pantanowitz, 2010; Lippi et al., 2020;
Luo et al., 2016; Procop et al., 2019).
Providing a team of MLP practitioners to select diagnostics tests with evidence based
ordering algorithms adapted for unique patient/consumers’ circumstances, i.e., an individualized
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diagnostics care plan, would help to remove many forms of cognitive bias from this portion of
the care path (Armstrong & Metlay, 2020; Bate et al., 2012; Cheloff & Huang, 2021; Maillet et
al., 2018). Provider and patient/consumer dyads could then use these evidence based materials in
the shared decision making process to arrive at a thoroughly informed consent for next steps in
patient/consumer care (Leibach, 2014).
For MLP, this consultative process dictates that the highest clinical research standards be
incorporated into each individual patient/consumer diagnostic care plan generated (Cheloff &
Huang, 2021). The knowledge created from evaluation of each care path implementation can be
generalized to refine diagnostics algorithms in an iterative quality improvement cycle that will
foster better value (quality outcomes per dollar spent) in healthcare services delivery (Del Mas et
al., 2020; Glaser, 2020). Because new information, potentially unique to individual
patients/consumers, would be discovered through this QI/CDS process, MLP should understand
and integrate the highest ethical standards in the generation and interpretation of clinical research
findings; the DCM© implementation requires unimpugnable provider integrity, knowledge,
objectivity, and ethics (Del Mas et al., 2020; Cheloff & Huang, 2021).
Patient-centered clinical decision support in MLP EBP. The recommendation to
incorporate Academy of Medicine (NAM) aims into practice, and the subsequent requirement to
develop measures in each of the national quality strategy domains and document their uptake,
obviates the debate regarding MLP responsibility for patient safety and health outcomes
assessment (Craig et al., 2020). Table 1 summarizes the relationship among the NAM aims and
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the quality measurement domains of the HHS. Also included in Table 1 are MLP examples of
measures in each quality domain.
Table 1
Examples of Quality Domain Measures Providing Evidence of IOM/NAM Aims
Operationalized in MLP Practice

1
2
3

NAM/IOM Aims1
for Healthcare
Delivery

U.S. HHS
Quality Measurement
Domains2

Safe

Safety

Effective

Clinical Care

Patient-centered

Population and Community

Timely

Care Coordination

Efficient

Cost and Efficiency

Equitable

Patient Experience and
Engagement

Example
Measures3
Specimen collection; Patient
Identification
Diagnostic (test ordering)
algorithm development
Informed consent; Shared decision
making
Critical values reporting;
Appropriate Ordering; Information
interpretation
Best practices reporting;
Benchmarking value-based
processes
Consultations

Institute of Medicine (IOM)/National Academy of Medicine (NAM), 2001
U.S. Department of Health and Human Services, 2012
Measures developed for the informed consent and shared decision making processes would
evaluate patient-centeredness of MLP services delivery. Also measured in the informed
consent and shared decision making process would be effectiveness through patient-specific
guidance development and services equity through feedback, from both patient/consumers and
providers, on consultative services. The informed consent and shared decision making process
would establish a platform for discussion of needs related to safety and cost efficiency because
of the opportunity for patient/consumers to document their values and preferences as process
requisites.
In order to accomplish quality improvement in the domains recommended by U.S. Health

and Human Services, MLP need to understand the ethical requirements of human subjects
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research as well as privacy and patient confidentiality as defined under the Health Insurance
Portability and Accountability Act (HIPAA) with subsequent amendments in the Health
Information Technology for Economic and Clinical Health (HITECH) Act, enacted under Title
XIII of the American Recovery and Reinvestment Act of 2009. In addition to these federal laws
regulating data collection and use, states generally have separate, sometime more stringent, laws
governing these aspects of data protection, as well. Some private certification bodies, such as
The Joint Commission, have rules governing data collection and use in their subscribing
facilities. HIPAA sets the “floor” for these data protections. Clinical activities, such as clinical
and quality improvement interventions or informed consent and shared decision making
consultations, must be evaluated by an approved institutional review board (IRB) by criteria
defining human subjects research, reanalysis of clinical samples, and limited and deidentified
data sets (HIPAA, 1996, rev. 2019; HITECH, 2009; Leibach, 2014).
Patient-centered quality in MLP EBP. Clinical laboratories (CL), those laboratories
producing information guiding diagnostic, screening, monitoring, prognostic, and therapeutic
decision making in healthcare, vary in annual test volume, menu of services offered, levels of
testing provided, types and complexity of instrumentation, numbers, and skill level of staff, and
patient populations served. Regardless of these variations, the primary goal of the CL is to
provide high quality services at the lowest possible cost (Procop et al, 2019). Therefore,
operational theories about factors influencing CL quality and/or cost are relevant to every
laboratory size and structure.
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The Diagnostics Consultation Model© Operational Theory Synthesis
Organizational theory. Macro-level, external pressures influence the quality of
healthcare services delivery. These relationships are graphically represented in Figure 7. Quality
theories that explore relationships among community structures and processes, variabilities in
access, and patient populations, though contributing to CL operations and policy, exert their
main influences on the CL indirectly (Siemieniuch & Sinclair, 2014; Yang, 2007; Yang, 2016).
These theories identifying external constructs describe CL connections through the primary
organizational level. Therefore, theories describing healthcare system organization could be
influenced by those proposing, first, more macro-level linkage among characteristics of the
external healthcare environment, e.g., community structures, access issues, and characteristics of
populations (Blokland & Reneirs, 2020). At a second level, then, those theories defining
relationships among external factors could influence the development of organizational
characteristics that vary with measurements of patient outcomes, patient safety, and cost-efficient
services delivery, i.e., internal environment measures.
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(External Environment)
Education Theory
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Social Theory

Economic Theory
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Organization Theory

Mimetic Pressures
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(Internal Environment)
Knowledge
Translation
(Institutional) Theory

Quality Frame
(Donabedian)

Quality Method
(A6 HCQR Method)

Clinical
Laboratory

Figure 7. Relationships among Healthcare Environmental and Organizational Theories
Influencing Clinical Laboratory Clinical and Quality Systems
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Health services research theory. Health services research (HSR), that is, research
focused on the contributions of the various constituents of the healthcare delivery system to
patient outcomes, can be directed at internal characteristics of patients and their living and work
environments which greatly influence their reactions to healthcare experiences, giving rise to
social system-based research investigations of individual characteristics and social networks
influencing healthcare choices (Applebaum & Robbins, 2016; Bradley, 2002; Carayon et al,
2018; Ospina et al., 2020; Putera, 2017; Shortell & Rundall, 2003). In addition, HSR can be
directed at external characteristics like different hierarchical levels of the delivery system, e.g.,
community, system, or organization, or even toward assessment of contributory influences to
access (Aday & Andersen, 1974; Del Mas et al, 2020; Lewanczuk et al., 2020; Modica, 2020;
Pelaccia et al., 2020; Porter et al., 2020; Rabi, 2020; Schrijvers, 2012;).
Quality theory. The 2001 NAM report, Crossing the Quality Chasm, has challenged the
health care delivery system to refocus on appropriate use of healthcare services. Following from
this, accreditors of clinical laboratories have taken up the challenge and are actively reviewing
progress toward this “new quality” of appropriate use of laboratory information relative to an
improvement in health outcomes, increase in patient safety, and decrease in medical errors (TJC,
2021a). The need for interpretation of laboratory information related to appropriate patient
assessment is a growing concern world-wide (Amaral et al., 2020; BBC News, 2008).
To identify, describe, measure, provide for, and improve the ordering, dissemination, and
utilization of medically effective and cost-efficient clinical laboratory information define the
quality objectives among the MLP and these quality objectives are also the focus of evidence
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based medical laboratory practice (MLP EBP) (Leibach, 2008a). The larger evidence based
medicine (EBM) movement, from which MLP EBP tenets are derived, is driven by
computerization and information synthesis, the need for cost-efficiency, and public demand for
best treatment options (Crews et al., 2020; Delahanty et al., 2019; Feeley et al., 2020; Gupte et
al., 2016; McQueen, 2001). By extension, MLP EBP should consider not only findings from
randomized clinical trials, but also clinical observational studies. Triangulating findings from
these quasi-experimental and qualitative methods in practice guidelines development, costefficiency analysis, and diagnostics outcomes studies will better approximate the broader
patient/consumer context (Hill et al., 2020; Kavsak, 2019; Lewanczuk et al., 2020). These mixed
methods studies also provide designs through which to compare effectiveness of protocols in a
broader patient/consumer context with associated process improvements related to particular
patient/consumer populations in various healthcare delivery settings. The goal of the MLP EBP
effort, in summary, is to provide quality healthcare in the most cost-effective way, which should
be proven and documented through these clinical and quality studies (Lewanczuk et al., 2020;
Price & St. John, 2019; Porter et al., 2020).
This emerging view of evidence based practice (EBP) in MLP is one with patientcentered focus and interaction. In venues in which the impact of laboratory information is
determined to impact patients’ well-being, MLP, functioning at levels of practice appropriate to
their professions and education in clinical research, will collate, interpret, and summarize clinical
laboratory information and consult with patients and other healthcare providers to optimize
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services delivery and desirable health outcomes (Education Statement, ASCLS, 2007; Church &
Naugler, 2020; Leibach, 2008b; Rubinstein et al., 2018).
Most research and practice treatments of quality issues rely on Donabedian’s classical
theoretical model proposing relationships among healthcare structures, processes, and outcomes
(Donabedian, 1988). In fact, CL quality processes employed to control the analytic phase of
testing are derived from Donabedian theory and operationalized under the rules of Westgard
(2006). However, since most medical laboratory errors with significant clinical outcomes occur
in non-analytic systems like ordering and utilization of information (results), new practices to
address this non-analytic quality gap in medical laboratory services delivery are being proposed
(Laposata & Cohen, 2016). These practices will be defined, first, in the healthcare institutional
setting where most supply-sensitive care, to include diagnostics testing, is provided (Fisher &
Wennberg, 2003). It will be this environment, producing the greatest volume of laboratory
information and consuming the largest amount of resources, which will be the most sensitive to
changes in practices addressing non-analytic quality gaps. It can be argued that the isomorphism
theory operationalized by Yang et al. (2016) is also derived from Donabedian’s seminal work if
clinical laboratories and resources are considered structures, isomorphic pressures considered
processes, and CL and patient health measures considered outcomes. The isomorphism
constructs of Yang et al. (2007, 2016) accommodate propositions, i.e., quality questions, from all
organizational and systems levels thus allowing for the system-wide expansion of CL quality
measurement necessary to control non-analytic performance measures and patient outcomes.
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Evidence based practice theory. In the prior theoretical discussion, aspects of
environmental factors impacting institutional knowledge creation were discussed and theories
were identified that serve to frame clinical questions guiding quality improvement studies (Craig
et al., 2020). Unlike quality assessment in the analytic phase, the laboratory medicine field has
only recently begun to implement pre-analytic and post-analytic performance measures
appropriate for evaluation of quality services delivery by measuring impact of diagnostic
information on health outcomes (Christenson, et al., 2011; Rubinstein et al., 2018; Provost, 2011;
Smith & Valenta, 2018). Findings from quality studies augmenting analytic laboratory quality
measures with health outcomes indicators can directly support clinical decision making
regarding best treatments, effective interventions, optimal health outcomes, and effective cost
management (Baird, 2014; Christenson et al., 2011; Kratz & Laposata, 2002; Procop et al., 2019;
Shah et al., 2021; Theparee et al., 2018).
Deming is credited with first observing the limitations of statistical analysis of dynamic
systems similar to healthcare delivery. And later, he designed a quality framework to assess these
dynamic systems (Deming, 1986). Building on the concepts of Deming, Rosenberg and Sackett
developed an epistemology related to analysis of healthcare delivery outcomes to inform practice
improvement (Rosenberg & Donald, 1995; Sackett et al., 1996). Understanding the cycle of
identifying best evidence from the healthcare literature, integrating this evidence with individual
patient findings to formulate an action plan, evaluating outcomes relative to the individual and
the literature, and creating population-based practice guidelines from the interaction is
fundamental to the EBP process. This epistemology has been designated evidence based
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medicine (EBM), or when applied to healthcare professions other than medicine, evidence based
practice (EBP). EBP epistemology is being developed in the CL, as in other health professions,
as the framework through which to evaluate operational processes, i.e., all phases of the testing
process, directly supporting clinical decision making (Christenson et al, 2011; Leibach, 2011;
Leibach & Russell, 2010; Procop et al., 2019; Smith & Valenta, 2018). MLP EBP development
also includes studies exploring the interactions between analytic and non-analytic testing phases
(Westgard, 2006; Westgard, 2013). Figure 7 graphically represents these theoretical associations.
The EBP paradigm represents a new direction in quality improvement for the CL
(Dickerson et al., 2017; Hill et al., 2020; Plebani et al., 2019a; Plebani et al, 2019b). Therefore,
to complete the theoretical discussion, consideration must be given to preparation of clinical
researchers who will need different skills sets to assess quality issues impacting the total
diagnostics testing and care process. In other words, practitioners will be required to integrate
evidence with practice outside the experimental, statistical model of analytic phase quality
control (Sapatnekar et al., 2021). Education in clinical and quality research methodology must be
directed to practitioners as well as student learners (Maness et al., 2020). Didactic coursework,
clinical internships, post-doctoral fellowships, and continuing professional education must be
designed to inform practice and expose students and practitioners alike to clinical experiences
providing the greatest opportunity to develop research skills necessary not only to utilize
evidence in clinical decision making but also to generate and communicate data-supported
practice guidelines, to monitor patients’ clinical paths, to evaluate and introduce new technology,
to develop quality indicators, and to create and analyze testing algorithms. Not only will health
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outcomes evidence be used in clinical decision making, but these ordering and utilization data
can be analyzed to support evidence for practice improvement across all healthcare delivery
systems, public and private (Aita, et al., 2019; Leibach, 2008a; Leibach, 2008b; Plebani et al.,
2017; Plebani et al., 2019; Siemieniuch & Sinclair, 2014).
Yang et al. (2007, 2015, 2016), Donabedian (1988), Westgard (2006, 2013), Christenson
et al. (2011), Leibach and Russell (2010), and Leibach (2011), have provided robust theoretical
frames for the design and operationalization of substantive CL quality improvement (i.e., clinical
and quality research) programs. Left to fit into the quality improvement (and/or clinical research)
agenda for investigation of the impact of MLP EBP are specific hypotheses related to CL quality
measurements in the various healthcare system components and pre-intervention (pre-change)
baseline studies for comparison. These aspects of the CL clinical and quality research agenda
will be considered next.
Diagnostics Consultation Model© theory and methods summary. More and more,
health services delivery is guided by evidence of medical effectiveness and cost efficiency
(Laposata & Cohen, 2016; Porter, 2010; Procop et al., 2019). Coercive, normative, and mimetic
pressures (e.g., regulatory healthcare reform; normative accreditation standards adoption; and
mimetic competitive cost-reduction and quality enhancement, respectively) have converged with
emerging informatics infrastructure and capability to create conditions favorable for the
development of evidence based quality improvement (QI) and clinical decision support in
clinical laboratory science as well as all other health professions (IOM/NAM, 2015).
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These evidence based QI methodologies provide the clinical research strategies and
structure to evaluate efficacy and effectiveness of CL services and provide evidence based
benefit/cost analyses for provider and consumer decision support (Bombard et al., 2018; Heyer et
al., 2012; Liebow et al., 2012; Snyder et al., 2012a; Snyder et al., 2012b; Yang, 2015; Yang,
2016;). Also inherent in this capability is possible methodology for determining the medical
effectiveness of emerging pharmacogenomics and other molecular testing options through
longitudinal observational studies of predictions and actual health outcomes (Bandeiras, 2020;
Caudell-Feagen & Thompson, 2021).
From a theoretical perspective, this emerging evidence based clinical research capability
allows for the investigation of the impact of isomorphic pressures on the delivery of quality CL
services, and alternatively, the capability of evidence based best practice recommendations to
modify these isomorphic pressures. The research structures now exist to document the quality
impact of all aspects of CL services delivery, analytic and practitioner-effectuated, for purposes
of optimizing medical effectiveness and cost efficiency for every patient/consumer in real time.
The practice emerging to direct these QI clinical research strategies, i.e., evidence based
(MLP) practice, must be cultivated and applied among students and practitioners alike (Chen et
al., 2021). The integration of evidence into practice requires research skills in addition to
technology-based heuristics. And these new competencies must be identified, unbundled to
foundational knowledge concepts and ordered in complexity, and curriculum prepared for
communication to and uptake by practitioners in both hierarchical formal education settings and
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through continuing professional education venues. These EBP clinical research methodologies
also provide strategies for both education and clinical QI program evaluation.
CL information underlies medical decision making in all professions of healthcare
providers (NAM, 2015). Therefore, the communication and uptake of CL EBP clinical research
methodologies as well as the understanding of and compliance with evidence based laboratory
recommendations must be integrated into the practice of all healthcare providers. Any useful,
descriptive, and forward-thinking evidence based research agenda must include provision for
multi- and inter-disciplinary healthcare provider collaborations (Bartman et al., 2021).
In the broadest sense, any evidence based research agenda for CL would not be
comprehensive and effective without the participation of all stakeholders, including MLP,
patients/consumers, and customer healthcare providers. In summary, the isomorphism theory of
Yang et al. (2007, 2016) and the SEIPS work system design model developed by Carayon and
colleagues (2006, 2014, 2018) provide a robust and broad theory base for future development
and implementation of the CL research agenda that incorporates quality and knowledge
creation/translation frameworks operationalized through EBP methodology.
The Diagnostics Consultation Model©: The Communications Portal for CDS
The NAM (2001) defined six domains for the referencing and measuring of health care
quality, the STEEEP typology: Safety, Timeliness, Effectiveness, Efficiency, Equitable, and
Patient-centeredness. Healthcare communications failures can impact services delivery in each of
these domains (Ballard et al., 2014 ; Craig et al., 2020). Therefore, each of these domains should
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be considered in the design, implementation, and evaluation of all healthcare communication
systems.
Though the impact of communications errors on quality of health services delivery has
been well documented for many years, nearly two-thirds of all sentinel events continue to be
related to communication failures (Burns et al., 2021). Further, information handoffs/handovers
are implicated in more than half these errors (Burns et al., 2021; Killin et al., 2021).
Recognizing the quality risks involved in healthcare communications, The Joint
Commission (TJC) has established patient safety goals for safe communications to include
structures for: (1) provision of interactive communications between the giver(s) and receiver(s),
(2) identification of priority information related to the patients’ continuity of care, treatment,
services, and changes in condition, (3) validation of information exchanged between givers and
receivers to assure a shared mental model, and (4) documentation that receivers can review
historical data with limited interruptions (Applebaum et al, 2021; TJC, 2021a).
A communications standard (NPSG.02.03.01) is also a National Patient Safety Goal® for
2021 in the TJC Clinical Laboratory Program (TJC 2021b). The overall goal of the
NPSG.02.03.01 standard is to “improve the effectiveness of communication among caregivers.”
The focus of guidance for performance measurement is the reporting of critical diagnostics
results: (1) “Collaborate with organization leaders to develop written procedures for managing
critical results” by defining critical results and procedures, tracking the recipients of critical
results, and setting and monitoring turnaround times for reporting, (2) implement procedures for
managing critical results, and (3) evaluate the timeliness of these procedures (TJC, 2021b). The
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College of American Pathologists (CAP, a clinical laboratory accrediting body) has adopted a
communication standard in the General Checklist that more specifically addresses information
handoffs:
GEN.61750: Handoff Communication
The laboratory implements a procedure for effective “handoff” communication.
NOTE: The laboratory should have a procedure for communicating information about
pending specimens, tests and patient care issues when responsibility is ‘handed off’ from
one person to another, such as at a change in shift, or when the responsibility for a case is
transferred from one pathologist to another. The procedure should include provision for
asking and responding to questions.
Evidence of compliance: Logs or message boards showing communication between
shifts (Veri, 2021, p. 8).
In this standard, a systems view of healthcare communications, embodied in the STEEEP aims
and implied in the TJC standard, is largely ignored, the focus being interlaboratory operations
(i.e., Safety I).
Since the establishment of TJC communication goals for healthcare institutions, many
approaches to improve communications have been reported (Veterans Administration, 2003). In
2021, Abraham and colleagues (2021) published a systematic review of standardized handoff
intervention studies between operating rooms (ORs) and intensive care units (ICUs) that were
reported between 2011 and 2019. Most of the studies included in the review compared “bundled”
interventions, using process-based protocols and information transfer/communication checklists,
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to existing baseline, non-standardized handoff procedures. All baseline and comparator processes
were manual and documented in the EHR only post hoc and to varying degrees. Abraham and
colleagues (2021) reported meta-analyses of process outcomes (technical errors, information
omissions, information sharing, handoff duration, transition and ordering time) and clinical
outcomes (time to analgesia dosing, antibiotic administration delays, ventilator time, realized
errors). Meta-analyses were performed on measures of technical errors, information omissions,
information sharing, and time to analgesia dosing. The overall effect sizes of each measure
favored the standardized handoff intervention. However, there was little standardization among
studies regarding inclusion of outcome measures within the handoff phases, e.g., selection of
priority patient care information to report during handoff, and within protocol/checklist
construction, e.g., self-report impressions and measures of satisfaction (Arsoniadis, 2020).
Carayon and colleagues (2006) reported an expansion of the Donabedian framework, the
Systems Engineering Initiative for Patient Safety (SEIPS) model, that integrates human factors
and ergonomics into traditional (Safety I) quality models. The detail of the SEIPS model has
been used to develop standardized approaches to interprofessional team (IPT) interactions within
and among institutions that address the interface of structures and process with human attitudinal
and behavioral (performance) factors. In 2018, Cao and colleagues reported a structured process
for IPT rounds in the medical ICU. Later, the design and implementation of IPT processes for
“mixed” rounding covering neurosurgery, neurology, cardiothoracic surgery, colorectal surgery,
general surgery, pediatrics, and medicine service lines were reported (Abraham et al., 2021;
Blazin et al., 2020; Brown et al., 2020). None of these processes address completely the SEIPS
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model construction, however. For instance, the SEIPS model includes measurement of patient
outcomes involving patient safety and quality of care (Carayon et al, 2006). To date,
standardized handoff and rounding efforts have focused on processes for sending and receiving
patient information and some measures of patient safety, e.g., medication errors, time to
treatment, but have not evaluated the impact of these processes on patient clinical outcomes
(Amaral, 2020; Blazin et al., 2020; Desmedt et al., 2020).
A primary contributor to the lack of information on the clinical effectiveness of
standardized communication tools is not only the heterogeneity of the tools themselves but also
the manual nature of the data collection systems supporting the tools (Arsoniadis, 2020). The
repository, transactional structure of EHRs has been reported as a major factor not only in
medical errors involving patient misdiagnosis, but also in provider burnout and moral injury
(Adler-Milstein et al., 2020; Ellis et al., 2020; Williams, 2021). Health informatics methodology,
designed to identify, capture, and analyze relevant data from the electronic health record (EHR),
is needed to compare medical effectiveness of algorithm variations and generate evidence on
which to base recommendations regarding best practices in communications (Casey et al., 2020;
Caudell-Feagen & Thompson, 2021; Glaser, 2020; Strizich & Kim, 2021). Researchers have
reported the utility of transactional EHR data, e.g., dashboards, in the improvement of
diagnostics test utilization and screening test follow-up (Krasowski et al., 2015: Shanbhag &
Bender, 2020; Sivashanker et al., 2021). However, much developmental work remains to be done
in clinical research and IT methodology before the integration of clinical outcomes with the
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transactional record to create electronic, searchable clinical summaries for care continuity
(Safety II) becomes feasible (Arsoniadis, 2020; Glaser, 2020; Weiskopf & Weng, 2013).
Non-MLP healthcare providers have signaled the need for assistance in navigating all
phases of the diagnostics testing process, i.e., pre-analytic, analytic, and post-analytic (Hickner et
al., 2014; Laposata & Cohen, 2016; Procop et al., 2019; Schmidt et al., 2014; Strizich & Kim,
2021). With the increasingly frequent application of business operations dashboard structure to
quality indicator tracking, application programming interfaces and middleware have been
developed to support consultation modules within pathology practice (Church & Naugler, 2020;
Rashidi et al., 2019; Schmidt et al., 2014; Stendhl et al., 2021; Theparee et al., 2018). Most of
these modules are designed for anatomic pathology practice and involve artificial
intelligence/machine learning approaches to image interpretation (Church & Naugler, 2020;
Rashidi et al., 2019). Some however, address Safety II aspects of diagnostics consultation
questions. The CL-based consultation modules reviewed are a blend of manual and digital
processes; addressed convenience samples of post-analytic questions only; provided no guidance
on IPT reporting, tracking, or work process analyses; and involved pathologists and pathology
residents only (Schmidt et al., 2014; Stendhl et al., 2021; Theparee et al., 2018).) The design of
these CL-based consultation modules, though commendable initial efforts, do not incorporate the
other error reporting, mitigating, and feedback functions of the CL, e.g., incident report followup, evaluation of reference test requests, optimization of test orders. Much of this additional CL
consultation work is conducted by MLP non-physicians and provides the CDS evidence base for
the majority of health providers (Hickner et al., 2014; Procop et al., 2019). In order to fully
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achieve the goals of the NAM Quality Aims and TJC and CAP communications standards, a
more robust CL-based consultation system is needed to address both interlaboratory and systemwide communications.
Documenting and characterizing the consultations of all medical laboratory professionals
(MLP, i.e., physicians and clinical laboratory scientists associated with the clinical laboratory)
with other healthcare practitioners could contribute significantly to Safety II objectives by
providing real time evidence for the types of clinical issues consuming substantial human and
material clinical laboratory resources, i.e., DCM© Arm 1 of the Clinical and Quality Research
Program. DCM© components associated with Arm 1 of the DCM© Research Program are
outlined in Figure 8.
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Figure 8. DCM© Components of Arm 1 of the DCM© Clinical and Quality Research Program.
Information flows through component work processes linking analytic and clinical data for
purposes of evidence based clinical and quality improvement.
Analysis of these data, addressed in Arm 2 of the DCM© Clinical and Quality Research
Program, could identify priority, resource-intensive diagnoses and conditions from the vantage
point of the clinical laboratory. DCM© components associated with Arm 2 of the DCM©
Research Program, i.e., the clinical database and patient/consumer data warehouse, are outlined
in Figure 9. The order of priority of these diagnoses (Arm 1) could then be compared to priority
diagnoses and chronic diseases documented enterprise-wide (Arm 2). Quality improvement
studies targeted toward development of diagnostics algorithms could then be designed for the
priority diagnoses in common to both of the DCM© Research Arms.
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Figure 9. DCM© Components of Arm 2 of the DCM© Clinical and Quality Research Program.
Information flows through component work processes linking analytic and clinical data for
purposes of evidence based diagnostics algorithm development
Once developed, these ordering algorithms could be applied to the real time monitoring
of patients with priority diagnoses. If ordering patterns in individual patients differ significantly
from documented “standard” clinical pathways (test ordering algorithms derived from EHRmined utilization data), MLP would investigate analytic and non-analytic circumstances
contributing to the variances, intervening when appropriate to address emergent patient safety
and care concerns. Recently, collection and warehousing of clinical information extracted from
the EHR for digital analysis has been accomplished through the use of clinical dashboards
(Kudler & Pantanowitz, 2010; Lippi et al., 2015; Luo et al., 2016; Mashinchi et al., 2020; Mercer
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et al., 2018; Naugler & Church, 2019; ONC, 2020; Plebani et al., 2019; Procop et al., 2014;
Rosenbaum & Baron, 2018; Rudolf & Dighe, 2019; Stockbine et al., 2020; Whitehead et al.,
2019b). This monitoring and patient safety activity would become standard of care for the
laboratory (Leibach, 2011).
Evidence based practice (EBP), and the operationalization of MLP EBP, has emerged as
the applied methodology guiding clinical and quality studies identifying priority diagnoses for
value-based improvement (Leibach, 2010; Leibach, 2011). Documenting and characterizing
MLP consultations through a communications portal interfacing with other healthcare
practitioners should be designed, implemented, evaluated, and maintained as a foundational part
of these institutional quality plans.
The Diagnostics Consultation Model©: The Framework of the Study
The overarching goal of this work is to describe the Diagnostics Consultation Model©
(DCM©), a clinical laboratory (CL) communications portal, designed and proposed to support
clinical decision making (CDM) within interprofessional teams, providers, and institutions. The
DCM© frames the theoretical and applied constructs of quality, clinical research, evidence based
practice, and clinical decision support necessary to address the associated diagnostics
communications workflow. The study’s research questions address the probability of developing
an accurate diagnostics workflow prediction model, i.e., the complexity index (CI), to direct
consultation requests to MLP practice levels with requisite education, CT competencies, and
experience to resolve consultations accurately, thoroughly, and efficiently. The data involved in
developing and evaluating the CI were gathered from real world consultation experiences of
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various levels of MLP practitioners in the clinical laboratory. These data will be analyzed to
determine the MLP levels of education, CT competencies, and work experiences best suited to
address consultations of differing complexities. Further, the DCM© framework suggests
workflow pathways for CDS communications among IPT members, individual healthcare
providers, and among institutions that accommodate various complexities encountered in
diagnostics consultation processes.
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CHAPTER 3
RESEARCH DESIGN AND METHODOLOGY
The study’s research questions address the probability of developing an accurate
diagnostics workflow prediction model, i.e., the complexity index (CI), to direct consultation
requests to MLP practice levels with requisite education, CT competencies, and experience to
resolve consultations accurately, thoroughly, and efficiently. The data involved in developing
and evaluating the CI were gathered from real world consultation experiences of various levels
of MLP practitioners in the clinical laboratory. Data were collected describing consultation
characteristics as well as workflow processes involved in consultation resolution. Initial
analyses, proffered in the pilot study, answered broad research questions addressing
documentation of CL consultation occurrence, consultation characteristics, and the association of
these characteristics with different MLP practice levels. The dissertation study built on pilot
study findings with focused research questions related to prospective prediction of MLP practice
levels best suited to address consultations of differing complexities using consultation
characteristics available upon consultation initiation.
The Pilot Study Summary
Pilot and dissertation study analyses were conducted on the same dataset with
development of the dissertation study research questions guided by findings from the pilot study.
The full and complete pilot study report is included as Appendix B; a summary is presented here.
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Pilot study purpose. To begin to address the CL knowledge and practice gap related to
diagnostics consultation, an exploratory pilot study, the “Clinical Laboratory Performance
Measures Project,” was conducted to document and characterize MLP involvement in
consultation with other healthcare providers. From analysis of these consultation interactions, the
impact of laboratory information in clinical decision making was measured and thus evidence
was provided regarding the role of MLP consultations in clinical decision support (CDS). The
project addressed research questions regarding aspects of the role of MLP in CDS through the
implementation of an electronic (and also paper) data collection log for capturing important
aspects of consultations among MLP. Characterizing these consultative interventions and
analyzing their complexity and medical subject focus led to the identification of consultations
that impact (and vary with) CDS.
Pilot study research questions. The following research questions were investigated:
(1) What are the characteristics of MLP consultations with other healthcare providers as
categorized by area of the clinical laboratory involved; time of day requested; medical
service/hospital location; urgency; healthcare provider type initiating the consultative event;
consultation type (i.e., phase of test cycle in question); number of handoffs/logic steps; and
medical subject area?
(2) Which consultation characteristics, i.e., area of the clinical laboratory involved; time of day
requested; medical service/hospital location; urgency; healthcare provider type initiating the
consultative event; test cycle phase involved); number of handoffs/logic steps; and medical
subject/hospital location, are associated with MLP practice level involved in final
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consultation disposition? The related hypothesis is that some conditions and levels of the
independent variables are associated with the MLP practice level involved in the final
disposition of consultations.
Pilot study design and methods.
Clinical laboratory data collection log development. MLP managers and clinical
pathology section chiefs (also considered MLP) were asked to participate in study instrument
design, piloting, implementation, analysis, and evaluation.
Population definition and sample characteristics. The study population was defined as
all documented interventions (consultations) between MLP and other healthcare providers
(hospital-based users of laboratory information) in a 600-bed, tertiary care hospital affiliated
with an academic medical center. Both electronic and face-to-face interactions were considered
as consultations. Data on 325 consultation events, i.e., N=325 consultation cases, were recorded
during the 11-week data collection period.
The CL data collection log (Appendix A) was completed by participating MLP during the
normal workday (24 hours per day, 7 days a week) as consultations occurred. MLP consultations
were described demographically by CL area, date/time, medical service/hospital location,
urgency status, type of provider initiating the consultation intervention, number of handoffs/logic
steps, and testing cycle phase, i.e., pre-, post-, and analytic, to which they related.
Data abstraction procedure. Algorithms for variable recoding to increase power for
analyses were developed from granular data as defined in Table 2. The original categories are
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shown in Figure 10. Further, a data abstraction table was created for recording additional
assessments derived from the statistics data table.
Table 2
Summary of Category Transformation Algorithms in the Pilot Study

Variable

Initial Number
of Levels

CL Area

12

Provider Type

7

Test Cycle Phase

7

Handoffs/logic
steps

5

MLP Practice
Level
Consultation
Disposition

6

Transformed (Recoded) Number
of Levels
0 = Professional Knowledge (non-specimen receiving areas)
1 = General Knowledge (specimen receiving area)
0 = Non-RN
1 = RN
1 = Pre-analytic (test select, place order, collect/ID/transport)
2 = Analytic (specimen analysis)
3 = Post-analytic (obtain result, results logic, other)
1 = One logic step, no handoffs
2 = Two hand-offs/logic steps
3 = Three or greater handoffs/logic steps
1 = MLP Level 1 (MLP complete, one logic step and no
handoff)
2 = MLP Level 2 (Referred to MLP/MLP Manager)
3 = MLP Level 3 (Referred to physician to include pathology
resident, pathologist, and medical resident/attending
physician)

These additional assessments, i.e., number of handoffs/logic steps, MLP practice level
disposition, and medical subject categories, were qualitatively derived from “consultation
summary,” “forward,” and “reviewer comments” entries in the consultations data collection log
(Appendix B). Resultant definitions of handoffs/logic steps and MLP practice level disposition
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categories are given in Table 3. Medical subject categories were derived from a thematic analysis
of consultation topics as reported in the consultation summary and reviewer comments sections,
also shown in Table 3.
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Table 3
Pilot Study Original Categories and/or Non-recoded Consultation Characteristics Summary
Original Categories and/or Non-recoded Consultation
Characteristics (IV) N = 325
Clinical Laboratory Area Involved
Chemistry
Clinical Pathologists/ Residents
Immunology/Send Outs
Outpatient (Medical Office Building)
Point of Care Testing
Receiving
Missing Data: % = (1.00 – n/N) x 100

Time of Day Initiated
8 a.m. – 12 p.m.
1 p.m. – 4 p.m.
Other
Missing Data: % = (1.00 – n/N) x 100

Medical Service/Location Origin
Emergency Department
Chemistry (Clinical Laboratory)
Other
Missing Data: % = (1.00 – n/N) x 100

Urgency
Routine
STAT
Missing Data: % = (1.00 – n/N) x 100

Healthcare Provider Type
RN
Other (administrators, MLP, medical
students, pharmacists, physicians,
respiratory therapists)
Missing Data: % = (1.00 – n/N) x 100

Consultation Type (Test Cycle Phase Involved)
Pre-analytic: Test Select, Place Order,
Collect/ID/Transport
Analytic: Test Parameters
Post-analytic: Obtain Result, Results Logic,
Other
Missing Data: % = (1.00 – n/N) x 100
Medical Subject
Education
Genetics/Molecular
Technology Decisions
IT Ordering
Pediatric Genetics/Molecular
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IV
Frequency

IV
Percent

n = 278
63
42
35
3
40
95
47
n = 182
37
37
26
143
n = 270
28
23
219
55
n = 278
191
87
47
n = 289
143
135

100
23
15
13
1
14
34
14
100
37
37
26
44
100
10
9
81
17
100
69
31
14
100
51
49

47

14

n = 278
137

100
49

86
55

31
20

47
n = 278
3
6
16
96
5

14
100
1
2
6
35
2

Results Resolution
Patient Safety/Identification
Test Integration/Evaluation
Proficiency Testing
Specimen Referral/Send Out
Missing Data: % = (1.00 – n/N) x 100

75
36
19
3
19
47

27
13
7
1
7
14

Each of the 325 recorded consultation events was assigned to a medical subject category
defined as either: (1) education, (2) genetics/molecular, (3) technology decisions, (4) information
technology/ordering, (5) pediatric genetics/molecular, (6) analytic results resolution, (7) patient
safety/identification, (8) test methodology integration/evaluation, (9) proficiency testing, or (10)
specimen referral/send out. The “comments” field was used to record free-form comments
related to issues arising from the consultation CDS process itself, or documentation from it.
Pilot study results.
Characterization of consultation requests (question 1). Data were collected on seven
characteristics (independent variables, IV): (1) CL area involved, (2) date/time, (3) medical
service/hospital location, (4) urgency, (5) healthcare provider initiating the consult, (6)
consultation type, i.e., testing cycle phase related to the consultation, and (7) number of
handoffs/logic steps. Consultation characteristics are reported in Table 3.
Definition of MLP practice level consultation disposition. Consultation disposition was
defined as the MLP practice level involved in final consultation resolution and was
originally assigned into one of four categories. Most consultations, 77% (214/278), were
completed at the time of initial contact with a MLP, e.g., by phone or in person, without the need
for further investigation; further investigation is defined as additional handoffs or logic steps
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requiring additional consultation with MLP practice levels 1-3 (MLP, MLP manager/technical
specialist, and/or MD/PhD/DCLS. Non-MLP practitioner consults were documented but nonMLP practitioners were not considered a MLP practice level because workflow processes
demonstrated that clinical information from non-MLP practitioners supported decision making
by MLP Practice Level 3. Therefore, for further future analyses, these non-MLP consult
frequencies were combined with MLP practice level 3 frequencies for a final total of three MLP
practice levels. Frequencies for all disposition categories are shown graphically in Figure 10.
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Completed

Referred to MLP
Manager

Referred to Clin
Path

Consult
Attending HS

Figure 10. Frequency of Consults by MLP Final Disposition Category:
MLP Practice Level 1: “Completed” = 77% (214/278 consults)
MLP Practice Level 2: “Referred to MLP Manager” = 15% (41/278 consults)
MLP Practice Level 3: “Referred to Clin Path” = ≤1% (2/278 consults)
Non-MLP Practitioner: “Consult Attending/HS” = ≤2% (6/278 consults)

Definition of consultation handoffs/logic steps. Pilot study data indicated that even
though consultation resolution could require multiple handoff/logic steps among multiple
individuals within each MLP practice level (i.e., up to 5), most consultations were resolved with
three or less handoffs/logic steps. Because of the low numbers of handoffs/logic steps in
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categories 4 and ≥ 5 handoffs/logic steps, variable values were recoded into three categories:
category 1, 1 logic step; category 2, 2 handoffs/logic steps; and category 3, ≥ 3 handoffs/logic
steps. See Table 2.
Consultation characteristics related to consultation disposition (question 2).
Transformation of medical service area data resulted in 11 medical services to be used in
analyses on this variable. See Table 4. In addition, two of the seven variables, i.e., date/time and
urgency, did not correlate with MLP practice level disposition. Analyses using date/time and
urgency were, therefore, not considered as potential predictor variables. Provider type was
removed from consideration as a predictor of MLP practice level consultation disposition
because missing data analysis resulted in significant mean differences between all cases and
cases with missing data eliminated. The variable, clinical laboratory area, was also excluded
from consideration as a predictor of MLP practice level consultation disposition due to data
collection limitations rather than missing data. Major CL areas for consultation, e.g., transfusion
service, microbiology, and hematology/coagulation, did not participate in the pilot study due to
work force shortages. Though data from the remaining participating CL areas is informative
from methodology and processes perspectives, conclusions drawn related to MLP practice level
and resources utilized in these areas would not be generalizable to the larger CL and potentially
misleading if reported.

77

Table 4.
Summary of Medical Service Transformation Algorithms

Original Medical
Service Areas
1, Allergy
2, Cardiology
3, Cardiac CCU
4, Dermatology
5, Endocrinology
6, ENT
(Otolaryngology)
7, Emergency/
Trauma
8, Family Medicine
9, Gastroenterology
10, Geriatrics
11, Gynecology
12, Hematology
13, Infectious
Disease
14, Medicine (Gen)
15, Medicine (Other)
16, Med ICU

17, Nephrology
18, Neurology
19, Neuro ICU
20, Nursery
21, Nursery ICU
22, Obstetrics (L&D)
23, Oncology
24, Ophthalmology
25, Orthopedics
26, Pediatrics
27, Pediatrics ICU
28, Pulmonology
29, Rheumatology
30, Surgery (Gen)

Consultation
Number
(Original
Areas)
1
14
0
0
0
0

Medical Service
Area
Transformations

1, Cardiology

14

2, Emergency/
Trauma
3, Family Medicine

58

4, ICU:
3 (Medicine)
6 (Neurology)
4 (Nursery)
10 (Pediatrics)
7 (Surgery)

30

5, Obstetrics
6, Oncology

34
10

7, Pediatrics

24

8, Surg Gen

18

9

10, Oncology

0
0
3

0
2
6
0
4
34
10
0
0
24
10
1
0
18

Consultation
Number
(Transformed
Areas)

37, Other

58
9
0
0
0
1
0

Transformed
Medical Service
Areas

37, Other
16, Med ICU
16, Med ICU

16, Med ICU
37, Other
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31, Surgery (Other)

13

32, Surgery ICU
33, Telemedicine
34, Transplant
35, Urology
36, Clin Lab
37, Other

7
0
8
0
59
40

9, Surg Other:
13 (Other)
8 (Transplant)

21

10, Clin Lab
11, Other:
40 (No Service
Noted)
1 (Allergy)
2 (Neurology)
1 (Pulmonology)

59
44

16, Med ICU
31, Surgery (Other)

The remaining potential predictor variables, i.e., consultation type (test cycle phase),
number of handoffs/logic steps, medical service/hospital location, and medical subject were then
assessed for their association with MLP practice level consultation disposition. A series of
crosstabulations were conducted using the potential predictor variables against the DV, MLP
practice level, i.e., levels 1-3, resolving the consultation case. The resulting contingency table
gives both the significance (Pearson’s Chi-square) as well as strengths (Cramer’s V) of the
relationships among variables. The results of these crosstabulations are given in Table 5.
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Table 5.
Statistical Inferences Among Variables Predicting MLP Practice Level
Consultation Disposition

Crosstabulation

Inferential Statistics
Cramer’s V

MLP Practice
Level Disposition
(3 Levels) by:

Value

df

Siga

Value

df

Siga

Value

Siga

Test Cycle Phaseb

32.387

4

≤ .01

28.533

4

≤ .01

.227

≤ .01

Medical Subjectc

98.390

18

≤ .01

74.838

18

≤ .01

.396

≤ .01

Medical Serviced

30.733

20

.059

39.479

20

.006

.218

.059

Pearson Chi-Square

Likelihood Ratio

Handoffs/Logic
97.166
4
≤ .01 122.713
4
≤ .01 .393
≤ .01
Stepse
an
Asymptotic significance
b
Test cycle phase = Consultation type, 3 levels (Pre-analytic, Analytic, Post-analytic)
c
Medical Subject = 10 levels (Education, Genetics/Molecular, Technology Decisions, IT
Ordering, Peds Genetics/Molecular, Results Resolution, Safety/ID, Test Integration/Evaluation,
Proficiency Testing, Specimen Referral/Transport)
d
Medical Service/Hospital Location = 11 Levels (Cardiology; Emergency/Trauma; Family
Medicine; ICUs; Obstetrics; Oncology; Pediatric; Surgery, General; Surgery, Other; Clinical
Laboratory; Other)
e
Handoffs/Logic Steps = 3 levels (completed with one logic step, no handoff; two handoffs/logic
steps; ≥3 handoffs/logic steps)
Findings from these crosstabulations corroborated that four predictor variables, test cycle
phase, medical service/hospital location, medical subject, and handoffs/logic steps, were
significantly associated with MLP practice level resolving consultations (Pearson’s Chi-square
and likelihood ratio statistics) and that the strengths of the relationships were strong (Cramer’s V
statistics). Medical service, though not significantly correlated (p=.059) with MLP practice level
disposition with 95% confidence, nevertheless, showed potential enough (likelihood ratio=.006)
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to be tested further in the CI regression model with test cycle phase. In addition, not all 11
medical service areas were found to be significant in the model. Further analyses determined
which medical services did not contribute to the model; those were removed and correlation
significance increased.
Diagnostics Consultation Model© research program construction. In the pilot study,
MLP consultation characteristics, e.g., test cycle phase, CL area, other health professionals
involved, medical service, medical subject, were described for the first time. Then correlations of
these characteristics with final consultation disposition by MLP practice type were considered.
The dissertation study builds on these correlations to question if certain characteristics
correlating with disposition by MLP practice type can predict workflow to the correlated MLP
practice types and suggest a communication strategy for consultation response both within the
clinical laboratory (intralaboratory/interlaboratory) and among health providers throughout the
health system.
The Study
Analyses from crosstabulations of pilot study data indicate that MLP practice level
consultation disposition can be predicted by test cycle phase, medical subject, medical service,
and number of handoffs/logic steps required to resolve the consultation clinical question. These
findings suggested the opportunity for further explorations in focusing laboratory information for
targeted clinical decision support (CDS) in patient/consumer care. Specifically, direction of
resources to appropriately prepared MLP practice level for consultation disposition could be
based on some combination of the four predictor variables correlated with MLP practice level
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disposition. Thus, a prediction model for allocation of appropriate resources based on
consultation characteristics was developed. These linkages also suggested the design of evidence
based operational processes, e.g., workflow direction through a communications portal, for
optimization of consultation resolution assessed by improvement in clinical and quality
outcomes.
Study design. The study was designed to further characterize consultations by
developing methodology to predict the MLP practice level most appropriate to resolve a
consultation case by using consultation descriptors available at the point of consultation
initiation. Pilot study findings suggested, further, that MLP practice levels resolving consultation
cases were correlated with other descriptors available only after consultation completion. The
descriptors available after consultation completion were used to test the predictive performance
of the methodology developed using descriptors collected at the point of consultation initiation,
i.e., pre-consultation.
Study aims. The study explored relationships among consultation case data and the MLP
practice levels resolving those consultations by investigating patterns in consultation resolution
that were hypothesized to predict the appropriately skilled MLP practice level most prepared to
address the consultation case. Findings from these analyses advance the capabilities of clinical
laboratory scientists to implement evidence based practice efficiently and effectively through
consultation.
Research question 1. Can the MLP practice level resolving consultations be predicted by
an index derived from the variables test cycle phase and medical service/hospital location?
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H1:

MLP practice level resolving consultations can be predicted by an index

derived from the variables test cycle phase and medical service/hospital location.
The CI adjusted to different variance contributions of the two individual predictors and
described the MLP practice level resolving the consultation more consistently than the
individual predictor variables alone.
Aim 1. Three MLP practice levels have been associated with consultation final
disposition: (a) MLP Level 1, MLP; (b) MLP Level 2, MLP/MLP Specialist/Manager; and (c)
MLP Level 3, clinical pathologist/resident/MD. Using data from consultation events occurring in
a variety of clinical settings, consultation cases were characterized by MLP practice level
resolving consultations using test cycle phase and medical service/hospital location as predictors.
A complexity causal model was developed from these two predictor variables to represent the
composite variable, complexity index (CI).
Research question 2: Can MLP practice levels resolving consultations be predicted by
number of handoffs/logic steps and medical subject associated with consultation cases?
H2:

MLP practice levels resolving consultations can be predicted by number of
handoffs/logic steps and medical subject associated with consultation cases.

These variable values, available only after consultation completion, defined a
typology of increasing scope of knowledge and professional responsibility represented by
MLP practice levels, 1-3.
Aim 2: Analyses of relationships among MLP practice levels and number of
handoffs/logic steps required for consultation resolution and medical subject involved were
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undertaken, also. These variable values, number of handoffs/logic steps and medical subject,
were available only after consultation resolution and predicted the same or similar MLP practice
level resolving consultations as the prediction model using IVs available at the point of
consultation initiation, i.e. pre-consultation. A comparison of the pre-consultation completion
and post-completion models was used to validate the prospective predictive performance of the
CI.
Study method. Study analyses progressed guided by these steps:
1. The consultation cases sample size (N=325) was considered large enough to power analyses
supporting the research questions of the study. Data were cleaned by evaluating missing data,
outliers, normality, and linearity. In preparation for regression analyses, homoscedasticity
and independence of residuals were also assessed. Power analyses were performed from the
determination of the ratio of cases to IVs.
2. MLP practice levels responsible for consultation resolution were defined in the pilot study by
analyses of final consultation disposition/resolution. MLP practice levels defined are (a)
MLP Level 1, MLP; (b) MLP Level 2, MLP/MLP Specialist/Manager; and (c) MLP Level 3,
clinical pathologist/resident/MD.
3. A diagnostics workflow prediction model, the complexity index (CI), was developed using
the independent variables, test cycle phase and medical service/hospital location, and
dependent variable, MLP practice level. The predictive performance of the complexity index
was then evaluated against variable values available after consultation completion, i.e.,
numbers of handoffs/logic steps and medical subject, that also correlated with MLP practice
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levels involved in consultation final disposition, i.e., MLP Levels 1-3. The CI predicted
similar MLP practice levels from both datasets, i.e., the independent variables available at the
point of consultation initiation and those available after consultation completion.
4. These findings formed the basis of methodology to identify work processes optimizing
workflow through the Diagnostics Consultation Model© communication portal. The
methodology described the development of a complexity index that is intended to function, at
the point of consultation initiation, to direct work orders to the MLP practice level with the
competency and experience skill set most closely aligned with the resources required for
resolution of the consultation case.
In summary, a complexity index was developed from consultation case data related to test
cycle phase and medical service/hospital location from which the consultation request originated.
Then MLP practice levels were described by number of handoffs/logic steps and medical subject
involved in consultation resolution. These MLP practice level descriptors, documented after
consultation completion, defined a typology of increasing scope of knowledge and professional
responsibility represented by MLP practice levels 1-3. The complexity index predicted the same
or similar MLP practice levels from the variables collected at the point of consultation initiation
(pre-consultation) as from those available after consultation completion.
Research question 1: study analyses. The research question related to the first aim is:
Can the MLP practice level resolving consultations be predicted by an index derived from the
variables test cycle phase and medical service/hospital location? Index variables (test cycle phase
and medical service area, i.e., independent variables, IV) were modeled with the MLP practice
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level involved in final consultation disposition (dependent variable, DV) to create the composite
predictor variable, complexity index.
1. Research question 1, qnalysis 1: Analysis 1 defined the complexity index by predicting the
relationship among the predictor variables, test cycle phase and medical service/hospital
location, and the dependent variable, MLP practice level (levels 1-3) involved in consultation
disposition. There were 2 IVs for this analysis: (1) test cycle phase (3 levels: pre-analytic,
analytic, post-analytic) and (2) medical service area (11 levels, see Table 4 for medical
service/hospital location categories). These IVs entered the regression model together to
distinguish the DV, MLP level involved in consultation disposition. The regression equations
follow:
a. Modeling with Test Cycle Phase:
MLP practice level = Test Cycle Phase (cyclic phases treated as continuous
variables).
b. Modeling with Medical Service/Hospital Location:
MLP practice level = Test Cycle Phase + Medical Service/Hospital Location (add
each service, one by one).
2. Research question 1, analysis 2: The full regression model defined the complexity index.
Candidate IVs included those categories of medical service/hospital location found
statistically significant with 95% confidence in the last step of the analysis. The model is:
MLP practice level = Test Cycle Phase + Medical Service/Hospital Location (best
predictors).
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All the regression models were evaluated using Multiple R2 and its associated p value
along with standardized beta weights for each of the IVs in the models.
Research question 2, study analyses. Handoffs/logic steps and medical subject were the
variables documented after consultation completion that correlate with MLP practice level.
These variables were tested to develop a model predicting the level of human resources required
to resolve consultation queries (i.e., MLP practice level) using these variable values available
after consultation completion.
1. Research question 2, analysis 1: Define the post-consultation completion predictive model by
testing the relationship among the IVs, handoffs/logic steps and medical subject, and the
dependent variable, MLP practice level (levels 1-3) involved in consultation disposition.
There were 2 IVs for this analysis: (1) handoffs/logic steps with 3 levels (completed with one
logic step, no handoff; two handoffs/logic steps; ≥3 handoffs/logic steps) and (2) medical
subject (10 levels). See Table 3 for medical subject categories. These IVs entered the
regression model together to distinguish the DV, MLP level involved in consultation
disposition. The regression equations follow.
a. Modeling with Handoffs/Logic Steps:
MLP practice level = Handoffs/Logic Steps (add each level, one by one).
b. Modeling with Medical Subject:
MLP practice level = Medical Subject (add each level, one by one).
3. Research question 2, analysis 2: The full regression equation defined the post-completion
prediction model. Candidate IVs included those categories of handoffs/logic steps and
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medical subject found statistically significant with 95% confidence in the last step of the
analysis. The model is:
MLP practice level = Handoffs/Logic Steps (best predictors) + Medical Subject (best
predictors).
All of the regression models were evaluated using Multiple R2 and its associated p value
along with standardized beta weights for each of the IVs in the models.
Study method summary. In summary, methods for continuous clinical and quality
improvement of CL CDS consultation services were described in this study. Methods are
proposed that, first, describe processes for documentation of characteristics of consultation
events occurring in CL operations. Then methodology to develop processes directing workflow
(i.e., consultation requests) to appropriately prepared MLP is described that is derived from
analyses of these consultation characteristics. This methodology describing processes that direct
workflow, i.e., the complexity index, is intended to be incorporated into workflow processes at
consultation initiation to increase the efficiency and medical effectiveness of the consultation
process by directing consultations to the appropriately prepared MLP. The quality of the
workflow direction process can be continuously improved by refining the CI with additional
consultation outcomes data.
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CHAPTER 4
Results
Study Development, Implementation, and Evaluation Process
Development, implementation, and evaluation of the dissertation study followed the steps
of the A6 HCQR Method. In Steps A1-A3 (ASK, ACQUIRE, APPRAISE), assessment of the
body of findings from the pilot study detailed in Appendix B led to the refinement of two
research questions and study methods formulated to frame analyses to address them. In Step A4
(ANALYZE), analyses were developed that determined the strength of the contribution of
consultation characteristics available at the point of consultation initiation to MLP practice level
consultation disposition. From these analyses, a diagnostics workflow prediction model, the
complexity index (CI), was designed and developed. In Steps A5 (APPLY) and A6 (ASSESS),
analyses were conducted and evaluated.
A6 HCQR Steps A1-A3: ASK, ACQUIRE, and APPRAISE
The two research questions investigated were: (1) Can the MLP practice level resolving
consultations be predicted by an index derived from the variables test cycle phase and medical
service/hospital location? and (2) Can MLP practice levels resolving consultations be predicted
by number of handoffs/logic steps and medical subject associated with consultation cases?
The independent variables, test cycle phase and medical service/hospital location, were
documented at the point of consultation initiation and thus are meaningful as contributors in
a prospective workflow predictive model (i.e., complexity index, CI). The independent variables
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handoffs/logic steps and medical subject involved in consultation resolution were documented
after consultation completion and define a typology of increasing scope of knowledge and
professional responsibility represented by MLP practice levels 1-3, the dependent variable in the
analyses.
The complexity index predicts the same or similar MLP practice levels from the variables
collected at the point of consultation initiation (research question 1) as MLP practice levels
predicted from those available after consultation completion (research question 2). Therefore, the
predictive model developed from post-consultation descriptors served to test the predictive
performance of the model (CI) developed using descriptors collected at the point of consultation
initiation.
Assessment of data fitness. The appraisal of findings included an evaluation of the
fitness of the data to support conclusions from analyses addressing the research questions. The
dataset was prepared by evaluating accuracy/coding errors, missing data, normality, linearity,
and outliers. In preparation for regression analyses, homoscedasticity (homogeneity of variance)
and independence of residuals (multivariate normality) were also assessed when appropriate.
Power was evaluated post hoc by the determination of the ratio of cases on each variable to each
IV or DV, also, to further assess statistical conclusion validity. The analytic variables assessed
are test cycle phase, medical service/hospital location, medical subject, handoffs/logic steps, and
MLP practice level. Medical service/hospital location and medical subject are categorical
variables and will be analyzed as such through a binary transformation of each level of the
variable. Test cycle phase, handoffs/logic steps, and MLP practice level are ordinal level
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measurements but will be analyzed as interval level justified by the relatively large number of
cases (N=325) and the assumptions of the central limit theorem (Tabachnick & Fidell, 2007).
Aim 1 analytic predictor variable: medical service/hospital location (categorical
level variable). Medical service/hospital location, a categorical variable, was collected in 37
categories or groups, i.e., from 37 medical service areas. Considering major service area
divisions and cases in each, these levels were subsequently recoded into 11 levels. Table 4 tracks
each step in the transformation from 37 to 11 levels. Two coding errors were resolved, and no
missing data were found in the recoded cases after review for accuracy. There are no univariate
outliers as all variables are discrete. One of the 11 levels, “other,” is comprised of cases with
either no medical service unit recorded or represented by less than three cases. Reasoning that
none of the cases in this level would prove significant in analyses, the 44 cases in the “other”
category were eliminated from further analysis but still considered in the total 325 cases as not
originating from one of the other 10 medical services/hospital locations. After elimination of this
category, the 10 categories remaining for analysis for aim 1 were represented by cases received
from medical services not in this “other” variable category for a total computational number of
325 cases. Homogeneity of variance and normality were then evaluated by examining cell case
counts. The smallest number of cases in any category is nine and the largest is 60. According to
Tabachnick & Fidell (2007), the smallest cell of a normally distributed categorical variable
should be at least 10% the size of the largest cell. Using this criterion for interpretation, the
distribution of medical service/hospital location variable can be assumed to be normal in further
analyses for aim 1.
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Aim 1 analytic predictor variable: test cycle phase (ordinal/interval level variable).
Test cycle phase, an ordinal variable, was collected in seven levels then recoded into three levels
for analysis: pre-analytic, analytic, and post-analytic. The pre-analytic level includes activities
occurring before analyte testing, i.e., test selection; order placement; and specimen collection,
identification, and transport. The analytic level encompasses analytic activities most commonly
performed using instrumentation and evaluating computerized outputs. The post-analytic level
includes activities occurring after analyte measurement related to documentation and
communication of testing results, i.e., obtaining a valid test result, explaining the context of the
result, and apprising the end user of additional information needed for interpretation and CDS.
No entry inaccuracies or missing data were found upon review; 325 cases were analyzed.
The test cycle phase variable, was found to be both skewed and kurtotic. See Figure 11. The
skew was slightly negative, -.703 (with a standard skew error of .135 resulting in a ratio of 5.21),
and kurtotic (-1.196 with a standard kurtosis error of .270 resulting in a ratio of 4.43). Normal
skew and kurtosis are both defined for this analysis as 3.3. or less (p=.001). The histogram
suggested, however, that the distribution was reasonably normal with slight negative skew that
might be improved by transformation.
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Figure 11. Non-transformed Histogram for the Test Cycle Phase Variable
Square root transformation produced a more symmetric histogram, meaning that skew is
closer to 0 (more values closer to the mean), though flatter (more negative kurtosis with less
values closer to the mean). Because skew was improved, the square root transformation was
adopted for use in the regression model even though the distribution remains non-normal. The
square root transformation histogram for the test cycle phase variable is shown in Figure 12.
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Figure 12. Square Root Transformation Histogram for the Test Cycle Phase Variable
Aim 2 analytic predictor variable: medical subject (categorical level variable). Data
on medical subject, a categorical variable, were collected into ten levels defined in Table 3. A
frequency distribution was reasonable and revealed no coding errors; there are no missing data.
There are no univariate outliers as the only values possible for the levels were between one and
ten, where each level was transformed into its own binary variable. Homogeneity of variance
was evaluated by comparing the category case counts. The medical subjects of “education” and
“proficiency testing” had insufficient number of cases to assume a predicted cell size less than or
equal to 5 (i.e., 10% or more of the largest cell number) in keeping with the homogeneity of
variance and normality assumption (Tabachnick & Fidell, 2007).
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Each of the ten category levels was transformed into a binary variable with a code of 1, if
the case fit into that category, and a code of 0 otherwise. The number of cases in each of the
resulting 10 binary variables was checked against total medical subject cases to verify the
accuracy of the transformations. These variables are distributed binomially (bimodally) by
definition and, with a sample size of 325, can be assumed to meet the normality assumption visà-vis the central limit theorem. In addition, with only two data points, 0 and 1, binary variables
are linear by definition. The binary variables in each level were used in regression analyses.
Aim 2 analytic predictor variable: handoffs/logic steps (ordinal/interval level
variable). Handoffs/logic steps, an ordinal variable, was collected in five levels then recoded
into three levels for analysis: one logic step, no handoffs; two handoffs/logic steps; and three or
greater handoffs/logic steps. Because of the low numbers of cases with handoffs/logic steps in
the original 4 and ≥ 5 handoffs/logic steps levels, variable values in these two levels were
recoded into level three, i.e., three or greater handoffs/logic steps, to conform with the
assumptions of homogeneity of variance and normality.
No entry anomalies or missing data were found upon review; 325 cases were analyzed.
The handoffs/logic steps variable, was found to be both skewed (-.586 with a standard skew error
of .135 resulting in a ratio of 4.34) and kurtotic (-1.034 with a standard kurtosis error of .270
resulting in a ratio of 3.83). Normal skew and kurtosis are both defined for this analysis as 3.3. or
less (p=.001). The histogram showed the skew was positive with the statistics and histogram
both suggesting a distribution significantly different from normal. The non-transformed
histogram for the handoffs/logic steps variable is shown in Figure 13.
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Figure 13. Non-transformed Histogram for the Handoffs/Logic Steps Variable
Several methods to improve normality of the distribution of the handoffs/logic steps
variable, i.e., log, inverse, and square root transformations, were undertaken (Tabachnick &
Fidell, 2007). All of the transformations exhibited increased kurtosis but the log and inverse
transforms are the least skewed. Transformation statistics are shown in Table 6. Of these two, the
log transformation was the least kurtotic and was adopted for further regression analysis, even
though the distribution remains significantly non-normal.
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Table 6
Handoffs/Logic Steps Normality Distribution Transformation Statistics
Transform
Method
Square
Root
Inverse
Log

Std. Error

Skewness
Statistic

Std. Error

Kurtosis
Statistic

Ratio

Ratio

-.782

.135

5.79

-704

.270

2.61

-.081
.267

.135
.135

-.60
1.98

-1.835
-1.551

.270
.270

6.79
5.74

The log transformation histogram for the handoffs/logic steps variable is displayed as Figure 14.

Aim 1
Figure 14. Log Transformation Histogram for the Handoffs/Logic Steps Variable
Aim 1 and aim 2 analytic outcome variable: MLP practice level (ordinal/interval
level variable). MLP practice level variable, the ordinal dependent variable for both aim 1 and
aim 2 analyses, was collected in four levels then recoded into three levels for
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analysis: MLP 1 (MLP bench practitioner), MLP 2 (MLP manager or technical specialist), and
MLP 3 (MD, PhD specialty scientist, DCLS). Non-MLP practitioner consults were documented
and combined with MLP Practice Level 3; workflow processes demonstrated that clinical
information from these non-MLP practitioners supported decision making by MLP Practice
Level 3. A final total of three MLP practice levels were structured that conformed to the
assumptions of homogeneity of variance and normality.
No entry inaccuracies or missing data were found upon review; 325 cases were analyzed.
The MLP practice level variable, was found to be both skewed (1.751 with a standard skew error
of .135 resulting in a ratio of 12.97) and kurtotic (1.896 with a standard kurtosis error of .270
resulting in a ratio of 7.022). Figure 15 displays the non-transformed histogram for this variable.

Figure 15. Non-transformed Histogram for the MLP Practice Level Variable
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The non-transformed histogram curve is both L-shaped and positively skewed. To
address these skewed and kurtotic presentations, both log and inverse transformations were
calculated (Tabachnick & Fidell, 2007). Transformation statistics are shown in Table 7.
Table 7
MLP Practice Level Normality Distribution Transformation Statistics
Transform
Method
Inverse
Log

Std. Error
-.081
.267

Skewness
Statistic
.135
.135

Ratio
-.60
1.98

Std. Error
-1.835
-1.551

Kurtosis
Statistic
.270
.270

Ratio
6.79
5.74

The transformation most approaching normal is the inverse, though the distribution
remains significantly non-normal, and was adopted for further regression analysis. The
histogram for the inverse transformation of the MLP practice level variable is shown in Figure
16. To be noted, inverse transformations reverse the direction of the scale and, therefore, impact
the interpretation of the beta weights in regression analyses.
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Figure 16. Inverse Transformation Histogram for the MLP Practice Level Variable
A6 HCQR Steps A4-A6: ANALYZE, APPLY, and ASSESS
In Steps A4-A6, first, analyses were developed to determine the strength of the
contribution of consultation characteristics available at the point of consultation initiation to the
DV, MLP practice level resolving the consultation (aim 1). From these analyses, a diagnostics
workflow prediction model, the complexity index (CI), was designed and assessed for its ability
to direct consultation workflow in clinical settings to appropriately prepared health professionals.
Also, analyses were developed to validate the predictive performance of the CI by assessing the
relationship among consultation characteristics available after consultation completion to the
three levels of MLP practice (aim 2).
Aim 1 research question 1: step A4 ANALYZE. The research question related to the
first aim was: Can the MLP practice level resolving consultations be predicted by an index
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derived from the variables test cycle phase and medical service/hospital location? Index variables
(test cycle phase and medical service area, i.e., independent variables, IV) were modeled with the
MLP practice level involved in final consultation disposition (dependent variable, DV) to create
the composite predictor variable, complexity index (CI).
Aim 1 regression analyses assumptions testing. For assumptions testing of the
categorical variable, medical service/hospital location, each of the 10 category levels was
transformed into a binary variable with a code of 1 if the case fit into that category and a code of
0 otherwise. The resulting 10 binary variables were checked against total medical
service/hospital location cases to show that the transformations were accurate. These variables
are distributed binomially (bimodally) by definition and, with only two data points, 0 and 1,
binary variables are linear by definition. These binary variables were used in subsequent
analyses.
Aim 1 regression variables: frequencies. Frequencies for cases in each of the aim 1
analytic variables and variable levels are summarized in Table 8. Consultation requests from
family medicine and oncology services did not meet minimum numbers for analysis against each
level of the dependent variable MLP practice level and were not included in further regression
analyses.
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Table 8
Aim 1 Analytic Variables: Frequencies (N = 306, Missing = 0 Cases)
Variable

Variable Levels
N (Cases)
Percent (%)
MLP 1
231
75.5%
MLP (3 Levels)a
MLP 2
53
17.3%
MLP 3
22
7.2%
Pre-analytic
70
22.9%
Test Cycle Phase
Analytic
54
17.6%
(3 Levels)
Post-analytic
182
59.5%
Cardiology (No = 0)
292
95.4%
Cardiology
Cardiology (Yes = 1)
14
4.6%
Emerg Med (No = 0)
248
81.0%
Emergency Medicine
Emerg Med (Yes = 1)
58
19.0%
Fam
Med
((No
=
0)
306
97.1%
Family Medicineb
Fam Med (Yes = 1)
9
2.9%
ICUs (No = 0)
276
90.2%
Intensive Care Units
(ICUs)
ICUs (Yes = 1)
30
9.8%
Obstet (No = 0)
272
88.9%
Obstetrics
Obstet (Yes = 1)
34
11.1%
Oncol (No = 0)
306
96.7%
Oncologyc
Oncol (Yes = 1)
10
3.3%
Peds (No = 0)
282
92.2%
Pediatrics
Peds (Yes = 1)
24
7.8%
Surg Gen (No = 0)
288
94.1%
Surgery, General
Surg Gen (Yes = 1)
18
5.9%
Surg Oth (No = 0)
284
92.8%
Surgery, Other
Surg Oth (Yes = 1)
22
7.2%
Clin Lab (No = 0)
244
79.7%
Clinical Laboratory
Clin Lab (Yes = 1)
62
20.3%
a
Dependent (outcome) variable = MLP (3 Levels)
b
All Family Medicine cases were multivariate outliers and deleted from the dataset for further
analysis.
c
All Oncology cases were multivariate outliers and deleted from the dataset for further analysis.
Aim 1 regression variables: descriptive statistics. Descriptive statistics for the
categorical regression variable, medical service/hospital location, are summarized in Table 9.
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Table 9
Aim 1 Analytic Variables: Descriptive Statistics (N = 306, Missing = 0 Cases)

Statistic

Inv
MLPb
1.32
.601
1.737

Test
Cyclec
2.37
.832
-.773

Variables and Variable Levels of
Medical Service/Hospital Locationa
Emerg
Card
ICUs
OB
Peds
Med
.0458 .1895 .0980 .1111 .078
.2093 .3926 .2979 .3148 .269
4.369 1.592 2.717 2.487 3.15

Surg
Gen
.059
.236
3.77

Surg
Oth
.072
.259
3.33

Clin
Lab
.2026
.4026
1.487

Mean
Std. Dev.
Skewd
Skew
.139
.139
.139
.139
.139
.139 .139 .139 .139 .139
Std. Error
Std.
12.50
-5.56 31.43 11.45 19.55 17.89 22.7 27.1 24.0 10.70
Skew
Kurtosisd
1.842
-1.12 17.20
.538
5.416 4.213 7.99 12.3 9.16 .213
Kurtosis
.278
.278
.278
.278
.278
.278 .278 .278 .278 .278
Std. Error
Std.
6.623
-.401 61.87
1.94
19.48 15.15 28.7 44.2 32.9 0.77
Kurtosis
a
Medical Services/Hospital Location (categorical predictor variable levels):
Card = Cardiology;
Peds = Pediatrics;
Emerg Med = Emergency Medicine;
Surg Gen = Surgery, General;
ICUs = Intensive Care Units;
Surg Oth = Surgery, Other;
OB = Obstetrics;
Clin Lab = Clinical Laboratory
All Family Medicine cases were multivariate outliers and deleted from the dataset for further
analysis.
All Oncology cases were multivariate outliers and deleted from the dataset for further analysis.
b
InvMLP = inverse MLP3Levels (ordinal outcome variable)
c
Test cycle = square root of test cycle phase (ordinal predictor variable)
d
Normal statistic for both skew and kurtosis is defined as 3.3 or less at p=.001.
The formula for calculation of the standard statistic for skew and kurtosis, both measures
of the degree to which the distributions differ from normal, is the ratio of the skew or kurtosis
measure over the skew or kurtosis standard error. Both the standard skew and standard kurtosis
statistics indicate significant non-normal distributions on all variable categories. All variable
categories show a positive skew (greater than 3.3) and most show positive kurtosis (leptokurtic,
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greater than 3.3). Two kurtosis statistics, on emergency medicine and clinical laboratory
categories, are substantially less than 3.3 indicating non-normal platykurtic (negative)
distributions. Binary transformations were undertaken on all medical services/hospital location
categorical variables to improve normality. However, using measurements from these nonnormal distributions for CDM increases the chance of type 1 error, threatening statistical
conclusion validity. This limitation could be addressed by collecting more cases in each variable
level in future research studies. However, if distributions remain naturally non-normal after
additional data collection, then non-parametric techniques, e.g., the examination of contingency
tables for outliers, should be employed to improve normality for subsequent analysis.
Descriptive statistics for the ordinal/interval regression variables, i.e., MLP, 3 levels, and
test cycle phase, 3 levels, are shown in Table 9, also. Both measures were significantly skewed
and kurtotic as compared to the standard parameters for a normal distribution, 3.3 at p=.001.
Inverse transformation for the MLP variable (Figure 16) and square root transformation for the
test cycle phase (Figure 12) variable were undertaken to improve normality. However, the
transformed distributions of both these variables remain non-normal. To be noted again, using
measurements from these non-normal distributions for CDM threatens statistical conclusion
validity and should be addressed by collecting more cases in each variable level in future
research studies.
Analysis of regression residuals, or error in the model, was used to test for multivariate
normality and equality of variance (homoscedasticity) (Tabachnick & Fidell, 2007). The test for
multivariate normality is Shapiro-Wilk’s test and the statistic suggest a statistically significant
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difference from multivariate normal (S=.795, df=306, p=.000). This increases the chance of type
1 error and threatens statistical conclusion validity, also.
In the aim 1 model, there are 10 potential predictors, derived from the 10 levels of the
medical service/hospital location variable, that entered into the model with test cycle phase and
were regressed against MLP practice level (DV). Aim 1 regression variables were examined for
multivariate outliers using the Mahalanobis D statistic and the chi square critical value of 31.2
(p=.001). Using this statistic, 19 cases, 5.8% of the dataset (19/325 cases), had Mahalanobis D
statistics greater than the chi square critical value 31.2 (p=.001) and were removed from further
analysis. Deletion of these 19 cases resulted in 306 cases for aim 1 analysis, a large enough
sample size remaining to conform to the assumptions of the central limit theorem (Tabachnick &
Fidell, 2007).
The test for equality of error variances is Levene’s test. For the aim 1 full model, i.e., all
11 medical service/hospital location predictors and test cycle phase, Levene’s test is statistically
significant (F=9.14, df=26/279, p<.001). This favors the null hypothesis that mean variances are
not equal and, therefore, that the assumption of equality of variance is not satisfied.
The lack of equality of variance usually results from small sample sizes in some or all
variable categories which increases the chance of type 1 error. Inverse, square root, and log
transformations for the ordinal/interval level variables, MLP level and test cycle phase,
respectively, were undertaken to improve the distributions of these variables in order to better
meet central limit theorem assumptions, decrease the chance of type 1 error, and therefore,
improve statistical conclusion validity.

105

Aim 1 regression model testing. The full regression model for aim 1 is:
inverseMLP3LevelDisposition = sqrTestCycle3Levels+ 10 binary medical service/hospital
location levels entered one by one against the dependent variable, MLP level. The inverse value
for the MLP DV and the square root value for the test cycle IV was used in regression analysis.
Binary values for each of the categories of the medical service/hospital location IV were entered
into the model one at a time.
A preliminary test of mean differences was undertaken to suggest the direction of the
regression findings. This preliminary analysis indicated that mean values of only two of the 11
potential predictors (test cycle phase and surgery, other) differed significantly among MLP levels
and, therefore, portend adding significantly to the predictive value of the regression model. For
the medical service/hospital location IV, the research hypothesis was that for each variable
category, a difference in MLP level mean values for the medical service group and the “not
medical service” group binary option are statistically different with 95% confidence. For the test
cycle phase independent variable, the hypothesis was that for each test cycle phase category, the
difference in MLP mean values for the three test cycle groups is statistically different with 95%
confidence. Eta squared or the percent variance explained for srvSurgeryOth was
.272/16.084=.017 and for sqrTestCycle3Levels was .488/16.084=.03. Both medical
service/hospital location and the test cycle phase variables explained very small amounts of the
variance in MLP mean value levels. Table 10 displays the coefficients for the test of mean
differences.
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Table 10
Aim 1 Regression Variables: Preliminary Test of Mean Differences Among Predictor
Variables and Variable Levels (N = 306, Missing = 0 Cases)
Coefficients
Predictor Variable/
a
b
Variable Level
SumSqr
df
MeanSqrc
Fd
Significance
Predictor (Ordinal):
Hypothesis
.488
2
.244
4.472
.012
sqrTestCycle3Levele
Error
16.084 295
.055
Predictors (Categorical):
MedServ/HospLoc Levelse
Cardiology
Hypothesis
.002
1
.002
.039
.843
Error
16.084 295
.055
Emergency Medicine Hypothesis
.014
1
.014
.250
.618
Error
16.084 295
.055
Family Medicinef
Hypothesis
.000
0
Error
Intensive Care Units
Hypothesis
.023
1
.023
.425
.515
Error
16.084 295
.055
Obstetrics
Hypothesis
.015
1
.015
.282
.596
Error
16.084 295
.055
Oncologyg
Hypothesis
.000
0
Error
Pediatrics
Hypothesis
.025
1
.025
.456
.500
Error
16.084 295
.055
Surgery, General
Hypothesis
.000
1
.000
.002
.966
Error
16.084 295
.055
Surgery, Other
Hypothesis
.272
1
.272
4.986
.026
Error
16.084 295
.055
Clinical Laboratory
Hypothesis
.090
1
.090
1.643
.201
Error
16.084 295
.055
.039
.843
a
SumSqr = Type III (partial) sum of squares
b
df = degrees of freedom
c
MeanSqr = Squares of the sample (level) means
d
F = F statistic
e
MedServ/HospLoc Levels = Medical Service/Hospital Location variable, 10 levels
f
All Family Medicine cases were multivariate outliers (missing correlations) and deleted from
the dataset.
g
All Oncology cases were multivariate outliers (missing correlations) and deleted from the
dataset.
107

Table 11 summarizes the coefficients for the full regression model:
invMLP3LevelDisposition = sqrTestCycle3Levels + medical service categories entered one at a
time. The t statistic values indicate that three variables/variable levels were significant predictors
of MLP level disposition (DV variable = invMLP3LevelDisposition) at p≥.020: test cycle phase
(p=.001); surgery, other (p=.008); and clinical laboratory (p=.020). Test cycle phase and the
medical service area “surgery, other” were predicted by the test of means differences. One
additional medical service area, clinical laboratory, emerged as a significant predictor in the
regression, explaining variance in the MLP DV not already accounted for by test cycle phase. All
remaining predictors, i.e., medical service/hospital location levels/areas, were eliminated from
further analyses since they resulted in no change to the model.
Table 11
Aim 1 Regression Variables: Full Model Coefficients (N = 306, Missing = 0 Cases)
Modela,b

Beta

t

Coefficients
Zero
Significance
Order
.001
.185
.946
.557
.624
.621
.321
.906
.008
.157
.020
-.164

Partial

Part

1 Test Cycle Phase Sqr.c
.185
3.277
.185
.185
2 Cardiology
.004
.068
3 Emergency Medicine
.033
.589
5 ICUs
.028
.491
6 Obstetrics
.028
.495
8 Pediatrics
-.056 -.994
9 Surgery, General
-.007 -.118
10 Surgery, Other
.148
2.650
.151
.148
11 Clinical Laboratory
-.133 -2.341
-.133
-.131
a
Full model is:
inverseMLP3LevelDisposition = sqrTestCycle3Levels + 8 binary medical service/hospital
locations variable categories entered one by one against the dependent variable, MLP level
b
Each model displays the beta weight for the predictor after adjusting for the variance of
sqrTestCycle3Levels.
c
Square root value of variable Test Cycle Phase, 3 levels = sqrTestCycle3Levels
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The final regression model testing independent variable contributions to MLP level
disposition is: invMLP3LevelDisposition = sqrTestCycle3Levels + srvSurgeryOther +
srvClinLab. Table 12 summarizes the coefficients for the final model. A positive beta weight for
an inverse scale measure for MLP means that the predictor is associated with a lower practice
level of MLP; likewise, a negative beta weight is interpreted as indicating a higher level of MLP
practice.
Table 12
Aim 1 Regression Variables: Final Model Coefficients (N = 306, Missing = 0 Cases)

Final Model

a

Beta

t

Coefficients
Zero
Significance
Order
.001
.185
.002
.185
.008
.157
.006
.185
.018
.157
.044
-.164

Partial

1 Test Cycle Phase Sqr.b
.185
3.277
.185
b
Test Cycle Phase Sqr.
.178
3.178
.180
2 Surgery, Other
.148
2.650
.151
b
Test Cycle Phase Sqr.
.156
2.758
.157
Surgery, Other
.133
2.369
.135
3 Clinical Laboratory
-.115
-2.020
-.115
a
Final model is:
invMLP3LevelDisposition= sqrTestCycle3Levels+ srvSurgeryOth+ srvClinLab
b
Model 1 is:
invMLP3LevelDisposition = sqrTestCycle3Levels
c
Model 2 is:
invMLP3LevelDisposition = sqrTestCycle3Levels + srvSurgeryOth
d
Model 3 is:
invMLP3LevelDisposition = sqrTestCycle3Levels + srvSurgeryOth + srvClinLab
e
Predictor: Square root value of variable Test Cycle Phase, 3 levels = sqrTestCycle3Levels
f
Predictor: Surgery, Other = srvSurgeryOth
g
Predictor: Clinical Laboratory = srvClinLab
h
Dependent Variable: inverse value of variable MLP, 3 levels = invMLP3LevelDisposition
Aim 1 regression model testing summary. Table 13 summaries important statistical
descriptors of the final regression model. The predictor influencing MLP practice level
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Part
.185
.177
.148
.153
.132
-.112

disposition the most is test cycle phase, explaining 3.4% of variance (R square change=.034,
p=.001). Test cycle beta weight is also significant at .178, p=.008; the positive beta weight, for
an inverse scale, indicates that the test cycle phase (1-3) is inversely associated with MLP
practice level (1-3); as the test cycle phase level measure increases, the MLP practice level (1-3)
decreases.
Table 13
Aim 1 Regression Variables: Final Model Summary (N = 306, Missing = 0 Cases)
Modela
R
R Square Δ
F
df1
df2
Sig. of F
b
e
1 Test Cycle Phase Sqr.
.185
.034
10.740
1
304
.001
e
Test Cycle Phase Sqr.
.185
.034
10.740
1
304
.001
2c Surgery, Other
.237
.056
7.022
1
303
.008
e
Test Cycle Phase Sqr.
.185
.034
10.740
1
304
.001
Surgery, Otherf
.237
.056
7.022
1
303
.008
d
g
3 Clinical Laboratory
.262
.069
4.082
1
302
.044
a
Final model is:
invMLP3LevelDisposition= sqrTestCycle3Levels+ srvSurgeryOth+ srvClinLab
b
Model 1 is:
invMLP3LevelDisposition = sqrTestCycle3Levels
c
Model 2 is:
invMLP3LevelDisposition = sqrTestCycle3Levels + srvSurgeryOth
d
Model 3 is:
invMLP3LevelDisposition = sqrTestCycle3Levels + srvSurgeryOth + srvClinLab
e
Predictor: Square root value of variable Test Cycle Phase, 3 levels = sqrTestCycle3Levels
f
Predictor: Surgery, Other = srvSurgeryOth
g
Predictor: Clinical Laboratory = srvClinLab
h
Dependent Variable: inverse value of variable MLP, 3 levels = invMLP3LevelDisposition
The next most influential predictor of MLP practice level was the measure associated
with the aggregation of surgical service areas other than general surgery, i.e. srvSurgeryOth.
These other surgery areas accounted for 2.2% of the variance (R square change=.022, p==.008)
in MLP level after adjusting for test cycle phase beta weight. The positive beta weight (.148,
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p=.008) for an inverse MLP3LevelDisposition scale, indicates here, also, that the other surgical
services measure is inversely associated with MLP practice level (1-3) ); as the srvSurgeryOth
measure increases, the MLP practice level (1-3) decreases. The clinical laboratory medical
service (srvClinLab) was the last of the predictors that explained significant variance in the
model. This service area explains 1.7% of the variance (R square change=.017, p=.020) left in
the DV invMLP3LevelDisposition, after adjusting for sqrTestCycle3Levels, and 1.3% of the
variance (R square change=.013, p=.044) after adjusting for both sqrTestCycle3Levels and
srvSurgeryOth. The negative beta weight (-.115, p=.044) for an inverse MLP3LevelDisposition
scale, indicates that the srvClinLab measure varies directly with MLP practice level (1-3); as the
srvClinLab measure increases becoming more negative, the MLP practice level (1-3) increases.
The three statistically significant predictors explained a total of 6.9% variance (i.e., test
cycle phase, 3.4%; srvSurgeryOth, 2.2%; and srvClinLab, 1.3%) in the DV,
invMLP3LevelsDisposition. p=.044. Their beta weights varied as the model grew in complexity
suggesting that explained variance in invMLP3LevelDisposition was shared among the
predictors. Beta weights are shown in Table 13. The beta weight for sqrTestCycle3Levels was
.185 by itself, .178 when considering srvSurgeryOth and .156 in the full model. Similarly, the
beta weight of srvSurgeryOth dropped from .148 to .133 when srvClinLab was added to the
model. Again, the negative beta weight suggests that if srvClinLab is the service category, the
MLP level goes up as the inverse value of MLP reverses the scale. A Bonferroni correction
applied to revise the alpha level to account for the simultaneous testing of three models, did not
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change the interpretation of significance, i.e., critical value of p<.05/3 tests = .017, for any of the
test models.
The interpretation of aim 1 regression findings was limited by these small explained
variances and the violations of regression assumptions which have been discussed previously. As
a consequence, these limitations should be considered when interpreting study findings.
However, a post hoc power calculation, where N=306, R Square Δ=.069, and number of
predictors is 3, returned a power estimate of .987 which mitigates, to some extent, the violation
of regression assumptions.
Aim 1 pre-consultation complexity index (CI) structure. Aim 1 regression modeling
against the MLP practice level outcome variable confirmed that a workflow prediction index, the
complexity index (CI), can be constructed from the values of three predictor characteristics
collected at the point of consultation initiation, i.e., test cycle phase and two medical services,
surgery, other and clinical laboratory. Using the beta weights from the final regression model, a
simple matrix was constructed to explain the logic for predicting the most appropriate MLP
practice level for consultation resolution. Positive beta weights for test cycle phase (.156,
p=.006) and surgery, other (.133, p=.018) indicated that these measures vary inversely with an
inverse MLP practice level. The negative beta weight (-.115, p=.044) of the clinical laboratory
predictor for an inverse MLP3LevelDisposition scale, indicated that the srvClinLab measure
varies directly with MLP practice level (1-3); as the srvClinLab measure increases becoming
more negative, the MLP practice level (1-3) increases. The matrix conceptualizing the logic in
the use of the CI for workflow prediction is shown in Table 14.
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Table 14
Aim 1 Complexity Index Definition Matrix
Consultation Point of Initiation Predictors
Test Cycle Phase
Surgery, Other
Clinical Laboratory
1a
3
3
1
b
2
2
2
2
3c
1
1
3
a
MLP practice level 1 = test cycle phase beta weight highest >.156 + surgery, other beta weight
highest >.133+ clinical laboratory beta weight lowest >-.115
b
MLP practice level 2 = test cycle phase beta weight high but <.156 + surgery, other beta weight
high but <.133 + clinical laboratory beta weight low but >-.115
c
MLP practice level 3 = test cycle phase beta weight lowest <.156 + surgery, other beta weight
lowest <.133+ clinical laboratory beta weight highest >-.115
MLP Practice Level

Interpreting the conceptual logic matrix, MLP practice level 1 would be indicated for
consultation resolution if the test cycle beta weight is high (>.156); surgery, other beta weight is
high (>.133); and clinical laboratory beta weight is low (<-.115). MLP practice level 2 would be
indicated for consultation resolution if beta weight for test cycle phase were high but less than
.156; beta weight for surgery, other high but less than .133; and beta weight for clinical
laboratory were low but greater than -.115. Continuing to follow this logic, MLP practice level 3,
then, would be indicated for consultation resolution if beta weight for test cycle phase were
lowest; beta weight for surgery, other were lowest; and beta weight for clinical laboratory were
highest.
In order to operationalize the CI in the future, the logic of the conceptual changes in beta
weights as presented in Table 14 were translated into values associated with predictor variables
that can enter into an algorithm describing the logic of the beta weight changes. The algorithm
would take the general form of the regression model: MLP practice level predicted = test cycle
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phase + surgery, other + clinical laboratory. More specifically, the MLP practice level to receive
the presenting consultation request would be indicated by a combination of values related to test
cycle level (pre-analytic, analytic, or post-analytic), presence/absence of surgery, other origin,
and presence/absence of clinical laboratory origin. The values entered into this algorithm were a
combination of beta weights of each of the variable levels calculated from the aim 1 dataset
(N=306 cases) and the associated intercept value. This more specific algorithm was developed by
using the actual beta weights from the regression equations and became: MLP practice level
(predicted) = beta weight (test cycle 1, 2, or 3) + 0 or beta weight (surgery, other) + 0 or beta
weight (clinical laboratory) + intercept (i.e., variance not explained by predictors). The MLP
practice level values derived from these algorithms can then be used to predict the MLP practice
level assigned for consultation resolution from the trendline plotted using the means for each
MLP practice level in the aim 1 dataset. Figure 17 displays the practice levels means trendline
plot for the aim 1 dataset.
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Means of Aim 1 MLP Practice Levels

1.24

1.22

1.2

1.18

1.16

1.14

1.12
Aim 1 MLP Level 1

Aim 1 MLP Level 2

Aim 1 MLP Level 3

Aim 1 Practice Levels

Figure 17. Aim 1 MLP practice level means trendline plot
Means for each MLP practice level in the aim1 dataset represent the average number of
consultation cases resolved by each practice level. In practice, ideally, the value generated from
the predicted MLP practice level algorithm would fall on the trendline within the confidence
limits of the mean of one of the MLP practice levels. Thus, the consultation request would be
directed to the MLP practice level with associated mean value closest to that predicted by the
algorithm.
Figure 18 summarizes and graphically displays the mean values and confidence limits for
each MLP practice level. While the means of all three practice levels were found to be
statistically significantly different, not all MLP practice levels can be clearly differentiated when
confidence intervals are examined. MLP level 1 values were clearly distinct from the other two
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levels and predicted MLP algorithm values falling between lower and upper confidence limits,
1.1388 and 1.1611, respectively, can be assigned as MLP practice level 1 with 95% confidence.
However, the confidence intervals of MLP practice levels 2 and 3 overlap to the extent that
predictions can only be estimated. Predicted algorithm values falling within the lower bound of
MLP 2 (1.1752) and the lower bound of MLP 3 (1.1861) can be assigned to MLP 2 with 95%
confidence. Likewise, predicted algorithm values above the upper limit of MLP 2 (1.2013) and
below the upper limit of MLP 3 (1.2470) can be assigned to MLP 3 with 95% confidence.
However, predicted algorithm values falling between the lower limit of MLP 3 (1.1861) and the
upper limit of MLP 2 (1.2013) could be either MLP 2 or 3. More precise assignment awaits the
identification of predictors explaining more variance in the CI model and/or more MLP level 2
and 3 assigned consultations, i.e., larger number of MLP level 2 and 3 data points.
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Figure 18. Aim 1 MLP practice level means with 95% confidence intervals
Aim 2 research question 2: step A4 ANALYZE. The research question related to the
second aim is: Can MLP practice levels resolving consultations be predicted by number of
handoffs/logic steps and medical subject associated with consultation cases? Index variables
(handoffs/logic steps and medical subject, i.e., independent variables, IV) were modeled with the
MLP practice level involved in final consultation disposition (dependent variable, DV) to define
a typology of increasing scope of knowledge and professional responsibility represented by MLP
practice levels 1-3.
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Aim 2 regression analyses assumptions testing. For assumptions testing of the
categorical variable, medical subject, each of the 10 category levels was transformed into a
binary variable with a code of 1 if the case fit into that category and a code of 0 otherwise. The
resulting 10 binary variables were checked against total medical subject cases to show that the
transformations were accurate. These variables are distributed binomially (bimodally) by
definition and, with a sample size of 308 for aim 2, can be assumed to meet the multivariate
normality and homoscedasticity assumptions invoked in the central limit theorem. In addition,
with only two data points, 0 and 1, binary variables are linear by definition. These binary
variables were used in preliminary regression analyses.
In the aim 2 model, there are 10 potential predictors, derived from the 10 levels of the
medical subject variable, that entered into the model with handoffs/logic steps and were
regressed against MLP practice level (DV). Aim 2 regression variables were examined for
multivariate outliers using the Mahalanobis D statistic and the chi square critical value of 29.6
(p=.001). Using this statistic, 17 cases, 5.2% of the dataset (17/325 cases), had Mahalanobis D
statistics greater than the chi square critical value 29.6 (p=.001) and were removed from further
analysis. Deletion of these 17 cases resulted in 308 cases for aim 2 analysis, a large enough
sample size remaining to conform to the assumptions of the central limit theorem (Tabachnick &
Fidell, 2007).
Aim 2 regression variables: frequencies. Frequencies for cases in each of the aim 2
analytic variables and variable levels are summarized in Table 15. Consultation requests
regarding the subjects of education, genetics/molecular, pediatrics genetics/molecular, and
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proficiency testing did not meet minimum numbers of cases for analysis against each level of the
dependent variable MLP practice level and were not included in further regression analyses.
Table 15
Aim 2 Analytic Variables: Frequencies (N = 308 Missing = 0 Cases)
Variable

Variable Level
N (Cases)
Percent (%)
MLP 1
237
76.9
MLP (3 Levels)
MLP 2
56
18.2
MLP 3
15
4.9
1 Logic Step; No Handoffs
151
49.0
Handoffs/Logic Steps
2 Handoffs/Logic Steps
102
33.1
(3 Levels)
≥3 Handoffs/Logic Steps
55
17.9
(No = 0)
308
Educationa
(Yes = 1)
0
(No = 0)
308
Genetics/Moleculara
(Yes = 1)
0
(No = 0)
292
94.8
Technology Decisions
(Yes = 1)
16
5.2
(No = 0)
192
62.3
IT Ordering
(Yes = 1)
116
37.7
(No = 0)
308
Peds
Genetics/Moleculara
(Yes = 1)
0
(No = 0)
206
66.9
Results Resolution
(Yes = 1)
102
33.1
(No = 0)
272
88.3
Safety ID
(Yes = 1)
36
11.7
(No = 0)
289
93.8
Test
Integration/Evaluation (Yes = 1)
19
6.2
(No = 0)
308
Proficiency Testinga
(Yes = 1)
0
(No = 0)
289
93.8
Specimen
Referral/Transport
(Yes = 1)
19
6.2
an
All cases from each subject category were multivariate outliers and deleted from the dataset for
regression testing.
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Aim 2 regression variables: descriptive statistics. Descriptive statistics for the
categorical regression variable, medical subject, and for the ordinal/interval variables MLP level
and handoffs/logic steps are summarized in Table 16.
Table 16
Aim 2 Analytic Variables: Descriptive Statistics (N = 308, Missing = 0 Cases)
Variables and Variable Levels of
Medical Subjecta
Statistic

invMLP
3Level

logHoff
/LS

Tech
Decisions

IT
Results
Order Resolve

Safety/
ID

Test
Integrate
/Eval
.0617
.24098
3.662

Spec
Refer/
Trans
.0617
.24098
3.662

Mean
.8766
1849
.0519
.3766
.3312
.1169
Std. Dev. .22814
.19130
.2223
.4853 .47140 .32180
Skew
-1.367
.271
4.058
.512
.721
2.397
Skew
.139
.139
.139
.139
.139
.139
.139
.139
Std. Error
Std.
.022
-1.551
14.56
-1.75 -1.490
3.768
11.481
11.481
Skew
Kurtosis
.277
.277
.277
.3766
.3312
.1169
.0617
.277
Kurtosis
.8766
1849
.0519
.4853 .47140 .32180
.24098
.0617
Std. Error
Std.
.22814
.19130
.2223
.512
.721
2.397
3.662
.24098
Kurtosis
a
Medical subject (categorical predictor variable levels):
Tech Decisions = Technology Decisions; Safety/ID = Patient Safety and ID Issues;
IT Ordering = Order Entry Issues;
Test Integrate/Eval = Testing Upgrade/Eval issues;
Results Resolve = Results Resolution;
Spec Refer/Trans = Specimen Referral Issues.
All cases from the medical subject categories education, genetics/molecular, pediatrics
genetics/molecular, and proficiency testing were multivariate outliers and deleted from the
dataset for regression testing.
b
InvMLP = inverse MLP3Levels (ordinal outcome variable)
c
Test cycle = square root of test cycle phase (ordinal predictor variable)
d
Normal statistic for both skew and kurtosis is defined as 3.3 or less at p=.001.
The formula for calculation of the standard statistic for skew and kurtosis, both measures
of the degree to which the distributions differ from normal, is the ratio of the skew or kurtosis
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measure over the skew or kurtosis standard error. Both the standard skew and standard kurtosis
statistics indicate significant non-normal distributions on all variable levels except test
integration/evaluation which can be considered normally distributed (skew=3.662;
kurtosis=3.662). All other variable levels were skewed, i.e., positive skew greater than or
negative skew less than 3.3, p=.001. Seven of the 8 variable levels showed platykurtic (negative)
distributions (kurtosis statistic less than 3.3, p=.001); Using measurements from the non-normal
distributions for clinical decision making (CDM) increases the chance of type 1 error,
threatening statistical conclusion validity.
Analysis of regression residuals or error in the model was used to test for multivariate
normality and equality of variance (homoscedasticity) (Tabachnick & Fidell, 2007). The test for
multivariate normality is Shapiro-Wilk’s test and the statistic suggests a statistically significant
difference from multivariate normal (S=.825, df=308, p=.000). This increases the chance of type
1 error and threatens statistical conclusion validity, also.
The test for equality of error variances is Levene’s test. For the aim 2 full model, i.e., all
10 medical subject predictors and handoffs/logic steps, Levene’s test was statistically significant
(F=11.846, df=17/290, p<.001). This favors the null hypothesis that mean variances are not equal
and, therefore, that the assumption of equality of variance is not satisfied. The lack of equality of
variance usually results from small sample sizes in some or all variable categories which
increases the chance of type 1 error.
Aim 2 regression model testing. The full regression model for aim 2 is:
inverseMLP3LevelDisposition = logHandoffsLS3LevelsTOT + 10 binary medical subject levels
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entered one by one against the dependent variable, MLP level. The inverse value for the MLP
DV and the log value for the handoffs/logic steps independent variable (IV) were used in
regression analysis. Binary values for each of the levels of the medical subject IV were entered
into the model one at a time.
A preliminary test of mean differences was undertaken to suggest the direction of the
regression findings. This preliminary analysis indicated that mean values of six of the 10
potential medical subject predictors differed significantly among MLP levels and, therefore,
portend adding significantly to the predictive value of the regression model. The four variable
levels that were excluded from regression analysis are sbjEducation, sbjGeneticsMolecular,
sbjPedsGeneticsMolecular, and sbjProficiencyTesting. None of the remaining six medical
subject levels was significant at p<.05, but all were significant at p<.052. The six significant
medical subject levels were sbjTechnologyDecisions (p<.052), sbjITOrdering (p<.050),
sbjResultsResolution (p<.051), sbjSafetyID (p<.051), sbjTestIntegrationEvaluation (p<.052),
sbjSpecimenReferralTransport (p<.052) and logHandoffsLS3LevelsTOT (p<.050). For the
medical subject IV, the research hypothesis was that for each variable level, a difference in MLP
level mean values for the medical subject group and the “not medical subject” group binary
option were statistically different with 95% confidence. For the handoffs/logic steps IV, the
hypothesis was that for each handoffs/logic steps level, the difference in MLP mean values for
the three handoff/logic steps groups was statistically different with 95% confidence. Eta Squared,
or the percent variance explained, for logHandoffsLS3LevelsTOT was .724/15.978=.045 (4.5%)
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but substantially lower for the medical subject variable levels. Table 17 displays the coefficients
for the ANOVA tests of mean differences.
Table 17
Aim 2 Regression Variables: Preliminary Test of Mean Differences Among Predictor
Variables and Variable Levels (N = 308, Missing = 0 Cases)
Predictor vs. Outcome Variable/
Variable Level
Combined
Predictor (Ordinal):
e
invMLP3LevelDisposition
Within
vs. logHoffsLS3LevelsTOT
Total

Coefficients
SumSqr

a

.724
15.254
15.978

df

b

2
305
307

MeanSqrc

Eta

Eta Sqrd

.362
.050

.213

.045

Predictors (Categorical):
Medical Subject Levels
Combined
.189
1
.189
Within
15.789 306
.052
.109
.012
Total
15.978 307
Combined
.808
1
.808
invMLP3LevelDispositione
Within
15.170 306
.050
.225
.051
vs. sbjITOrdering
Total
15.978 307
Combined
.404
1
.404
.159
.025
invMLP3LevelDispositione
Within
15.575 306
.051
vs. sbjResultsResolution
Total
15.978 307
Combined
.051
1
.051
invMLP3LevelDispositione
Within
15.927 306
.052
.057
.003
vs. sbjSafetyID
Total
15.978 307
Combined
.154
1
.154
invMLP3LevelDispositione
Within
15.825 306
.052
.098
.010
vs. sbjTestIntegratEvaluation
Total
15.978 307
Combined
.006
1
.006
invMLP3LevelDispositione
Within
15.973 306
.052
.019
.000
vs. sbjSpecimenReferTrans
Total
15.978 307
a
SumSqr = Type III (partial) sum of squares
b
df = degrees of freedom
c
MeanSqr = Squares of the sample (level) means
d
Eta Sqr. = Eta squared, the percent DV variance explained by the variable/variable category
e
DV = invMLP3LevelDisposition (inverse value of MLP Levels 1-3 disposition)
invMLP3LevelDispositione
vs. sbjTechnologyDecisions
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Table 18 summaries the coefficients for the aim 2 full regression model:
invMLP3LevelDisposition = logHandoffsLS3LevelsTOT + 6 medical subject categories entered
one at a time. The t statistic values indicated that four variables/variable levels were significant
predictors of MLP level disposition (DV variable = invMLP3LevelDisposition) at p≤.016:
logHandoffsLS3LevelsTOT (p=.000); sbjITOrdering (p=.000); sbjSafetyID (p=.016); and
sbjResultsResolution (p=.000). The Eta squared values (i.e., percent variance explained) from the
test of means differences suggested the significance of these variables, also. All remaining
medical subject level predictors were eliminated from further analyses since they resulted in no
significant change to the model.
Table 18
Aim 2 Regression Variables: Full Model Coefficients (N = 308, Missing = 0 Cases)

Model

Coefficients
Zero
Significance
Order
.000
.225
.000
-.203
.000
-.159
.016
.057
.101
.157
.591

a

Beta

t

Partial

Part

1 sbjITOrdering
.225 4.038
.225
.225
2 logHandoffsLS3LevelsTOT -.203 -3.633
-.203
-.203
3 sbjResultsResolution
-.241 -4.311
-.204
-.200
4 sbjSafetyID
.143 2.412
.137
.134
b
5 sbjTechnologyDecisions
-1.644
-.094
b
6 sbjTestIntegratEvaluation
-1.419
-.081
7 sbjSpecimenReferTransportb
.537
.031
a
Full model is:
inverseMLP3LevelDisposition = logHandoffsLS3LevelsTOT + 6 binary medical subject levels
entered one by one against the dependent variable, MLP level.
b
Medical subject category did not significantly change the full model and were removed from
the final model.
The final aim 2 regression model testing IV contributions to MLP level disposition is:
invMLP3LevelDisposition = sbjITOrdering + logHandoffsLS3LevelsTOT + sbjSafetyID +
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sbjResultsResolution. The significant model variables, i.e., sbjITOrdering,
logHandoffsLS3LevelsTOT, sbjSafetyID, and sbjResultsResolution together explain 15.0% of
the variance in invMLP3LevelDisposition. The variable level sbjITOrdering explained 5.1%,
logHandoffsLS3LevelsTOT explained 4.1%, sbjResultsResolution explained 4.0%, and
sbjSafetyID explained 1.8%. The model was statistically significant at p=.001.
Table 19 summarizes the coefficients for the aim 2 final model. Even though the medical
subject level, results resolution, was a significant predictor by itself and explained 4.0% of the
variance in the MLP DV, it did not significantly add to the prediction model after adjusting for
IT ordering, handoffs/logic steps, and safety/ID (p=.540). The final model was thus reduced to
three predictors of MLP practice level: IT ordering, handoffs/logic steps, and safety/ID.
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Table 19
Aim 2 Regression Variables: Final Model Coefficients (N = 308, Missing = 0 Cases)
Final Modela

Beta

t

Coefficients
Zero
Significance
Order
.000
.225
.001
.225
.006
-.203
.000
.225
.000
-.203
.001
.057

Partial

1b sbjITOrderinge
.225
4.038
.225
sbjITOrdering
.185
3.258
.183
c
f
2 logHandoffsLS3LevelsTOT
-.157 -2.752
-.156
sbjITOrdering
.226
3.937
.220
logHandoffsLS3LevelsTOT
-.212 -3.623
-.203
3d sbjSafetyIDg
.193
3.263
.184
an
Aim 2 final model is:
invMLP3LevelDisposition = sbjITOrdering + logHandoffsLS3LevelsTOT + sbjSafetyID
b
Model 1 is:
invMLP3LevelDisposition = sbjITOrdering
c
Model 2 is:
invMLP3LevelDisposition = sbjITOrdering + logHandoffsLS3LevelsTOT
d
Model 3 is:
invMLP3LevelDisposition = sbjITOrdering + logHandoffsLS3LevelsTOT + sbjSafetyID
e
Predictor: Medical subject level IT Ordering = sbjITOrdering
f
Predictor: Handoffs/Logic Steps, 3 levels = logHandoffsLS3LevelsTOT
g
Predictor: Medical subject level Safety/ID = sbjSafetyID
h
Dependent Variable: inverse value of variable MLP, 3 levels = invMLP3LevelDisposition

Part
.225
.180
-.152
.214
-.197
.177

A positive beta weight for an inverse scale measure for MLP means that the predictor is
associated with a lower practice level of MLP; likewise, a negative beta weight is interpreted as
indicating a higher level of MLP practice.
Aim 2 regression model testing summary. Table 20 summarizes important statistical
descriptors of the final regression model. The aim 2 predictor influencing MLP practice level
disposition the most was medical subject IT ordering, explaining 5.1% of variance (R square
change=.051, p=.000). Handoffs/logic steps was also significant with 4.1% variance explained
(R square change=.041, p=.000) after adjusting for the contribution of IT ordering. The third
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significant predictor in the model was medical subject safety/ID explaining 1.8% (R square
change=.018, p=.016) of the variance in MLP practice level after adjusting for the contributions
of both IT ordering and handoffs/logic steps variables. Positive beta weights for an inverse
MLP3LevelDisposition scale, indicate that the associated measure is inversely associated with
MLP practice level (1-3); as the measure increases, the MLP practice level (1-3) decreases. On
the other hand, negative beta weights for an inverse MLP3LevelDisposition scale, as seen with
the log value of the handoffs/logic steps variable, indicate that the measure varies directly with
MLP practice level (1-3); as the handoffs/logic steps measure increases becoming less negative,
the MLP practice level (1-3) increases.
Table 20
Aim 2 Regression Variables: Final Model Summary (N = 308, Missing = 0 Cases)
Modela
R
R Square Δ
FΔ
df1
df2 Sig. of F Δ
1 sbjITOrderingf
.225
.051
16.304
1
306
.000
sbjITOrdering
.225
.051
16.304
1
306
.000
c
2 logHandoffsLS3LevelsTOTg
.271
.023
7.573
1
305
.006
sbjITOrdering
.225
.051
16.304
1
306
.000
logHandoffsLS3LevelsTOT
.271
.023
7.573
1
305
.006
3d sbjSafetyIDh
.324
.031
10.647
1
304
.001
an
Aim 2 final model is:
invMLP3LevelDisposition = sbjITOrdering + logHandoffsLS3LevelsTOT + sbjSafetyID
b
Model 1 is:
invMLP3LevelDisposition = sbjITOrdering
c
Model 2 is:
invMLP3LevelDisposition = sbjITOrdering + logHandoffsLS3LevelsTOT
d
Model 3 is:
invMLP3LevelDisposition = sbjITOrdering + logHandoffsLS3LevelsTOT + sbjSafetyID
f
Predictor: Medical subject level IT Ordering = sbjITOrdering
g
Predictor: Handoffs/Logic Steps, 3 levels = logHandoffsLS3LevelsTOT
h
Predictor: Medical subject level Safety/ID = sbjSafetyID
i
Dependent Variable: inverse value of variable MLP, 3 levels = invMLP3LevelDisposition
b
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The three significant predictors of MLP practice level, logHandoffsLS3LevelsTOT,
sbjITOrdering and sbjSafetyID, together explained 10.5% of the variance in the
invMLP3LevelDisposition DV. The predictor accounting for the most variance was
sbjITOrdering at 5.1%, followed by logHandoffsLS3LevelsTOT at 2.3%, and sbjSafetyID at
3.1%. The model was statistically significant at p=.001. The medical subject level
sbjResultsResolution dropped from the final model because the predictor did not significantly
contribute to the model after adjustment for the other predictors accounting for more variance.
Beta weights of the three predictors varied as the model grew in complexity suggesting that
explained variance in invMLP3LevelDisposition was shared among the predictors. The beta
weight for sbjITOrdering was .225 by itself, .185 when considering handoffs, and .226 in the
final model (Table 19). Similarly, the beta weight of handoffs increased from -.157 to -.212
when sbjSafetyID was added to the model. The beta weight for sbjSafetyID alone was .193. A
Bonferroni correction applied to revise the alpha level to account for the simultaneous testing of
three models, did not change the interpretation of significance, i.e., critical value of p<.05/3 tests
= .017, for any of the test models.
The interpretation of aim 2 regression findings is limited by the small explained variances
and the violations of regression assumptions which have been discussed previously. As a
consequence, these limitations should be considered when interpreting study findings. However,
a post-hoc power calculation, where N=308, R Square Δ=.105, p=.05, and number of predictors
is 3, returned a power estimate of .9996 which mitigates, to some extent, the violation of
regression assumptions.
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Aim 2 post-consultation prediction index structure. Aim 2 regression modeling against
the MLP practice level outcome variable confirmed that a workflow prediction index can also be
constructed from the values of three post-consultation predictor characteristics only available
after consultation completion, i.e., handoffs/logic steps and two medical subject level variables,
IT ordering and safetyID. Using the beta weights from the final regression model, a simple
matrix was constructed to predict the most appropriate MLP practice level for consultation
resolution. Positive beta weights for IT ordering (.226 p=.000) and safetyID (.196, p=.001)
indicate that these measures vary inversely with an inverse MLP practice level. The negative
beta weight (-.212, p=.000) of the handoffs/logic steps predictor for an inverse
MLP3LevelDisposition scale, indicates that the handoffs/logic steps measure varies directly with
MLP practice level (1-3); as the handoffs/logic steps measure increases becoming more negative,
the MLP practice level (1-3) increases. A preliminary matrix defining the logic in the use of the
post-consultation workflow prediction index is shown in Table 21.
Table 21
Aim 2 Post-Consultation Workflow Predictive Index Definition Matrix
Post-Consultation Workflow Predictors
IT Ordering
SafetyID
Handoffs/Logic Steps
a
1
3
3
1
2b
2
2
2
c
3
1
1
3
a
MLP practice level 1 = IT ordering beta weight highest >.226+ safetyID beta weight
highest >.196+ handoffs/logic steps beta weight lowest <-.212
b
MLP practice level 2 = IT ordering beta weight high but <.226 + safetyID beta weight
high but <.196 + clinical laboratory beta weight low but >-.212
c
MLP practice level 3 = IT ordering beta weight lowest <.226+ safetyID beta weight
lowest <.196+ clinical laboratory beta weight highest >-.212
MLP Practice Level
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Interpreting the preliminary logic matrix, MLP practice level 1 would be indicated for
consultation resolution if the IT ordering beta weight is high (>.226); safetyID beta weight is
high (>.196); and handoffs/logic steps beta weight is low (<-.212). MLP practice level 2 would
be indicated for consultation resolution if beta weight for test IT ordering were high but less than
.226; beta weight for safetyID high but less than .196; and beta weight for handoffs/logic steps
were low but greater than -.212. Continuing to follow this logic, MLP practice level 3, then,
would be indicated for consultation resolution if beta weight for IT ordering were lowest; beta
weight for safetyID were lowest; and beta weight for handoffs/logic steps were highest.
Aim 1 and aim 2 regression models comparison: step A5 APPLY. Both workflow
prediction indices, i.e., the aim 1 CI and the aim 2 post-consultation index, categorize the same
DV, MLP practice level, into one of three levels. The models were covaried against each other to
validate the predictive performance of the CI using measures available only after consultation
completion. In other words, two competing predictor datasets were utilized to categorize levels
of MLP practice and the results compared.
Covariance analysis measures and removes the influence of joint variability of predictors
on the DV MLP measure. The analysis identified the variance in model 1 after adjusting for
model 2 and the variance in model 2 after adjusting for model 1. In preparation for these
regressions, the multivariate outliers were eliminated from both the aim 1 model and the aim 2
model leaving 290 (N=308-18) cases for the analysis. Next the final models of each aim were
analyzed using the shared dataset. The final model comparison summaries for each aim are given
in Table 22
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Table 22
Aim 1 and Aim 2 Final Model Comparison Summary (N=290 Cases)
Comparison Modelsa
R
R Square Δ
FΔ
df1
df2 Sig. of F Δ
b
1 Aim 1 (added first)
.259
.067
6.883
3
286
.000
Aim 2c
.384
.147
8.859
3
283
.000
c
2 Aim 2 (added first)
.353
.124
13.540
3
286
.000
Aim 1b
.384
.023
2.550
3
283
.056
a
Dependent Variable: inverse value of variable MLP, 3 levels = invMLP3LevelDisposition
b
Aim 1 Predictors: srvClinLab + srvSurgOth + sqrTestCycle3LevelsTOT
c
Aim 2 Predictors: srvClinLab + srvSurgOth + sqrTestCycle3LevelsTOT +
logHandoffsJS3LevelsTOT +sbjSafetyID + sbjITOrdering
Interpreting the summary, the aim 1 model alone was statistically significant with R
square of .067 (p=.000). Also, the aim 2 model alone was statistically significant with R square
of .124 (p=.000). Adding aim 2 predictors’ variances to aim 1, the R square changes from .067 to
.147. This .08 R square change (119% = .08/.067; p=.000) indicated the addition of a significant
contribution to the variance explained in aim 1. On the other hand, adding aim 1 predictors’
variances to aim 2 resulted in a statistically insignificant R square change of .023 (.124 to .147,
p=.056). A Bonferroni correction applied to revise the alpha level to account for the
simultaneous performance of two tests (aim 1 and aim 2 regressors), did not change the
interpretation of significance, i.e., critical value of p<.05/2 tests = .025, for either test model or
the comparison.
It can be concluded from the comparison analysis that both the CI (aim 1 workflow
predictive model) and the aim 2 post-consultation workflow predictive model were statistically
significant and different from one another yet predicted, in general, similar MLP practice levels.
When comparing regression models that use the same dependent variable and the same
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estimation period, as is the case with aim 1 and aim 2, R square change was used as a criterion
for comparing them. Figure 19 graphically demonstrated the similarity of the practice level
means trendlines for aim 1 and aim 2 as well as the linearity of their mean plots. Each of the
models explained only small amounts of variance in the MLP practice level DV, however.
1.24

Means of Practice Levels

1.22

1.2

1.18
Aim 1
Aim 2

1.16

Linear ( Aim 1)
Linear ( Aim 2)

1.14

1.12
MLP Level 1

MLP Level 2

MLP Level 3

Figure 19. Aim 1 and Aim 2 MLP practice level means trendlines comparison
Aim 1 research question 1 results summary: step A6 ASSESS. Research question 1
was: Can the MLP practice level resolving consultations be predicted by an index derived from
the variables test cycle phase and medical service/hospital location? The two variable categories
tested in the prediction model, i.e., the complexity index (CI), were test cycle phase ( preanalytic, analytic, and post-analytic levels) and 10 medical service/hospital locations.
Crosstabulations and regression modeling were undertaken to determine the contribution of each
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of these variables and/or variable levels to the MLP practice level ultimately resolving the
consultation case. The final regression model for aim 1 was: invMLP3LevelDisposition=
sqrTestCycle3Levels+ srvSurgeryOth+ srvClinLab. Test cycle phase as well as two medical
service locations, surgery other than general and clinical laboratory, were significant
determinants of MLP practice level consultation resolution. The CI thus created from this
discovery provided a numerical value indexed to one of the three MLP practice levels most
appropriate for consultation resolution.
Aim 2 research question 2 results summary: step A6 ASSESS. Research question 2
was: Can MLP practice levels resolving consultations be predicted by number of handoffs/logic
steps and medical subject associated with consultation cases? To address this question, a
different dataset of consultation characteristics was analyzed for the significance of their
contributions to the choice of MLP practitioner resolving consultation cases; the characteristics
analyzed for this question were available only after consultation completion. The MLP practice
level thus generated by the post-completion workflow predictive model serves as a validation
method for the CI developed for prospective application.
The variable categories tested in the full post-completion prediction model were
handoffs/logic steps (3 levels) and six medical subject categories shown in Table 18. ANOVA
and regression modeling were undertaken to determine the contribution of each of these
variables and/or variable levels to the MLP practice level ultimately resolving the consultation
case. The final regression model for aim 2 was: invMLP3LevelDisposition = sbjITOrdering +
logHandoffsLS3LevelsTOT + sbjSafetyID. Handoffs/logic steps as well as two medical subjects,
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IT ordering and safety/ID, were significant determinants of MLP practice level consultation
resolution. The post-completion workflow prediction model thus created from these analyses
also provided a numerical value indexed to one of the three MLP practice levels most
appropriate for consultation resolution.
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CHAPTER 5
Discussion and Implications
Study Context and Worldview
Following a brief summary of findings from this study, implications and potential
significance for practice in healthcare, education, and research will be discussed. Results will be
viewed through the lens of current practice in each of these contexts, and heuristics developed
from the findings will be proffered as strategies for advancing quality in all these environments.
The chapter concludes with suggestions for further studies.
Potential significance of the findings is drawn from the principles put forth in the study
assumptions. First, the field of healthcare diagnostics is based in the assumption that there is
empirical truth, e.g., accurate results from clinical analyses, reproducible evidence from clinical
research, and unbiased curricula developed from educational outcomes tracked to improvement
in quality of life measures (Ballard et al., 2014; Carayon et al., 2006, 2014, 2018; IOM/NAM,
2015). The assumption of empirical truth underlies the reliance on diagnostics in CDM as the
primary source of objective data. The assumption of truth is also evident in the scientific
approach to evidence based clinical and quality studies as well as evidence based practice. The
overarching goal of this study was to develop methodology based on empirical truth intended to
increase the efficiency and effectiveness of CL communications for the improvement of care for
patient/consumers.
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Next is the assumption that critical thinking (CT), as the bedrock of ethics, is grounded in
truth-seeking and shields against bias and its effects; ethics and evidence based practice are
operationalized through CT. Evidence based practice itself is feasible only because of the
assumption that quality is desirable, can be improved, and that high quality costs less than poor
quality in both material and human resources measures (Carayon et al., 2018; Deming, 1986;
Donabedian, 1988; Porter et al., 2013, 2020). The design, implementation, and evaluation of this
study illustrated that healthcare practitioners are highly skilled and motivated to provide quality
care and critically think in the provision of services. Ethics defining equity, justice, and
autonomy as well as privacy and confidentiality were evident in the care given to study training
sessions and in data collection tool design and data collection by study participants. The
identification and assessment of study bias and limitations, both critical factors in assessing truth
in clinical and quality improvement studies, was possible because of the critical thinking and
ethical practice of the study participants.
The last study assumption is that patient/consumers should drive healthcare services
delivery within the context of truth, critical thinking and ethics, and quality gauged by
improvement in health outcomes for individuals and society as a whole (Ballard et al, 2014;
IOM/NAM, 2015; Procop et al., 2019; Proctor et al., 2011; Protection of Human Subjects
Revised Common Rule, 2018). The specific research questions of this study addressed the
development and assessment of a prediction model, the complexity index, intended in practice to
direct consultation workflow to appropriate MLP for resolution. CI implementation is the first
step in actualization of the DCM© designed as a communications portal “to support clinical
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decision making (CDM) within interprofessional teams, providers, and institutions." The
assumption of improvement in patient/consumer-centered care as evaluated by the measurement
of STEEEP outcomes documented through DCM© and A6 HCQR methodology is preeminent in
DCM© design and purpose.
The adoption of a worldview encompassing these four assumptions through
implementation of the DCM©, i.e., truth, CT in EBP, quality, and patient/consumercenteredness, has implications for healthcare delivery, education, and research in macro as well
as micro practice environments.
Study Results Redux and Significance
The overarching goal of this work is “to describe the Diagnostics Consultation Model©
(DCM©), a clinical laboratory (CL) communications portal, designed and proposed to support
clinical decision making (CDM) within interprofessional teams, providers, and institutions."
Specific aims supporting the purpose were to design, develop and evaluate a workflow prediction
index (the complexity index, CI) that could assign consultation requests for resolution based on
an algorithm comprised of consultation characteristics available at the point of consultation
initiation. In practice, the CI is intended to function as the entry point into a workflow process
directing diagnostics consultation requests, first, to the appropriately qualified MLP for
investigation and then branching into processes for tracking medical history and clinical
information accumulation, documenting resolution logic and detail, verifying conclusions, and
communicating recommendations for clinical decision support to all health professionals
involved and the health record.
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Data to develop and validate the CI were collected during clinical laboratory (CL) daily
activities documented during an institutional review board-approved study conducted in 2011.
Data elements collected describe types of consultation requests brought to the CL, types of
health professionals requesting consultation, steps and health professionals involved in the
request resolution process, and processes involved in results reporting. From analysis of data
collected at the point of consultation initiation, test cycle phase and medical service of origin
emerged as statistically significant pre-consultation predictors of the MLP practice level best
prepared to resolve particular consultations.
A second workflow predictive model was constructed from data collected after
consultation completion. Number of handoffs/logic steps and medical subject emerged as
statistically significant post-consultation predictors of the MLP practice level best prepared to
resolve particular consultations.
Both pre-consultation and post-consultation models predicted one of three MLP levels of
practice defined by education, experience, and position responsibilities and were both
determined to be statistically significant predictors of MLP practice level appropriate for
consultation resolution. The post-consultation predictors, handoffs/logic steps and medical
subject, were demonstrated to be more specific predictors of MLP practice level, i.e., postconsultation predictors accounted for more variance in the MLP DV, than pre-consultation
predictors, test cycle phase and medical service. Findings from the post-consultation model were
employed to assess the predictive performance of the CI.
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Study significance for healthcare delivery. Others have reported inadequate healthcare
IPT communications and CDM leading to quality gaps in patient/consumer care (Abraham et al.,
2021; Cao et al., 2018; Carayon et al., 2006). Though the impact of these communications errors
on quality of health services delivery are well documented, nearly two-thirds of all sentinel
events continue to be related to communication failures (Burns et al., 2021). Further, information
handoffs/handovers are implicated in more than half these errors (Burns et al., 2021; Killin et al.,
2021). CL information, as the primary source of objective data for CDS, underlies medical
decision making in all professions of healthcare providers (NAM, 2015). Focusing specifically
on the role of the CL in providing quality CDS, non-MLP healthcare providers have also
signaled the need for assistance in navigating all phases of the diagnostics testing process, i.e.,
pre-analytic, analytic, and post-analytic (Hickner et al., 2014; Laposata & Cohen, 2016; Procop
et al., 2019; Schmidt et al., 2014; Strizich & Kim, 2021). Therefore, any quality and evidence
based communications system would not be comprehensive and effective without the
participation of all stakeholders, including MLP, patients/consumers, and customer healthcare
providers. This study began to address the gap in communication of diagnostics information.
Codifying methodology for development of the CI is the first step in actualization of the
DCM© communications portal, i.e., appropriately prepared MLP are identified by the CI and
engaged to begin consultation resolution work. Codifying methodology for development of the
post-consultation workflow prediction model is a companion step in communications portal
actualization. By definition, the post-consultation model analyses describe methods to identify
significant predictors of MLP practice level entering into the consultation workflow as steps are
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completed or documented at final consultation completion. Using methods similar to those
employed to develop the predictive models in this study, models could be developed predicting
workflow in an ever expanding communications system related to consultation resolution, e.g.,
number and level of practice of MLP and other health practitioners involved in handoffs, CT
practice competencies utilized in resolution, databases searched for CDS, number and scope of
communication tools employed. This scope expansion would become the foundation for the
design of the next steps in actualization of the DCM©.
Figure 20 is a diagram of work process steps to be investigated in order to supply the
evidence base for completion of the DCM© communications system. DCM© initiation would
begin with direction of consultation requests to appropriate MLP by the CI. Direction of each
subsequent step in the workflow would require analyses similar to those described in this study
to identify significant afferent and efferent predictors guiding further steps in the consultation
resolution and communications processes among providers involved in consultation completion.
Once predictors are identified at each step, workflow direction could be automated by artificial
intelligence (AI) algorithms completed with predictors found to be significant at each step.
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Figure 20. Diagnostics Consultation Model© (DCM©) Work Processes Flow:
1.
Consultations are requested by providers as well as patient/consumers.
2.
MLP Diagnostics Consultants review applicable evidence from curated
databases, e.g., PubMed, through the lens of individuals’ health information
(i.e., precision medicine).
3.
Diagnostics Consultants draw on the expertise and knowledge of other
healthcare providers as well as historical diagnostics information from
the CL laboratory information systems/laboratory information and
management systems in the consultation process.
4.
Consultation summaries along with demographic and other PHI (protected
health Information) are documented in local clinical databases.
5.
With patient/consumer consent, all health record data are sent to the
patient/consumer-controlled electronic data warehouse for continuing
workflow beyond that would follow from documentation of the practitioners,
competences, and databases involved in handoffs/logic steps and the consultation
medical subject.
The potential significance of this work for healthcare delivery relates to improvement in
decision making not only within departments but also throughout health systems. At the unit
level, work can be distributed based on medical complexity directly to practitioners with
commensurate competencies. Verification rules establishing release of results and
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recommendations for further medical interventions can be designed based on the complexity of
the cases and number and types of practitioners and services required beyond the unit level
services. Further, stepwise and summary documentation of all medical decisions and evidence
supporting them would be maintained in the medical record for all interprofessional team
members involved to review to assure continuity of care. Documentation of services in this way
could also serve as a basis for reimbursement based on value of practitioners to the healthcare
team and provide evidence for justification of hiring decisions. And perhaps most importantly,
because data from consultations would be evaluated continuously for impact on health outcomes
and maintained in one record, patient/consumers could be brought into care plan planning,
evaluation, and decision making even as care environments proceed from community to
institution and back to community for post-event follow-up.
Study significance for clinical and quality research. Prior to the widespread adoption
of electronic health records (EHR) in health systems and provider practices, clinical data were
available only for clinical trials through strict experimental protocols approved by institutional
review boards. Data generated through patient care were generally considered to be only for
internal quality improvement analysis, examined only in the aggregate, and not to be published
outside the institution where gathered (Kudler et al., 2010; Leibach, 2014). Often studies
involving clinical data generated through healthcare services delivery were not considered to be
research, but rather quality improvement (Leibach, 2014; Protection of Human Subjects
Common Rule, 2009; Protection of Human Subjects Revised Common Rule, 2018). EHRs have
provided improved and more standardized access to patient/consumer and delivery
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processes data while regulations protecting patent/consumer privacy and confidentiality have
better defined circumstances under which clinical data may be studied and communicated
(IOM/NAM, 2015; Laposata & Cohen, 2016; Leibach, 2008; Porter, 2010; Procop et al., 2019).
Even though access to clinical data has improved, understanding of the informatics
techniques required to extract data elements and build the requisite dashboard data displays for
clinical research studies is limited in most institutions to a small number of information
technology (IT) specialists in institutional level quality and utilization review roles (AdlerMilstein et al., 2020; Ellis et al., 2020; Williams, 2021). Health informatics methodology,
designed to identify, capture, and analyze relevant data from the electronic health record (EHR),
is needed to compare medical effectiveness of algorithm variations and generate evidence on
which to base recommendations regarding best practices in communications (Casey et al., 2020;
Caudell-Feagen & Thompson, 2021; Glaser, 2020; Strizich & Kim, 2021). Much developmental
work is needed in codifying interoperability among databases and standardization in IT
methodology before the integration of clinical outcomes with the transactional record to create
electronic, searchable clinical summaries for care continuity becomes feasible (Arsoniadis, 2020;
Glaser, 2020; Sivashanker et al., 2021; Weiskopf & Weng, 2013).
On the other side of the clinical and quality research equation, most healthcare
practitioners who understand the relationship between clinical and diagnostics interventions and
health outcomes lack the IT skills to build EHR based clinical studies at the same time IT
specialists lack clinical knowledge and experience. Whereas some application programming
interfaces and middleware have been developed to support consultation modules within
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pathology practice, most of these modules are designed for anatomic pathology and involve
artificial intelligence/machine learning approaches to image interpretation (Church & Naugler,
2020; Rashidi et al., 2019; Schmidt et al., 2014; Stendhl et al., 2021; Theparee et al., 2018). The
CL-based consultation modules reviewed that do address aspects of diagnostics consultation
questions, however, were a blend of manual and digital processes; addressed convenience
samples of post-analytic questions only; provided no guidance on IPT reporting, tracking, or
work process analyses; and involved pathologists and pathology residents only (Church &
Naugler, 2020; Rashidi et al., 2019; Schmidt et al., 2014; Stendhl et al., 2021; Theparee et al.,
2018).) The design of these CL-based consultation modules does not incorporate the other error
reporting, mitigating, and feedback functions of the CL, e.g., incident report follow-up,
evaluation of reference test requests, optimization of test orders. Many of these additional CL
consultation work processes are conducted by MLP non-physicians, are subsumed in DCM©
design, and provide the CDS evidence base for the majority of health providers (Hickner et al.,
2014; Procop et al., 2019).
The potential significance of this work in forwarding clinical and quality research lies in
the development of a structured framework to serve as a guide for continuous quality
improvement studies. This framework, the A6 Method for Healthcare Clinical and Quality
Research (A6 HCQR), describes methodology for building an evidence base for efficient and
effective delivery of patient/consumer-centered care through work processes of the DCM©. The
A6 HCQR integrates the rigor of the well-characterized literature synthesis process into the
classic Quality Theoretical Framework developed and first reported in 1988 by Donabedian and
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detailed more thoroughly in the SEIPS Model (Carayon et al., 2006; Carayon et al., 2014;
Carayon et al., 2018; Donabedian, 1988; Reinke, 2017). The A6 HCQR describes a clinical and
quality research structure that not only allows for, but requires, the design, development,
implementation, and evaluation of clinical studies utilizing clinical outcomes data (evidence of
impact) generated through analyses of health services delivery care paths.
The A6 HCQR method is comprised of six steps (ASK, ACQUIRE, APPRAISE,
ANALYZE, APPLY, ASSESS) guiding the design, implementation, evaluation, and
communication of findings of clinical and quality research studies. Table 23 summarizes the
constructs in each step and offers the steps in the progression of this study as exemplars. The A6
HCQR methodology, with adaptations for specific clinical questions, could guide clinical and
quality studies in all healthcare settings as illustrated by its application in the study described
here.
Table 23
A6 Method for Healthcare Clinical and Quality Research: Steps A1-A6 Definitions and
Examples
A6 Method for Healthcare Clinical and Quality Research (A6 HCQR)
A6 HCQR Step

A1 ASK

A2 ACQUIRE

A6 HCQR Step Definition

A6 HCQR Step Example

Topic area (EBI, evidence based
initiative) is identified that is considered
to contribute significantly in performance
related to failure, achievement, and/or
maintenance of a quality goal.
A1 topic is distilled into a specific and
measurable clinical question. Preliminary
review of the literature is conducted to
determine the strength of the body of
evidence supporting the clinical impact

Data were presented that justify
the selection and evaluation of
consultation characteristics as
predictors of MLP practice
level consultation resolution.
Literature related to major
theories influencing the
construction of the
communications portal of the
DCM©, the evidence based
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A3 APPRAISE

A4 ANALYZE

A5 APPLY

A6 ASSESS

of the question and to discover seminal
reports that could inform further, more
extensive literature search strategies.
A pool of candidate practices is
generated from the extensive, if not
exhaustive, review of literature evaluated
on strength of reported evidence as well
as relevancy to the clinical situation for
which the EBI is being designed. Also, a
pool of variables, i.e., measures reported
to vary with changes in the EBI-related
practice, is accumulated. Literature
identified previously will be analyzed in
two processes, article abstraction and
variable extraction to compile the
candidate practices and variable pools.
All the products of previous planning
steps are synthesized into an EBI
implementation protocol. Details of
protocol implementation and variable
analysis are identified and described to
include IRB and administrative
permissions and approvals, personnel
participation secured, preparation of
training materials, design of data
collection tools, schedule of educational
sessions, timeline for accomplishment of
major milestones, and evaluation
methods.
Training, data collection, and analysis
begins. Implementation barriers and
hurdles are documented and their impacts
on study findings considered.
Adaptations are considered by the
research team and, if feasible, workarounds developed, documented, and
implemented.

EBI evaluation strategies are conducted.
Analysts prepare data for assessment to
include pooling of indicators from
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initiative (EBI) to be
investigated, was accumulated
Literature from theories
supporting DCM© design as
well as pilot study data were
presented that justified the
selection and evaluation of test
cycle phase, medical
service/hospital location,
medical subject, and
handoffs/logic steps as
predictors of MLP practice
level consultation resolution.
Research questions were
refined.
Datasets were evaluated for
accuracy and fitness. Analyses
were planned to determine if
models predicting MLP practice
level resolution could be
constructed from preconsultation (research question
1) and post-consultation
(research question 2)
characteristics. IRB approval
was obtained for the study.
Evaluation methods were
planned.
Analyses were conducted to
determine the significance of
contributions of both preconsultation characteristics (test
cycle phase and medical service
area) and post-consultation
characteristics (handoffs/logic
steps and medical subject) to
the choice of MLP practitioner
resolving the consultation case.
Pre-consultation and postconsultation predictive models
were evaluated quantitatively

different collection sources and by
different variable types, missing data
analyses, sensitivity analyses, and power
determinations. Data are then analyzed
descriptively by individual variables as
well as variable groups. These analyses
are then used to assess significant
differences between baseline and EBI
performance on specific indicators and to
perform inferential analyses to determine
the contribution of variable combinations
to overall EBI path effectiveness.

and qualitatively. Statistical
inferences were drawn
regarding the strength of
evidence predicting MLP
practice level in both preconsultation and postconsultation datasets. Study
design and data collection
limitations were identified,
documented, and assessed for
their impact on the internal
validity and generalizability of
study findings.

Study significance for education in quality. Tracking measures of quality performance
and the achievement of quality goals are priorities in health services delivery (TJC, 2021a,
2021b). Not only do licensing and accrediting bodies monitor closely and publish institutional
performance metrics but federal payments to providers and reimbursements to institutions are
often linked to performance against quality standards (D’Avena, et al.,2020; Cattell et al., 2020;
Porter, 2008, 2009, 2010; Porter et al., 2013, 2020). Yang et al. (2007, 2015, 2016), Donabedian
(1988), Westgard (2006, 2013), Christenson et al. (2011), Leibach and Russell (2010), and
Leibach (2011), have provided robust theoretical frames for the design and operationalization of
substantive CL quality improvement (i.e., clinical and quality research) programs. Historically,
quality measures have focused on error rates (failures) in process steps or slippage in
patient/consumer satisfaction (Blokland & Reniers, 2020; Sapatnekar et al., 2021; Westgard,
2006, 2013). With increased focus on value based care (highest quality/lowest cost), measures
are being developed that include health outcomes that can be objectively documented through
audits of patient records. However, the capabilities of the current transactional and interoperable
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structure of electronic health records inhibits auditing of statistically valid numbers of cases to
support evidence based care path design (Del Mas et al, 2020; Lewanczuk et al., 2020; Modica,
2020; Pelaccia et al., 2020; Porter et al., 2020; Procop et al, 2019; Rabi, 2020; Schrijvers, 2012).
The EBP paradigm represents a new direction in education as well as quality
improvement for the CL (Dickerson et al., 2017; Hill et al., 2020; Plebani et al., 2019a; Plebani
et al, 2019b). Clinical and quality researchers will need different skills sets to assess quality
issues impacting the total diagnostics testing and care process. Practitioners will be required to
integrate evidence with practice outside the experimental, statistical model of analytic phase
quality control (Sapatnekar et al., 2021). Education in clinical and quality research methodology
must be directed to practitioners as well as student learners (Maness et al., 2020). Didactic
coursework, clinical internships, and continuing professional education must be designed to
inform practice and expose students and practitioners alike to clinical experiences providing the
greatest opportunity to develop research skills necessary not only to utilize evidence in clinical
decision making but also to generate and communicate data-supported practice guidelines, to
monitor patients’ clinical paths, to evaluate and introduce new technology, to develop quality
indicators, and to create and analyze testing algorithms. Not only will health outcomes evidence
be used in clinical decision making, but these utilization data can be analyzed to support
evidence for practice improvement across all healthcare delivery systems, public and private
(Aita, et al., 2019; Leibach, 2008a; Leibach, 2008b; Plebani et al., 2017; Plebani et al., 2019;
Siemieniuch & Sinclair, 2014).
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Implementation of DCM© methodology would serve to educate practitioners in quality
tenets and link them into the institution-wide delivery, measurement, evaluation, and reporting of
quality services. The A6 Method for Healthcare Quality and Clinical Research (A6 HCQR),
providing the structure for the DCM© quality studies described in this work, would serve as the
educational framework for implementation of homologous studies in medical service areas
beyond the clinical laboratory. Following the A6 HCQR steps, medical services would collect
data related to daily unit activities to analyze, set priorities, and assign workflow on the basis of
resources, both material and human, required to resolve consultations most effectively within
their scopes of practice. The establishment of this initial data collection and analysis work
processes is analogous to development of the CL CI and would follow the same methodology.
Past the establishment of this first step in workflow direction, the medical service unit would
then become the next step in DCM© actualization, if CL consultation resolution required
participation of an IPT member from that medical service. Or if the consultation request were not
primarily dependent on diagnostics information for resolution, the CL would become a process
step, and a MLP IPT member, in the medical service unit’s consultation resolution workflow
process. Providers from medical services other than CL would enter the DCM© at step one in
Figure 17.
Prior to DCM© implementation, practitioners in all medical and support services and
administrative units would be educated as to its institutional structure, related work processes in
their areas, and functions required to fulfill their roles in documenting, analyzing, and/or
reporting outcomes. The integration of all these DCM© quality functions would be the

149

foundation of an institutional or system-wide value based quality initiative that would meet and
exceed all current reporting requirements; that is, the fully actualized DCM© would provide the
evidence for a learning health system based on the measurement and evaluation of health
outcomes for both individuals and populations served by the provider system (Ballard et al.,
2014). In addition, a curriculum based on DCM© methodology and A6 HCQR clinical and
quality research constructs, i.e., health services science, could be developed as a guideline for
continuing or formal education certification in health services science earned through
participation in quality activities in the learning health system or after completion of formal
programs to be developed in health services science (Leibach, 2007, 2008a, 2008b, 2010, 2011;
Leibach & Russell, 2010).
Study limitations. The limitations of the study relate to potential bias in the collection
and interpretation of data elements, i.e. consultation characteristics. First, the complete and
accurate recording of all data cannot be assured. In addition, no attempt was made to standardize
individual research participants’ perceptions of consultation questions through interrater
comparisons. Although interpretations of research participants’ were guided by commonly held
practice understandings, there was also no strict control on the interpretation of categories into
which primary data were assigned; in some instances, data were placed in categories, e.g., test
cycle phase assignment, without clear support and documentation for the choice by the research
participant.
In addition, the statistically significant CI predictors derived from the aim 1 and aim 2
datasets in this study represent very small variances in the MLP practice level DV. Therefore, the
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predictive performance of both the pre-consultation CI and the post-consultation model are
subject to increased type 1 error. In addition, generalizability to other clinical settings is limited;
findings from data collection and analyses in different clinical settings is expected to vary
seasonally, with specific catchment populations, and with clinical services provided.
Limitations of this study defining the complexity index (CI) can be overcome in the
future by improved data collection practices, the evaluation of more specific predictors for the
CI, greater participation of practitioners throughout the various sections of the CL and
automating the DCM© workflow processes.
Study conclusions. Though the study reported here has significant bias introduced in the
data collection process and by the exclusion of PHI, it has produced methodology for
establishing processes to generate data for streamlining workflow and improving clinical
decision support for MLP and other health professionals throughout the health system and for
use in the design of data collection processes and collection tools for use in multiple clinical
settings. The overarching goal of this work was “to describe the Diagnostics Consultation
Model© (DCM©), a clinical laboratory (CL) communications portal, designed and proposed to
support clinical decision making (CDM) within interprofessional teams, providers, and
institutions.” Methodology describing the complexity index developed in this study was the first
step in actualizing this overarching goal.
Datasets and analyses described in this study are intended to be utilized as the foundation
of continuous, evidence based CL and enterprise clinical and quality improvement studies.
Because implementation of the DCM© methodology is predicated on the collection of data
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(evidence) related to work processes, findings can also support internal CL job analysis and
workflow process improvements as operations structures change. Larger studies, in multiple
health system settings, to refine data collection platforms along with continuous analyses of
findings at all practice levels will contribute to the refinement of setting-specific algorithms
derived from this methodology. Given the goal of methodology development, it can be
concluded that the study adequately addressed the research questions posed.
Implementation of DCM© methods and curriculum in health professions’ daily practice
and formal and continuing education venues has the potential to change health services delivery
by the redistribution of care through interprofessional teams (IPT) coordinated by standardized
workflow and communication processes (Ballard et al., 2014). IPT membership would be
determined by developments necessitating changes in care paths and would follow
patient/consumers through all care environments and levels of care. In addition, this care
delivery structure portends the capability to follow individuals’ medical histories longitudinally
and, through regular consultations, to address issues of access, equity, and compliance for the
purpose of development of an evidence based, individualized care plan for every
patient/consumer.
Future studies. Future studies to refine the DCM© CI should focus, then, on identifying
CI predictors explaining more variance in MLP practice level. Identification of more specific CI
predictors could be accomplished by collection of more consultation data and reestablishing
priority of predictor significance through regression analysis. For instance, diagnosis (ICD)
codes are projected to explain significant variance in the CI model because they describe
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diagnosis acuity and complexity. However, theses codes were not available at the time
of data collection for this study. The collection of ICD codes, including co-morbidities, could be
added to the study protocol to increase specificity in consultation characteristics definition and
thus increased CI specificity. In addition, only some levels of the medical service variable were
significant predictors. If consultation requests originate from a medical service area found to be
statistically non-significant, then a value would not be entered into the CI prediction algorithm
resulting in compromised MLP level assignment due to the omission of explained variance,
albeit small. Future studies should focus on the identification of more “forced choice” predictors,
e.g., test cycle phase, that add significantly to the variance in MLP practice level. These “forced
choice” variables would fit into one mutually exclusive variable category and would, therefore,
always enter a value into the algorithm.
To summarize continuing DCM© expansion, future studies should focus on three more
critical next steps: (1) identification of more specific predictors for the CI (the point of entry into
the portal) (2) systematic, unbiased collection of afferent and efferent workflow characteristics
(i.e., number and types of practitioners, handoffs/logic steps, practice competencies, and
databases) as well as communications involved in CDM at each work process step, and (3)
DCM© automation.
Results from studies implementing DCM© communications processes among all
providers involved in consultation resolution would then become the basis of expansion of the
DCM© throughout the healthcare system. With this expansion, the DCM© would grow into full
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potential as the conduit for patient/consumer information in all levels of care, i.e., primary,
secondary, tertiary, and referral.
Results from studies in DCM© automation should focus on development of AI
algorithms to increase the feasibility of implementation. In its current manual form, data
collection for study analyses is labor intensive and subject to significant collection bias. Also,
workflow processes are manually initiated and dependent on practitioner priority for initiation
and follow through. Automation of collection, workflow direction, IPT and EHR
communications, and continuous evaluation would increase both the quality and value of DCM©
processes through the improvement of process efficiency and assessment of medical
effectiveness.
Future studies in healthcare education and clinical and quality research should focus on
conducting and reporting findings from services delivery and clinical outcomes quality
improvement investigations. A6 HCQR methods and related curriculum are being developed and
implemented in CL doctoral training programs for the purpose of objectifying a standardized,
reproducible, consistently communicated approach to the generation and incorporation of clinical
research findings into daily practice to improve quality and value of services. A6 HCQR-guided
curriculum should also be adapted for post-doctoral programs and incorporation into position
responsibilities of all CL practitioners with quality and utilization review responsibilities to
increase the integration of clinical and quality research methods into practice, focus
patient/consumer care on communication of clinical and quality study findings, and promote
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EHR research methods innovation to codify approaches to algorithm development guiding
individualized patient/consumer care.
The significance of future studies should be evaluated by the extent to which STEEEP
aims (i.e., safe, timely, efficient, effective, equitable, patient-centered) are improved by the
direction of consultations and consultation information summaries to appropriate MLP at the
point of consultation initiation and, subsequently, to all IPT members involved in consultation
resolution. Future studies employing DCM© methodology could be structured to identify
outcomes measures related to STEEEP aims in all healthcare practices, in all modes of health
communications, and in diagnostics algorithm and treatment guideline development and
evaluation. DCM© curriculum could be employed in formal and continuing education programs
to educate healthcare providers in quality and clinical research tenets as the basis for continuous
quality improvement. In this way, the DCM©, employed as a health system approach to evidence
based practice, quality improvement, and individualized patient/consumer care (i.e., health
services science), could provide the foundation for value based healthcare continuously
optimized to address the needs of individuals, populations, and health systems throughout the
continuum of care.
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Clinical Laboratory Data Collection Log Abstract
IRB #10-12-126; Georgia Regents University
Clinical Laboratory Performance Measures Project
Clinical Laboratory Data Collection Log, v.9/16/11
Pathologist/Manager/Designee:
Inclusive Dates:
Submitted By, CL Area, and Date:
Legend:

_________________________________________________
_________________________________________________
_________________________________________________

AD = Administrator; AT = Attending Physician; HS = Housestaff; MT = Medical
Technologist/Clinical Laboratory Scientist; RN = Nurse: CP = Pathologist; OT = Other
Healthcare Provider (define in space provided below); Test Select = Test Selection
Query (Check); Place Order = Order Placement Clarification (Check); Collect/ID/Tran =
Specimen ID, Collection, Transport Details (Check); Obtain Result = Preliminary or Final
Results Inquiry (Check); Results Logic = Interpretation and/or Reflex Logic (Check);
Test = Analytic Query (Check); Other = Miscellaneous requests, e.g., billing information
(check); Forward = Forward to Manager’s/Pathologist’s Attention (Check)
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The Pilot Study
Introduction
Neither methods for characterization of MLP consultations nor attribution of MLP
consultations to significant diagnoses or health outcomes have been reported. To address these
gaps regarding the role of MLP consultations in clinical decision support (CDS), an exploratory
study was conducted to document and characterize MLP involvement in consultation with other
health providers regarding questions they have about access to and utilization of clinical
laboratory (CL) information. Being able to predict the pathway and direction of questions about
laboratory information would not only provide the methodology to monitor for and correct
patient safety concerns but would also significantly inform efforts to staff laboratories and
educate students appropriately for consultation practice (Leibach, 2011).
The exploratory pilot study, the “Clinical Laboratory Performance Measures Project,”
was conducted to document and characterize MLP involvement in consultation with other
healthcare providers regarding the impact of laboratory information in clinical decision making
and thus provide evidence regarding the role of MLP consultations in clinical decision support
(CDS). The pilot project addressed research questions regarding aspects of the role of MLP in
CDS through the implementation of an electronic (and also paper) data collection log for
capturing important aspects of consultations among MLP. Characterizing these consultative
interventions and analyzing their complexity and medical subject focus led to the identification
of consultations that impact (and vary with) CDS. The project (Elizabeth Kenimer Leibach,
Ed.D., Principal Investigator) was approved for expedited review March 11, 2011 by the
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Institutional Review Board (IRB) of Augusta University (formerly Georgia Regents University)
as IRB #10-12-126/IRBNet #611273-2.
Pilot Study Research Questions
The following research questions were investigated:
1. What are the characteristics of MLP consultations with other healthcare providers as
categorized by area of the clinical laboratory involved; time of day requested; medical
service/hospital location; urgency; healthcare provider type initiating the consultative event;
consultation type (i.e., phase of test cycle in question); number of handoffs/logic steps; and
medical subject area?
2. Which consultation characteristics, i.e., area of the clinical laboratory involved; time of day
requested; medical service/hospital location; urgency; healthcare provider type initiating the
consultative event; test cycle phase involved); number of handoffs/logic steps; and medical
subject/hospital location, are associated with MLP practice level involved in final
consultation disposition? The related hypothesis is that some conditions and levels of the
independent variables are associated with the MLP practice level involved in the final
disposition of consultations.
Pilot Study Design and Methods
Clinical laboratory data collection log development. MLP managers and clinical
pathology section chiefs (also considered MLP) were asked to participate in study instrument
design, piloting, implementation, analysis, and evaluation. Between June and October 2011, four
meetings were conducted. The first meeting (June 2011) was dedicated to a project overview
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and design of the data collection log. During July 2011, the data collection instrument was
piloted and a second meeting was conducted with participating MLP to refine the initial data
collection log. The CL consultations data collection log, an Excel worksheet, is Appendix A.
Instructions regarding completion of the log as well as information regarding goals and
objectives of the project were shared with MLP participants during educational sessions
conducted prior to the beginning of data collection.
Population definition and sample characteristics. The study population was defined as
all documented interventions (consultations) between MLP and other healthcare providers
(hospital-based users of laboratory information) in a 600-bed, tertiary care hospital affiliated
with an academic medical center. Both electronic and face-to-face interactions were considered
as consultations.
The study sample consisted of an 11-week documentation (September 19, 2011 –
November 22, 2011) of these electronic and face-to-face interactions among MLP and other
healthcare providers. Data logs of consultative events were maintained during the study period
by 7 of 13 areas of the clinical pathology laboratory (CL). The sample was a purposeful,
convenience sample of descriptions of as many consultative events involving MLP as possible
for the 11 weeks of study duration. Sampling was not randomized nor was there any attempt to
assess inter-rater bias potentially associated with differences in MLP perceptions or work shift
variations in MLP and/or healthcare provider characteristics and position responsibilities. Data
on 325 consultation events, i.e., N=325 consultation cases, were recorded.
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The CL data collection log (Figure 1a and Appendix A) was completed by participating
MLP during the normal workday (24 hours per day, 7 days a week) as consultations occurred.
Cumulative data collection logs were submitted electronically to the principal investigator every
two weeks; an email reminder prompt was sent before each submission was due. MLP
consultations were described demographically by CL area, date/time, medical service/hospital
location, urgency status, type of provider initiating the consultation intervention, number of
handoffs/logic steps, and testing cycle phase, i.e., pre-, post-, and analytic, to which they related.
A statistics data table was then created in SPSS Statistics (v. 22) for manual entry of variable
values and subsequent data analysis.
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IRB #10-12-126; Georgia Regents University
Clinical Laboratory Performance Measures Project
Clinical Laboratory Data Collection Log, v.9/16/11
Pathologist/Manager/Designee:
Inclusive Dates:
Submitted By, CL Area, and Date:
Legend:

_________________________________________________
_________________________________________________
_________________________________________________

AD = Administrator; AT = Attending Physician; HS = Housestaff; MT = Medical
Technologist/Clinical Laboratory Scientist; RN = Nurse: CP = Pathologist; OT = Other
Healthcare Provider (define in space provided below); Test Select = Test Selection
Query (Check); Place Order = Order Placement Clarification (Check); Collect/ID/Tran =
Specimen ID, Collection, Transport Details (Check); Obtain Result = Preliminary or Final
Results Inquiry (Check); Results Logic = Interpretation and/or Reflex Logic (Check);
Test = Analytic Query (Check); Other = Miscellaneous requests, e.g., billing information
(check); Forward = Forward to Manager’s/Pathologist’s Attention (Check)

Figure 1a and Appendix A. CLPM Pilot Project Consultations Data Collection Log Abstract
Data abstraction procedure. Algorithms for variable recoding to increase power for
analyses were developed from granular data as defined in Table 2a. Further, a data abstraction
table was created for recording additional assessments derived from the statistics data table.
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Table 2a
Summary of Category Transformation Algorithms in the Pilot Study

Variable

Initial Number
of Levels

CL Area

12

Provider Type

7

Test Cycle Phase

7

Handoffs/logic
steps

5

MLP Practice
Level
Consultation
Disposition

6

Transformed (Recoded) Number
of Levels
0 = Professional Knowledge (non-specimen receiving areas)
1 = General Knowledge (specimen receiving area)
0 = Non-RN
1 = RN
1 = Pre-analytic (test select, place order, collect/ID/transport)
2 = Analytic (specimen analysis)
3 = Post-analytic (obtain result, results logic, other)
1 = One logic step, no handoffs
2 = Two hand-offs/logic steps
3 = Three or greater handoffs/logic steps
1 = MLP Level 1 (MLP complete, one logic step and no
handoff)
2 = MLP Level 2 (Referred to MLP/MLP Manager)
3 = MLP Level 3 (Referred to physician to include pathology
resident, pathologist, and medical resident/attending
physician)

These additional assessments, i.e., number of handoffs/logic steps, MLP practice level
disposition, and medical subject categories, were qualitatively derived from “consultation
summary,” “forward,” and “reviewer comments” entries in the consultations data collection log.
Resultant definitions of handoffs/logic steps and MLP practice level disposition categories are
given in Table 2a.
Each of the 325 recorded consultation events was assigned to a medical subject category
defined as either: (1) education, (2) genetics/molecular, (3) technology decisions, (4) information
technology/ordering, (5) pediatric genetics/molecular, (6) analytic results resolution, (7) patient
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safety/identification, (8) test methodology integration/evaluation, (9) proficiency testing, or (10)
specimen referral/send out. Medical subject categories were derived from a thematic analysis of
consultation topics as reported in the consultation summary and reviewer comments sections,
also shown in Pilot Study Table 3a. Also, the original and/or non-recoded categories are shown
in Table 3a. Lastly, the “comments” field was used to record free-form comments related to
issues arising from the consultation CDS process itself, or documentation from it.
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Table 3a
Pilot Study Original Categories and/or Non-recoded Consultation Characteristics Summary
Original Categories and/or Non-recoded Consultation
Characteristics (IV) N = 325
Clinical Laboratory Area Involved
Chemistry
Clinical Pathologists/ Residents
Immunology/Send Outs
Outpatient (Medical Office Building)
Point of Care Testing
Receiving
Missing Data: % = (1.00 – n/N) x 100

Time of Day Initiated
8 a.m. – 12 p.m.
1 p.m. – 4 p.m.
Other
Missing Data: % = (1.00 – n/N) x 100

Medical Service/Location Origin
Emergency Department
Chemistry (Clinical Laboratory)
Other
Missing Data: % = (1.00 – n/N) x 100

Urgency
Routine
STAT
Missing Data: % = (1.00 – n/N) x 100

Healthcare Provider Type
RN
Other (administrators, MLP, medical
students, pharmacists, physicians,
respiratory therapists)
Missing Data: % = (1.00 – n/N) x 100

Consultation Type (Test Cycle Phase Involved)
Pre-analytic: Test Select, Place Order,
Collect/ID/Transport
Analytic: Test Parameters
Post-analytic: Obtain Result, Results Logic,
Other
Missing Data: % = (1.00 – n/N) x 100
Medical Subject
Education
Genetics/Molecular
Technology Decisions
IT Ordering
Pediatric Genetics/Molecular
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IV
Frequency

IV
Percent

n = 278
63
42
35
3
40
95
47
n = 182
37
37
26
143
n = 270
28
23
219
55
n = 278
191
87
47
n = 289
143
135

100
23
15
13
1
14
34
14
100
37
37
26
44
100
10
9
81
17
100
69
31
14
100
51
49

47

14

n = 278
137

100
49

86
55

31
20

47
n = 278
3
6
16
96
5

14
100
1
2
6
35
2

Results Resolution
Patient Safety/Identification
Test Integration/Evaluation
Proficiency Testing
Specimen Referral/Send Out
Missing Data: % = (1.00 – n/N) x 100

75
36
19
3
19
47

27
13
7
1
7
14

Pilot Study Data Analysis
All descriptive and inferential statistical analyses were performed using IBM SPSS
Statistics, v. 22; standard formatting conventions, as well as thresholds and significance levels
for regression modeling were used. In preparation for descriptive characterization of
consultations, data were initially collected into multiple levels of categorical measurements to
preserve granularity. However, total number of consultations was insufficient to allow for
analysis on all independent variables (IV) at all levels, and for some analyses, data were recoded
according to the algorithms given in Table 2a.
Pilot Study Results
Characterization of consultation requests (question 1). During the 11-week pilot study
period, 325 consultative events were documented. Data were collected on seven characteristics
(independent variables, IV): (1) CL area involved, (2) date/time, (3) medical service/hospital
location, (4) urgency, (5) healthcare provider initiating the consult, (6) consultation type, i.e.,
testing cycle phase related to the consultation, and (7) number of handoffs/logic steps. Data were
cleaned and a missing values analysis performed to determine the impact of these missing data.
After missing data cases were eliminated, 278 consultative events remained. Percentage of
missing data from variable fields was 5% or less except in the parameters healthcare provider
type (11%, 36/325) and time of day of consultation (44%, 143/325). Descriptive parameters
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reported were calculated using data with missing values removed unless otherwise indicated.
Consultation characteristics are reported in Table 3a.
Comparing means of all cases to means of those with missing data cases eliminated
resulted in significant mean differences only in provider type. Therefore, provider type was
removed from further consideration as a predictor of MLP practice level consultation disposition.
The variable, clinical laboratory area, was also excluded from consideration as a predictor
of MLP practice level consultation disposition due to data collection limitations rather than
missing data. Major CL areas for consultation, e.g., transfusion service, microbiology, and
hematology/coagulation, did not participate in the pilot study due to work force shortages.
Though data from the remaining participating CL areas is informative from methodology and
processes perspectives, conclusions drawn related to MLP practice level resources utilized in
these areas would not be generalizable to the larger CL and potentially misleading if reported.
Definition of MLP practice level consultation disposition. Consultation disposition was
defined as the MLP practice level involved in final consultation resolution. In initial analyses,
four (4) MLP practitioner levels were defined in consultation disposition: (1) MLP Practice
Level 1 (“Completed” at the time of initial contact by MLP), (2) MLP Practice Level 2
(“Referred to MLP or MLP technical specialist/manager”), (3) MLP Practice Level 3 (“Referred
to clinical pathologist/resident/MD”), and (4) “Consult Attending/HS,” defined as a request for
additional information from the attending physician or resident/house staff. Most consultations,
77% (214/278), were completed at the time of initial contact with a MLP, e.g., by phone or in
person, without the need for further investigation; further investigation is defined as handoffs or
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logic steps requiring additional consultation with MLP Practice Levels 1-3 (MLP, MLP
manager/technical specialist, and/or clinical pathologist/resident). Resolution of some
consultation questions involved information from non-MLP health practitioners, for instance,
attending physicians or medical residents. Non-MLP practitioner consults were documented but
non-MLP practitioners were not considered a MLP practice level because workflow processes
demonstrated that clinical information from non-MLP practitioners supported decision making
by MLP Practice Level 3. Therefore, for further future analyses, these non-MLP consult
frequencies were combined with MLP Practice Level 3 frequencies. Frequencies for all MLP
practice level disposition categories are shown graphically in Figure 10a.
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Completed

Referred to MLP
Manager

Referred to Clin
Path

Consult
Attending HS

Pilot Study Figure 10a. Frequency of MLP Consults by MLP Final Disposition Category:
MLP Practice Level 1: “Completed” = 77% (214/278 consults)
MLP Practice Level 2: “Referred to MLP Manager” = 15% (41/278 consults)
MLP Practice Level 3: “Referred to Clin Path” = ≤1% (2/278 consults)
Non-MLP Practitioner: “Consult Attending/HS” = ≤2% (6/278 consults)

Definition of consultation handoffs/logic steps. In the pilot study, five (5) categories
(levels) of handoffs/logic steps were assigned and defined as cognitive processes, requiring
either literature (technical manuals, publications, guidelines) review or referral to another MLP
level. With the data collection log, consultation workflow was tracked through all cognitive CDS
(logic) steps or referrals to other MLP (handoffs). Pilot study data indicated that even though
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consultation resolution could require multiple handoff/logic steps among multiple individuals
within each MLP practice level (i.e., up to 5), most consultations were resolved with 3 or less
handoffs/logic steps. Because of the low numbers of handoffs/logic steps in categories 4 and ≥ 5
handoffs/logic steps, variable values were recoded into three categories: category 1, 1 logic step;
category 2, 2 handoffs/logic steps; and category 3, ≥ 3 handoffs/logic steps. See Table 2a.
Consultation characteristics related to consultation disposition (question 2).
Healthcare providers from 97 medical service locations were available to seek consultations
during the data collection period. However, the numbers of cases from most of the medical
service units were less than numbers required for analysis. The variable, “medical
service/hospital location,” was recoded, first, from the original number of 97 medical services
available, to 37 by eliminating those medical services not consulting with the CL during the pilot
study. The resulting 37 medical services were then recoded as appropriate on the basis of
commonality among medical specialties, resulting in 11 medical services to be used in analyses
on this variable. See Table 4a. In addition, two of the seven variables, i.e., date/time and urgency,
did not correlate with MLP practice level disposition; all category levels of these IVs were
equally distributed across MLP practice levels (DV) for resolution. (Data not shown.) Analyses
using date/time and urgency were, therefore, not considered as potential predictor variables.
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Pilot Study Table 4a
Summary of Medical Service Transformation Algorithms
Original Medical
Service Areas
1, Allergy
2, Cardiology
3, Cardiac CCU
4, Dermatology
5, Endocrinology
6, ENT
(Otolaryngology)
7, Emergency/
Trauma

Consultation
Number
(Original
Areas)
1
14
0
0
0
0

Medical Service
Area
Transformations

Transformed
Medical Service
Areas

Consultation
Number
(Transforme
d Areas)

37, Other
1, Cardiology

14

58

2, Emergency/
Trauma

58

8, Family Medicine
9, Gastroenterology
10, Geriatrics
11, Gynecology
12, Hematology
13, Infectious
Disease
14, Medicine (Gen)
15, Medicine (Other)
16, Med ICU

9
0
0
0
1
0

3, Family Medicine

9

4, ICU:
3 (Medicine)
6 (Neurology)
4 (Nursery)
10 (Pediatrics)
7 (Surgery)

30

17, Nephrology
18, Neurology
19, Neuro ICU
20, Nursery
21, Nursery ICU
22, Obstetrics (L&D)
23, Oncology
24, Ophthalmology
25, Orthopedics
26, Pediatrics
27, Pediatrics ICU
28, Pulmonology
29, Rheumatology
30, Surgery (Gen)

0
2
6
0
4
34
10
0
0
24
10
1
0
18

5, Obstetrics
6, Oncology

34
10

7, Pediatrics

24

8, Surg Gen

18

10, Oncology

0
0
3

37, Other
16, Med ICU
16, Med ICU

16, Med ICU
37, Other
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31, Surgery (Other)

13

32, Surgery ICU
33, Telemedicine
34, Transplant
35, Urology
36, Clin Lab
37, Other

7
0
8
0
59
40

9, Surg Other:
13 (Other)
8 (Transplant)

21

10, Clin Lab
11, Other:
40 (No Service
Noted)
1 (Allergy)
2 (Neurology)
1 (Pulmonology)

59
44

16, Med ICU
31, Surgery (Other)

The remaining potential predictor variables, i.e., consultation type (test cycle phase),
number of handoffs/logic steps, medical service/hospital location, and medical subject were then
assessed for their association with MLP practice level consultation disposition. A series of
crosstabulations were conducted using the potential predictor variables against the DV, MLP
practice level, i.e., levels 1-3, resolving the consultation case. The resulting contingency table,
with the significance (Pearson’s Chi-square) as well as strengths (Cramer’s V) of the
relationships among variables, is given in Table 5a.
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Table 5a
Statistical Inferences Among Variables Predicting MLP Practice Level Consultation
Disposition

Crosstabulation

Inferential Statistics
Cramer’s V

MLP Practice
Level Disposition
(3 Levels) by:

Value

df

Siga

Value

df

Siga

Value

Siga

Test Cycle Phaseb

32.387

4

≤ .01

28.533

4

≤ .01

.227

≤ .01

Medical Subjectc

98.390

18

≤ .01

74.838

18

≤ .01

.396

≤ .01

Medical Serviced

30.733

20

.059

39.479

20

.006

.218

.059

Pearson Chi-Square

Likelihood Ratio

Handoffs/Logic
97.166
4
≤ .01 122.713
4
≤ .01 .393
≤ .01
Stepse
a
Asymptotic significance
b
Test cycle phase = Consultation type, 3 levels (Pre-analytic, Analytic, Post-analytic)
c
Medical Subject = 10 levels (Education, Genetics/Molecular, Technology Decisions, IT
Ordering, Peds Genetics/Molecular, Results Resolution, Safety/ID, Test Integration/Evaluation,
Proficiency Testing, Specimen Referral/Transport)
d
Medical Service/Hospital Location = 11 Levels (Cardiology; Emergency/Trauma; Family
Medicine; ICUs; Obstetrics; Oncology; Pediatric; Surgery, General; Surgery, Other; Clinical
Laboratory; Other)
e
Handoffs/Logic Steps = 3 levels (completed with one logic step, no handoff; two handoffs/logic
steps; ≥3 handoffs/logic steps)
Findings from these crosstabulations corroborate that four predictor variables, test cycle
phase, medical service/hospital location, medical subject, and handoffs/logic steps, are
significantly associated with MLP practice level resolving consultations (Pearson’s Chi-square
and likelihood ratio statistics) and that the strengths of the relationships are strong (Cramer’s V
statistics). Medical service, though not significantly correlated (p=.059) with MLP practice level
disposition with 95% confidence, nevertheless, shows potential enough (likelihood ratio=.006) to
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be tested further in the CI regression model with test cycle phase. And not all 11 medical service
areas are expected to be significant in the model. Further analyses determined
which medical services did not contribute to the model, they were removed, and correlation
significance increased.
Medical subject and handoffs/logic steps, the two predictor variables whose values are
not known until consultation completion, were tested together in a separate regression model for
prediction of MLP practice level disposition after consultation completion. The results of the two
regression models, i.e., comparing the model using variables available at the point of
consultation initiation to the model using variables after consultation completion, were analyzed
to determine the prediction performance of the CI.
Diagnostics Consultation Model© research program construction. From analyses of
data from structures, processes, and outcomes collected in the pilot study, a research program
was formulated that describes two arms for the collection and analysis of clinical laboratory
information required to establish a continuous quality improvement system based on evidence of
increased value to patients/consumers. The first arm of the Research Program, Consultation
Characterization and Implementation Science, is established to investigate and document
characteristics of consultation events in multiple clinical settings. Investigations within the first
aim of this arm, Consultation Characterization, utilize data collection tools comprised of
measurement elements derived from narrative analysis of encounters with both healthcare
providers and patients/consumers alike. Investigations in aim 1 of arm 1 of the Research program
will address the general question, “What are the characteristics of healthcare professionals’
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consultations?” Research questions in both the pilot study and dissertation study addressed
queries and analyses under arm 1, aim 1 of the DCM© Research Program.
In the pilot study, MLP consultation characteristics, e.g., test cycle phase, CL area, other
health professionals involved, medical service, medical subject, were described for the first time.
Then correlations of these characteristics with final consultation disposition by MLP practice
type were considered. The dissertation study builds on these correlations to question if certain
characteristics correlating with disposition by MLP practice type can predict workflow to the
correlated MLP practice types and suggest a communication strategy for consultation response
both within the clinical laboratory (intralaboratory/interlaboratory) and among health providers
throughout the health system.
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DCM© DATA DICTIONARY (DD), v. 8.5.20
: “20 8-5.DCM Non-transformed Data Dictionary.App.B.
”
: “20 8-3.DCM Non”
VARIABLE
VARIABLE
DATA
ALLOWED VALUES
DESCRIPTION
NAME
TYPE
Case ID
CaseID
Numeric Integers
Assigned accession number
in order received
Date
Date(Date
Numeric MM/DD/YY
The date the exception
Picker)
case appeared
Medical Record
MedRec
Numeric Integers
Permanent Patient
Number
Identifier
Patient Age
PtAge
Alpha1=< 30 days
The age range of the
numeric 2=1-11 months
patient when the exception
3=1-17 years
case was generated
4=18-44 years
5=45-64 years
6=65-85 years
7=>85 years
Patient
Gender
Alpha1=Male
Documented gender when
Gender
numeric 2=Female
the case was received.
3=Undisclosed
Define “Other” in
4=Other
“Comments.”
ST
Primary
1 Dx
Alpha
Free Text
The primary diagnosis of
Patient Dx
the patient when the case
was received
Primary Dx
PrimICD10
AlphaA00.000-Z00.000
The ICD-10 code that
ICD-10 Code
numeric
correlates with the written
primary diagnosis of the
patient when the exception
case was generated.
Ordering
ProvTyp
Alpha1=Attending Physician
Practitioner type placing
Provider Type
numeric (AP)
test order. Define “Other”
2=Resident Physician
in “Comments.”
(RP)
3=Consulting Physician
(CP)
4=Nurse (RN/APN)
5=Pharmacy (PharmD)
6=CL Protocol (Prot)
7=Other (O)
Ordering Service MedServ
Alpha1=Allergy
The location of the patient
/ Patient
numeric 2=Cardiology
when exception generated.
Location
3=Cardiac CCU
Define “Other” in
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Clinical Lab Area
Associated with
Test(s)

CLArea

Alphanumeric

4=Dermatology
5=Endocrinology
6=ENT (Otolaryngology)
7=Emergency/Trauma
8=Family Medicine
9=Gastroenterology
10=Geriatrics
11=Gynecology
12=Hematology
13=Infectious Disease
14=Medicine (Gen)
15=Medicine (Other)
16=MedICU
17=Nephrology
18=Neurology
19=NeuroICU
20=Nursery
21=NurseryICU
22=Obstetrics (L&D)
23=Oncology
24=Ophthalmology
25=Orthopedics
26=Pediatrics
27=PedsICU
28=Pulmonology
29=Rheumatology
30=Surgery (Gen)
31=Surgery (Other)
32=SurgICU
33=Telemedicine
34=Transplant
35=Urology
36=Other
1=AP/CP
2=Blood Bank
3=Chemistry
4=Coagulation
5=Genetics
6=Hematology
7=Immunology
8=LIS/IT
9=Microbiology
10=Molecular
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“Comments.”

The primary clinical
laboratory area related to
the exception case. Define
“Other” in “Comments.”

Test Name(s)

TestName

Alpha

11=POCT
12=Receiving
13=Send out/Referral
14=Toxicology
15=Other
Free Text

Test CPT Code(s)

TestCPT

Numeric

80000-89999

Case Exception
Trigger Criterion

Trigger

Alphanumeric

Case Test Cycle
Phase

TestPhase

Alphanumeric

Case Treatment
Phase

TxPhase

Alphanumeric

Sequence of
Hand-offs/Logic
Steps Among

Handoffs

Numeric

1=Duplicate Order
2=Medically
Unnecessary Order
3=Medical Necessity
Evaluation
4=Sample Improper
Collection (clotted,
leaking, tube type, QNS)
5=Sample Hemolyzed /
Lipemic
6=Test Cost >$200
7=Order
Deferred/Clarification
8=Cost/Insurance Issues
9=Other
1=Test Select/Order
2=ID/Collect/Transport
3=Analysis/Assay
4=Result Reporting
5=Interpretation/
Recommendation
6=Other
1=Screening
2=Diagnosis
3=Monitoring
4=Prognosis
5=Other
1=DCLS (DCLS)
2=MLP (SO/Specialist
MLP)
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The specific test(s) that
generated the exception
case.
The Current Procedural
Terminology (CPT) code
that correlates to the
specific test(s) generating
the exception case.
The criterion rule violation
generating the exception
case. Define “Other” in
“Comments.”

The test cycle phase
associated with the
exception. Define “Other”
in “Comments.”

Exception case treatment
phase. Define “Other” in
“Comments .”

List IPT member number in
sequence in order of handoffs/Logic Steps (delimited

Interprofessional
Team in Case
Review

Total Number of
Hand-offs / Logic
Steps

#Handoffs

Alphanumeric

Case Resolution

ResolveTyp

Alphanumeric

Date Resolution
Report Sent
Resolution
Report Authority

NoticeDate
(Date Picker)
NoticeAuth

Numeric

Resolution
Report Format

RptForm

Alphanumeric

Alphanumeric

3=GC (Genetic
Counselor)
4=MIC (Clin Micro)
5=RES (Clin Path
Resident)
6=PATH (Pathologist)
7=ADM (CL Admin)
8=PharmD (Clin Pharm)
9=ML (Med Librarian)
10=EPI (Epidemiologist)
11-=Nurse (RN)
12=Mid-level (APN/PA)
13=Other (Other)
1=I handoff/logic step
2=2 handoffs/logic steps
3=3 handoffs/logic steps
4=4 handoffs/logic steps
5=5 handoff/logic steps
6->5 handoffs/logic steps

by commas). Define
“Other” in “Comments.”
≥

1=Testing Performed
2=Testing
Denied/Canceled
3=Testing Substituted
4=Additional Tests
Ordered
5=Testing Deferred
6=New Algorithm
Proposed
7=Other
MM/DD/YY

Type of resolution action
resulting from case review
completion. Define “Other”
in “Comments.”

1=CL Protocol
2=CL Med Director
3=DCLS
4=Other
1=Phone Call
2=Email
3=Secure Message
4=EHR Note
5=EHR Consultation
Report
6=Other
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The total number of handoffs / logic steps involved in
case resolution. Define
“Other” in “Comments.”

Date provider notified of
case resolution
Authority to release notice.
Define “Other” in
“Comments.”
Consultation reporting
mechanism. Define “Other”
in “Comments.”

Provider Type(s)
Notified

ProvTypNotif Alphanumeric

Date of Provider
Response

RespDate
(Date Picker)

Numeric

Provider Followup Action

ProvAct

Alphanumeric

Length of Stay /
Admission to
date of
consultation
request

LOStoCon

Alphanumeric

Days to
Consultation
Case Resolution

ResolveDays

Alphanumeric

Mortality During
Case
Consultation
Cost (Charges)
Change (Delta)

Mortal

Alphanumeric

Cost

Currency

0=None
1=Attending Physician
(AP)
2=Resident (Res)
3=Mid-level (APN/PA)
4=CL Med Director (CL)
5=Nurse (RN)
6=Other
MM/DD/YY

1=Order Cancelled, Prov
2=Test Reordered, Prov
3=No response
4=Other
1=1 Day
2=2 days
3=3 days
4=4-5 days
5=6-10 days
6=11-15 days
7=16-20 days
8=≥21 days
9=Outpatient (OP)
10=Other
1=1 day
2=2 days
3=3 days
4=4-5 days
5=6-10 days
6=11-15 days
7=16-20 days
8=≥21 days
9=Outpatient (OP)
10=Other
1=Yes
2=No
$*****.**
+/-
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Roles / positions notified of
resolution. (List numbers
corresponding to all
notified.) Define “Other” in
“Comments.”

Date provider
acknowledged case
resolution notice. Enter
1/ 1/ 1 if “No Response.”
Provider response to
resolution notice. Define
“Other” in “Comments .”
LOS from time of admission
to time of consultation.
Define “Other” in
“Comments.” ≥

Days from case review
request to case resolution.
Define “Other” in
“Comments.”

Patient death during
consultation period
The resulting costs or
savings related to case
resolution (from reference
lab charges and charge

Comment(s)

AddInfo

Alpha

Free Text
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masters).
Explanation of “Other”
and/or additional
information
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DCM© DATA COLLECTION TOOL (Column Headers Only), v. 8.5.20

Case ID

Date (right click
for Date Picker)

Ordering
Service /
Location

Case
Treatment
Phase

Resolution
Report
Format

Medical
Record
Number

Test Name(s)

Clinical Lab
Area

IP Team
Handoffs
Sequence

Total Handoffs
/ Logic Steps

Provider
Type(s)
Notified (List
Corresponding
Numbers)

Mortality
During Case Cost Savings
Consultation
(+/-)

Patient
Age

Date of
Provider
Response
(Date
Picker)

Patient
Gender

Primary
Patient
Diagnosis

Primary
Diagnosis
Code
(ICD- 10)

Test CPT
Code(s)

Case Trigger
Criterion

Case Test
Cycle Phase

Case
Resolution

Date
Resolution
Report Sent to
Provider
(Date Picker)

Resolution
Report
Authority

Provider
Follow-up
Action

LOS to Case
Consultation

Days to Case
Resolution

Comment(s)
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Ordering
Provider
Type

Vita
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